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Obesity is tightly linked with the development of insulin resistance and associated metabolic 
diseases, including type 2 diabetes. Many of the health complications in obesity can be attributed 
to abnormalities associated with the excessive storage of fat within subcutaneous adipose tissue 
(SAT), such as hypertrophic adipocytes, tissue hypoxia, fibrosis, and inflammation. Therefore, 
given the continued alarming increase in the prevalence of obesity, identifying strategies to 
modify SAT structure and metabolic function in ways to more “healthfully” store body fat has 
very high clinical impact. Exercise is a powerful tool to reduce cardio-metabolic disease risk, but 
the effects of exercise on SAT are poorly understood. The overall purpose of this dissertation 
was to assess the effects of exercise on factors regulating SAT structural remodeling, metabolic 
function, and inflammation.  In Project 1, RNA sequencing was performed on abdominal SAT 
samples collected from obese adults before and 1 hour after a session of exercise at either high-
intensity (10x1min ~90% HRpeak; n=14) or moderate-intensity (45min ~70% HRpeak; n=15). 
Interestingly, gene set responses were not different between the high- and moderate-intensity 
exercise protocols, and gene sets involved in inflammation were up-regulated after exercise (IL6-
JAK-STAT3 signaling, allograft rejection, TNFA signaling via NFKB, and inflammatory 
response; FDR q-value < 0.25), while gene sets related to adipogenesis and oxidative metabolism 
were down-regulated. These findings from Project 1 indicate that rapid responses to acute 
exercise at both moderate- and high-intensity feature coordinated changes in inflammatory 
signaling genes. In Project 2, we collected abdominal SAT from a separate cohort of obese adults 
(BMI 33±3kg/m2, body fat 41±7%) the morning after a 1-hour session of moderate/vigorous 
intensity endurance-type exercise (80±3% HRpeak) versus sedentary control to establish whether 
these signals alter stromal vascular cell (SVC) proportions 12 hours after exercise. Exercise 
decreased preadipocyte number (38±7% vs. 30±13% SVC; P=0.04), which was driven 
exclusively by a reduction in CD34hi preadipocytes (18±5% vs. 13±6% SVC; P=0.002), a subset 
of preadipocytes that yield highly lipolytic fat cells. There was no change in the proportion of 
immune cells in SAT. Not only do these findings demonstrate exercise can rapidly remodel the 
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adipocyte progenitor pool, but these changes may also contribute to an important health benefit 
by modifying SAT metabolism. Finally, Project 3 was designed to examine the effects 
overeating on factors regulating adipose tissue remodeling in regular endurance exercisers (EX, 
n=11) compared with a cohort of non-exercisers (nonEX, n=11) who were matched for BMI 
(25±3kg/m2). After 1 week of a standardized overeating protocol (30% energy surplus/day) all 
subjects gained ~1 kg (P<0.01), and insulin sensitivity (Matsuda ISI) declined by ~15% in both 
groups (P=0.04). Gene expression of factors involved in lipid metabolism (HSL, ATGL, DGAT, 
PPARγ) and angiogenesis (HIF1A, KDR) were increased (P<0.05).  Interestingly, there was no 
difference in SAT responses between EX and nonEX.  Findings from Project 3 indicate that 
overeating can rapidly impair insulin sensitivity, and modify gene expression for factors 
regulating angiogenesis and metabolism in SAT, but regular endurance-type exercise does not 
appear to alter these early adaptive responses to overeating. Overall, the projects in this 
dissertation demonstrate exercise can rapidly trigger signals involved in SAT remodeling, 
metabolic function, and inflammatory signaling. These outcomes have important health 
implications by revealing new metabolic pathways that could impact SAT structure and function 




Chapter I. Statement of the Problem 
 
Over one third of American adults are obese (1). This alarming public health problem confers an 
increased risk of all-cause mortality (2), as well as a host of cardio-metabolic diseases including 
cardiovascular disease and type 2 diabetes (3,4). Beyond the impact of these health 
complications on quality of life of many obese adults, obesity-related disorders also place an 
enormous burden on the health care system, costing nearly $2 trillion per year in the US, 
according to recent estimates (5). Research aimed at better understanding key factors underlying 
the cardio-metabolic health complications in obesity is essential for optimizing therapies (e.g., 
exercise, nutritional, pharmacological) for the prevention and treatment of obesity-related 
diseases. 
Excessive adipose tissue mass is a hallmark of obesity, and increasing evidence 
implicates associated factors such as high rates of fatty acid release from adipose tissue, adipose 
tissue hypoxia, and macrophage/immune cell infiltration within expanded adipose tissue depots 
as central to the development of many metabolic abnormalities (6–8). During periods of weight 
gain, adipose tissue expands primarily via adipocyte (i.e., fat cell) hypertrophy; but adipocytes 
can also undergo hyperplasia (i.e., adipogenesis), resulting in new and smaller fat cells. The 
degree of hypertrophy vs. hyperplasia, as well as accompanying structural adaptations to the 
extracellular matrix (ECM) and adipose tissue vasculature that occur during weight gain can vary 
greatly between people (9,10). These variations in adipose tissue phenotypes (e.g., differences in 
ECM structure and composition, capillarization, adipogenic capacity) may help dictate the 
severity of weight-gain-related metabolic complications. Consistent with this notion, the 
“adipose expandability hypothesis,” posits that adipose tissue that can more readily expand 
during periods of weight-gain can more effectively store excess energy as neutral lipid (i.e., 
triacylglycerol). This is thought to reduce ectopic lipid deposition and adipose tissue 
inflammation, thereby protecting against the metabolic dysfunction that typically accompanies 
weight gain and obesity (11–13). Therefore, strategies aimed at modifying adipose tissue 
extracellular matrix, angiogenic capacity (formation of new blood vessels), adipogenic capacity 
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(formation of new fat cells), and immune cell infiltration could greatly improve metabolic health 
in obesity. 
Regular exercise is known to improve metabolic health, and is often prescribed as part of 
the first-line approach for treating obesity-related diseases, such as type 2 diabetes. However, the 
mechanisms responsible for the metabolic health benefits of exercise are incompletely 
understood. The vast majority of research in this area has focused on exercise-induced 
adaptations within skeletal muscle, while adaptations within adipose tissue in response to 
exercise are not yet well characterized. Certainly, adipose tissue plays a key role in exercise. 
Adipose tissue lipolytic rate and blood flow rapidly increase during each exercise session to 
supply fatty acids to meet the energy demand of contracting muscle (14). In turn, these processes 
are known to trigger important adaptive responses, such as the upregulation of angiogenesis and 
adipogenesis (15–17). However, there is a paucity of data on the potential for exercise to alter 
adipose tissue vascularity, adipocyte hyperplasia, ECM composition/structure, and adipose tissue 
triglyceride storage capacity. Because long-term adaptations to exercise training are often a 
consequence of an accumulation of acute responses that occur during or soon after each session 
of exercise, there is a need to characterize the signaling events that could lead to modifications to 
adipose tissue structure and function in response to acute exercise. Moreover, because the 
intensity of exercise can have profound influence on the magnitude of metabolic adaptations 
(18), examining the acute effects of exercise intensity on markers of cellular signaling events in 
adipose tissue is essential at this stage in understanding adipose tissue adaptations to exercise. 
Such experiments will greatly enhance our understanding of the potential cumulative effects of 
exercise-related signals on adaptive metabolic and morphologic responses in adipose tissue, as 
well as provide valuable information for optimizing exercise prescriptions. The Specific Aims 
for project 1 of my dissertation were (1) to determine the effects of acute moderate-intensity 
steady state exercise on the adipose tissue transcriptome in adipose tissue; and (2) to compare 
the adipose tissue transcriptional response to a single session of moderate-intensity exercise 
versus high-intensity interval exercise. 
Adipose tissue is a complex of many cell types (e.g., adipocytes, immune cells, 
endothelial cells, adipocyte precursor cells,) each of which can communicate and contribute to 
the metabolic “health” and function of adipose tissue. Therefore, to truly understand how 
exercise affects adipose tissue function, it is essential to understand how exercise affects the 
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individual cell populations in human adipose tissue. Some recent evidence suggests that exercise 
may induce anti-inflammatory effects on adipose tissue (19,20). However, the regulation of 
individual adipose tissue immune cell populations by exercise is largely unexplored, especially 
in humans. There is also evidence that acute exercise increases the expression of factors related 
to angiogenesis and adipogenesis in adipose tissue. Yet, there is no work directly assessing 
endothelial cell or adipocyte precursor cell responses to exercise. The Specific Aim for project 2 
of my dissertation was to determine the effects of acute moderate-intensity endurance exercise 
on macrophage, endothelial cell, and preadipocyte number in human subcutaneous adipose 
tissue from obese adults. These potential exercise-induced modifications in adipose tissue 
constituents can directly impact metabolism, but may also remodel adipose tissue structure to 
increase its capacity for expansion. These changes could therefore represent key mechanisms to 
help accommodate storage of extra energy (triglycerides) during periods of overeating. 
It is important to emphasize that an enhanced capacity for adipose tissue expansion does 
not lead to a greater body fat mass, because gaining body weight and body fat can only be 
achieved by a positive energy balance (i.e., when energy intake exceeds energy expenditure). 
Based on recent work from our lab (6), an important underlying premise of my dissertation 
studies is that when matched for total body fat mass, individuals with an enhanced capacity for 
their adipose tissue to effectively store excess energy may actually be somewhat protected 
against the negative health effects of overeating and weight gain. With this in mind, the benefits 
of having (or acquiring) an enhanced capacity to expand adipose tissue may not be clinically 
relevant until a person experiences meaningful weight gain; which unfortunately is the norm for 
the vast majority of adults living in developed countries. Along these lines, the prospect that 
some of the metabolic health benefits of exercise may be due to adipose tissue responses that 
foster effective fat storage and therefore reduced inflammation during periods of energy surplus 
is very intriguing and opens the door to the development of new “adipo-centric” strategies to 
improve metabolic health. The Specific Aims for project 3 of my dissertation were (1) to 
determine the effects of one week of overeating (30% increase in energy intake above that 
estimated to maintain body weight) on factors involved in regulating adipose tissue metabolism 
(i.e. lipolytic rate); storage capcity (i.e. adipogenesis, angiogenesis, and ECM remodeling; 
inflammation) in human subcutaneous adipose tissue; and (2) to determine the effects of exercise 
on overeating-induced changes in factors involved in regulating adipose tissue metabolism (i.e. 
	4	
lipolytic rate); storage capacity (i.e. adipogenesis, angiogenesis, and ECM remodeling; 
inflammation) in human subcutaneous adipose tissue. 
In summary, these projects address the following specific aims: 
PROJECT 1: 
Specific Aim 1: Determine the effects of acute moderate-intensity steady state exercise on the 
adipose tissue transcriptome in adipose tissue. 
Specific Aim 2 Compare the adipose tissue transcriptional response to a single session of 
moderate-intensity exercise versus high-intensity interval exercise. 
 
PROJECT 2: 
Specific Aim: Determine the effects of acute moderate-intensity endurance exercise on 
macrophage, endothelial cell, and preadipocyte number in human subcutaneous adipose tissue. 
 
PROJECT 3: 
Specific Aim 1:  Determine the effects of one week of overeating (30% increase in energy intake 
above that estimated to maintain body weight) on factors involved in regulating adipose tissue 
metabolism (i.e. lipolytic rate); storage capcity (i.e. adipogenesis, angiogenesis, and ECM 
remodeling; inflammation) in human subcutaneous adipose tissue. 
Specific Aim 2: Determine the effects of exercise on overeating-induced changes in factors 
involved in regulating adipose tissue metabolism (i.e. lipolytic rate); storage capcity (i.e. 
adipogenesis, angiogenesis, and ECM remodeling; inflammation) in human subcutaneous 
adipose tissue. 
 
These proposed dissertation projects were designed to test the overall hypothesis that exercise 
induces signals for adipose tissue remodeling that may prime adipose tissue to be a more 
effective storage site when exposed to episodes of energy surplus (i.e., overeating), thereby 
reducing inflammatory pathway activation, pro-inflammatory cytokine release, and weight-gain 
related insulin resistance.  The proposed experiments will generate novel information on 
mechanisms underlying adipose tissue dysfunction in humans that will contribute to lifestyle and 
pharmacological interventions aimed to reduce tissue-specific and systemic inflammation and 
insulin resistance in humans. 
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Chapter II. Review of Literature 
 
Introduction 
Obesity is an epidemic associated with increased mortality, disease risk, reduced quality 
of life, and stigmatization, and it afflicts over one third of adults in America (1–4). Obesity 
confers a high risk of cardio-metabolic diseases, especially insulin resistance and Type 2 
Diabetes (3,21). Together, this places an enormous burden on the health care system currently 
worth ~$2 trillion USD per year (5). The Surgeon General’s Report has identified overweight 
and obesity as one of the most pressing national health problems and there is a profound need for 
interventions that can prevent and treat the metabolic complications associated with excessive 
weight gain (22,23). 
Adipose tissue is the primary storage site for the excess energy when energy consumption 
exceeds energy expenditure (24). While “healthy” adipose tissue is exquisitely effective at 
storing and releasing fatty acids according to metabolic need, excessive expansion of this depot 
can result in structural changes and dysfunction (25). There is strong evidence that adipose tissue 
dysfunction and the consequent ectopic lipid deposition (i.e. excessive lipid storage in other 
tissues such as liver and skeletal muscle) are central to the development of obesity-related insulin 
resistance (26). Even among obese adults, there is a range of insulin sensitivity, and up to one 
third of obese adults have been found to remain insulin sensitive (27). Understanding the factors 
within the adipose tissue that could preserve metabolic health during the periods of weight gain 
that seem inevitable in the Western world could provide a major breakthrough towards 
developing therapies that can reduce the public health burden of obesity. 
Cross-sectional data identify some important structural features of adipose tissue from 
obese adults that may impact normal function, which may in turn underlie the corresponding 
ectopic lipid deposition and metabolic abnormalities. Chief among these structural features that 
can impact adipose tissue function are: insufficient vascularization/hypoxia (7,28), fibrotic 
extracellular matrix (ECM) (6,29), and excessive pro-inflammatory immune cell infiltration 
	6	
(30,31). Structural changes within adipose tissue have been coined adipose tissue “remodeling”, 
and collectively these changes can influence the ability of adipose tissue to effectively sequester 
fat as neutral lipid, thereby minimizing its deleterious effects on insulin sensitivity and cardio-
metabolic health (32). While the mechanisms conferring “healthier expansion” of adipose tisse 
are not well understood, the common phenotype among obese adults who remain insulin 
sensitive appears to be more effective storage within the adipose tissue (6,33,34). Given the 
complexity of adipose tissue remodeling in obesogenic expansion, no pharmacological treatment 
to effectively mitigate the adipose tissue dysfunction that often accompanies obesity exists as of 
yet. 
Regular exercise improves whole body insulin sensitivity and metabolic health (35,36), 
but the underlying mechanisms are incompletely understood. In particular, the acute and chronic 
effects of exercise on adipose tissue structure and function are grossly understudied, especially in 
humans. Since the discovery of the protein irisin, which has been suggested to be released during 
exercise to trigger white adipose tissue “browning” (37), there has been considerable attention on 
the potential for exercise to increase thermogenesis and mitochondrial uncoupling within adipose 
tissue (38–41). While the possibility that exercise might modify adipose tissue thermogenesis is 
intriguing, the role of exercise-induced irisin on adipose tissue remodeling in humans is heavily 
debated. In addition to any potential effects of exercise on adipose tissue thermogenesis, exercise 
may also modify adipose structure and function in ways to allow it to store fat more effectively 
(thereby reducing ectopic lipid deposition). For example, some evidence suggests exercise 
training can increase adipose tissue capillarization and decrease inflammation (42–44); but no 
work to our knowledge has comprehensively assessed the exercise stimulus or signals that might 
achieve meaningful changes in adipose tissue structure. Certainly, there is unexplored potential 
for the signaling changes induced by each session of exercise to alter adipose tissue structure and 
function in the hours and days after exercise to make it a more effective storage depot during 
periods of nutrient excess. 
This review will provide background on the importance of effective fat storage in 
subcutaneous adipose tissue, and the regulation of fatty acid storage and release. It will then 
outline the regulation of adipose tissue expansion in response to energy surplus/overeating (e.g. 
adipocyte hypertrophy and hyperplasia), along with the structural changes that accompany 
adipose tissue remodeling (e.g. angiogenesis, ECM remodeling, and immune cell infiltration). 
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Throughout, I will propose pathways through which we hypothesize that regular exercise might 
increase adipose tissue expandability and storage capacity to reduce ectopic lipid deposition and 
the ensuing insulin resistance. 
 
Fatty Acid Metabolism in Adipose Tissue 
Effective fat storage in subcutaneous adipose tissue is important for insulin sensitivity 
 The importance of adipose tissue in preserving whole body insulin sensitivity is canonically 
illustrated by studies of lipodystrophy. Lipodystrophy is a group of genetic diseases 
characterized by impaired fat storage/adipose tissue mass and often associated with diabetes 
(45). Work showing that the transplantation of adipose tissue explants into lipodystrophic rats 
reduces ectopic lipid deposition and improves glycemic control led to a frameshift in thinking, 
revealing the importance of adipose tissue for metabolic health (46). Santomauro et al. (47) 
supported the importance of fatty acid storage in humans by showing that the administration of 
acipimox (an anti-lipolytic drug that lowered plasma fatty acids 60-70%) improved insulin 
sensitivity with a hyperinsulinemic euglycemic clamp and oral glucose tolerance test. 
Our group has recently reported that fatty acid mobilization from adipose tissue dictates 
the degree of insulin resistance among obese adults (33). Strikingly, among obese adults matched 
for adiposity, those with relatively low rates of basal fatty acid mobilization from adipose tissue 
(i.e. in vivo rate of release of fatty acids from adipose tissue into the systemic circulation) were 
largely protected from developing insulin resistance (6,33). However, the factors (genetic or 
environmental) conferring more or less effective fatty acid storage in the adipose tissue are not 
clear. Given that the subcutaneous adipose tissue is responsible for ~80-90% of systemic fatty 
acid release (48), discussion of therapies to improve fatty acid storage in this review will focus 
on the subcutaneous adipose tissue. Identifying mechanisms for improving fatty acid storage in 
adipose tissue requires an understanding of the regulation of lipolysis and esterification; as well 
as a strong grasp of the processes involved in adipose tissue expansion, and how these can be 
modified to maximize adipose tissue storage capacity. The remainder of this section will outline 
the regulation of fatty acid metabolism in adipose tissue focusing on the adipocyte. 
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Regulation of esterification in adipose tissue 
Adipose tissue is heterogeneous, containing adipocytes, preadipocytes, endothelial cells, ECM 
components, and immune cells among other stromal cells (49).  Adipocytes are the biggest 
constituent of adipose tissue by volume, and are the site for most of the body’s energy stores 
(50). Nearly all of the energy stored in adipocytes is delivered to adipose tissue in the form of 
TGs in VLDL and chylomicrons, as well as a small amount of albumin-bound fatty acids (51). 
Fatty acid uptake into adipose tissue relies on the enzyme lipoprotein lipase (LPL), which is 
synthesized by adipocytes and acts at the capillary lumen (endothelial cells) to bind circulating 
triglycerides and hydrolyze their fatty acids for subsequent diffusion or active transport (via fatty 
acid transport proteins) into adipocytes (52,53). Similarly, albumin-bound fatty acids are directly 
taken up at the adipocyte plasma membrane by diffusion or via fatty acid transport proteins. 
Within the adipocyte, fatty acids are esterified with glycerol-3-phosphate (G3P) into triglyceride 
for storage in the lipid droplet. G3P is predominantly derived from glyceroneogenesis by 
phosphoenolpyruvate carboxykinase (PEPCK) decarboxylation of oxaloacetate to form 
phosphoenolpyruvate; for which PDK4 inhibition of the PDH complex is a key regulator of 
pyruvate availability (54). Fatty acids are then acylated (energy-dependent) by key enzymes 
DGAT and GPAT for re-esterification with G3P (55). Insulin is  a key regulator of re-
esterification, and the increase in insulin following a meal increases both LPL activation and re-
esterification enzymes (51). Fat storage within the adipocyte is also regulated by lipid droplet 
proteins (in particular the PLIN family of proteins), whose regulation is not well understood but 
will be briefly discussed in the section “Regulation of adipose tissue lipolysis,” below.  
Altogether, these factors regulating fatty acid re-esterification within adipose tissue are key 
contributors to the rate of fatty acid mobilization. Importantly, healthy or excessive fatty acid 
mobilization by adipose tissue depends on the balance of rates of re-esterification and lipolysis.  
 
Regulation of adipose tissue lipolysis 
Adipose tissue lipolysis involves the sequential hydrolysis of fatty acids from glycerol by 
lipolytic enzymes adipose triglyceride lipase (ATGL), hormone-sensitivite lipase (HSL), and 
monoglyceride lipase (MGL) (56). This occurs within the lipid droplet in the adipocyte, which is 
coated with surface proteins of the PLIN family (57). Phosphorylation of PLIN1 has been shown 
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to be essential for maximal adipose tissue lipolysis by facilitating access of lipases to the lipid 
droplet (58).  While HSL can also release the first FA from triglycerides, ATGL is now known to 
be essential for this stage of adipose tissue lipolysis (59). There is some activation of ATGL by 
phosphorylation (by protein kinase-A; PKA), but the majority of increased ATGL activity is 
related to PKA phosphorylation of CGI-58, signaling its localization to ATGL and thereby 
increasing ATGL activity (60). There are other fat interacting proteins important for the 
regulation of lipolysis, which are reviewed by Tsiloulis et al. (61). HSL is rate-limiting in 
lipolysis, and its Serine phosphorylation by PKA increases its localization to the lipid droplet as 
well as its activity (there is also inhibitory regulation on HSL by different phosphorylation 
site(s)) (62). Evidently, the control of lipolysis requires coordination of these processes as well as 
other players beyond the scope of this review. 
Lipolysis, like re-esterification, is regulated primarily at the hormonal level by insulin 
(inhibitory), and catecholamines (stimulatory); though our knowledge of other hormonal 
regulators is growing. Resting lipolytic rate is maintained mostly by α-adrenergic-inhibition (63). 
With increasing energy demand (e.g. exercise), there is a rapid increase in catecholamines that 
increase β-adrenergic stimulation, and decrease α-adrenergic-inhibition of lipolysis (63). 
Catecholamine binding to β-adrenergic receptors increases lipolysis by G-protein-coupled 
increase in PKA (64), which phosphorylates lipolytic rate-limiting enzyme HSL (65), as well as 
PLIN proteins, CGI-58, and ATGL (66). Adipose tissue is very sensitive to small increases in 
epinephrine, and the largest increase in lipolysis occurs with the onset of low-intensity exercise. 
Insulin inhibits lipolysis by stimulating PDE-3B, which lowers cAMP and thereby PKA activity 
(67). Insulin therefore regulates both re-esterification and lipolysis, as the reduction in insulin 
during exercise facilitates the increase in lipolysis and this reciprocal control of supply versus 
storage is a suitable system. There are a variety of other hormonal regulators of lipolysis, 
including cortisol (increases lipolysis), and ANP (increases lipolysis) (61). Adipose tissue 
vasculature is also important in the regulation of fatty acid uptake and release, as fatty acids and 
triglycerides are hydrophobic, so transport is a key process controlled by the capillaries (14). The 
increase in adipose tissue blood flow during exercise is required for the increase in lipolysis (68). 
Adipose tissue blood flow decreases immediately after exercise, but increases above baseline by 
~30 minutes post-exercise (14). An endurance exercise training effect on adipose tissue 
sensitivity to adrenergic stimulation and/or major lipolytic proteins remains equivocal (61). 
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The section above outlines the regulation of fatty acid uptake and release in response to 
normal fluctuations in food intake and energy demand within an individual. Importantly, a higher 
basal lipolytic rate is seen in obese versus lean persons (69,70). However; within obese adults 
matched for BMI and fat mass, there is a range of basal lipolytic rates, and higher lipolytic rate 
correlates with worse insulin sensitivity (6,33). This suggests that there are different responses to 
weight gain that could exacerbate or attenuate the phenotype of excessive fatty acid mobilization 
among obese individuals. Importantly, this reduction in fatty acid mobilization might reduce 
ectopic lipid deposition and protect against obesity-related insulin resistance. 
	
Figure II-1 Simplified representation of major regulators of fat storage in the adipocyte. 
Triglyceride (TG) storage in the lipid droplet within the adipocyte is regulated by the balance between fatty acid 
(FA) esterification and lipolysis. Key players include (i) esterification proteins acyl-CoA:monoacylglycerol 
acyltransferase (MGAT) and acyl-CoA:diacylglycerol acyltransferase (DGAT); (ii) lipases adipose triglyceride 
lipase (ATGL), hormone-sensitive lipase (HSL), and monoglyceride lipase (MGL); (iii) fatty acid transport proteins 
(FATPs); and lipid droplet protein Perilipin. Figure redrawn from Yen et al (71). 
	11	
Adipose Tissue Remodeling 
Adipose Tissue Expandability Hypothesis 
Adipose tissue storage capacity is heavily influenced by the structural accommodation of the 
expanding fat mass. Differences in adipose tissue mass at the onset of diabetes has led to the 
hypothesis that each individual has a maximal threshold for adipose tissue expansion; depicted in 
Figure II-2 below (12). Commonly referred to as the “adipose expandability hypothesis,” there is 
support that individuals with a better capacity for healthy adipose tissue expansion may be 
protected from insulin resistance by sequestering fatty acids as neutral lipids within the adipose 
tissue and out of other important insulin-responsive tissues (liver, skeletal muscle, pancreas, etc.) 
(26). Kim et al. (72) directly increased adipose tissue expansion capacity in ob/ob mice with a 
leptin knockout/adiponectin overexpression model and found that despite greater body mass and 
fat mass, these animals had comparable glucose tolerance to wild-type animals (i.e. the genotype 
prevented the glucose intolerance that was observed in the ob/ob counterparts that represented a 
model of exhausted adipose tissue expansion). Adipose tissue expansion capacity is likely to 
depend on a variety of structural features of adipose tissue that have been linked with metabolic 
function. Hypertrophy, adipogenesis, angiogenesis, and ECM remodeling are key players in 
adipose tissue expandability (11). The sections following here will explain our current 
understanding of these processes. Each section will highlight the potential for exercise to impact 
adipose tissue health in humans. 
	
Figure II-2 Adipose tissue expandability threshold. 
Differences in adipose tissue mass at the onset of diabetes led to the hypothesis that each individual has a maximal 
threshold for adipose tissue expansion before excess free fatty acid (FFA) mobilization from adipose tissue results in 
ectopic lipid accumulation and insulin resistance. Modified from Gray & Vidal-Puig (12). 
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Adipocyte Hypertrophy 
Adipose tissue can expand by hypertrophy (enlargement of existing adipocytes), and/or 
hyperplasia (production of new adipocytes from precursor cells; adipogenesis) (73). Adipocyte 
hypertrophy is largely regulated by the balance of fatty acid lipolysis and esterification, which 
increase triglyceride content within the lipid droplet in the adipocyte in conditions of caloric 
surplus (outlined in the “Fatty Acid Metabolism in Adipose Tissue” section above). However, 
the cellular and structural surroundings of the adipocyte also impact its ability to expand. In 
particular, sufficient vasculature and “compliant” (versus fibrotic) ECM are important features to 
support healthy adipocyte hypertrophy. In other words; adipocyte hypertrophy might be limited 
by insufficient vasculature resulting in adipocyte hypoxia and insufficient nutrient exchange 
(7,74). Similarly, dense, fibrotic ECM is thought to physically limit adipocyte hypertrophy 
(75,76). Adipose tissue vascularization and extracellular matrix remodeling are also required for 
adipogenesis (77,78), and altogether the balance of adipogenesis, angiogenesis, and ECM 
remodeling are likely to represent important targets for improving adipose tissue expandability. 
Adipogenesis 
While the majority of adipose tissue expansion occurs by hypertrophy, adipose tissue mass also 
expands by hyperplasia. Though few, direct assessments of adipogenesis in humans demonstrate 
a small contribution to the mature adipocyte population. 2H2O/deuterium incorporation into 
adipocyte DNA has been used to assess adipocyte replacement rates (from fraction of new 
adipocytes) in lean and obese, weight-stable humans (79,80). Marc Hellerstein’s group has 
contributed these seminal assessments using 2H2O/deuterium incorporation into triglyceride 
glycerol, triglyceride palmitate, and DNA to determine total triglyceride synthesis, de novo 
lipogenesis, and cell proliferation in vivo over several weeks. This technique has allowed the 
determination of adipocyte replacement rates (from fraction of new adipocytes) as 0.16-0.29% 
per year in healthy, weight-stable humans (79). Allister et al. (80) subsequently applied this 
technique in BMI-matched insulin sensitive versus insulin-resistant humans to measure 
adipocyte “proliferation” rates of 0.6% and 0.7% per day respectively. However, to truly assess 
the regulation of adipogenesis it seems logical to examine this process under conditions where 
there is a stimulus for adipose tissue expansion, as is the case during periods of overeating.  
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Unfortunately, to our knowledge no study has assessed the rate of adipogenesis during weight 
gain in humans. 
Cross-sectional comparisons of adipocyte size have been used to assess differences in 
adipogenesis (i.e., adipose tissue with more, smaller fat cells considered to have higher 
adipogenic rates) and also to infer the contribution of adipogenesis to metabolic health.  While 
the rationale for this approach is reasonable, these findings are limited. These cross-sectional 
comparisons do not capture information on the rate of adipogenesis, and therefore cannot 
ascertain whether the smaller adipocyte size really was a consequence of elevated adipogenesis. 
In other words, more smaller adipocytes could represent increased adipogenesis; but a person 
may have more smaller adipocytes for other reasons, such as structural limitations preventing 
further hypertrophy It is therefore not surprising that there is no consensus on the relationship 
between adipocyte size and metabolic health from such comparisons (9,75,81,82). However, 
studies examining the regulation of adipogenesis in mice on a high-fat diet suggest that 
adipogenic capacity is affected by the local environment. Jeffrey et al. (83) reported that high-fat 
feeding induces adipogenesis more in visceral adipose tissue in male mice, and subcutaneous 
adipose tissue in female mice; and transplantation in the male mice (of preadipocytes if visceral 
origin to subcutaneous fat pads and vice versa) has suggested that the these adipogenic rates are 
regulated by the microenvironment, not the source (because this phenotype did not persist after 
transplantation, i.e. transplanted preadipocytes differentiated according to the environment into 
which they were ). Similarly, the local inflammatory environment can regulate adipocyte 
differentiation. Macrophage-secreted factors, (such as TNF-α and IL-1β) have been shown to 
decrease differentiation of 3T3-L1 cells and primary human preadipocytes, partly through 
activation of Wnt-signaling (84–86). Many of these experiments use rodent-derived cell 
populations that are quite different from human adipocyte precursor cells; but these findings 
provide intriguing support that the environment can be manipulated to influence adipogenic 
capacity in vivo. 
The regulation of adipogenesis involves complex transcriptional regulation on several 
potential precursor populations that has not been elucidated especially in adult humans. A 
comprehensive account of our understanding of the factors involved in adipocyte differentiation 
is reviewed in detail elsewhere (87,88). In short, peroxisome proliferator-activated receptor-γ 
(PPARγ) was identified as a master regulator of adipogenesis over 20 years ago (89,90). Since 
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then, CCAAT/enhancer-binding proteins (C/EBPs; α, β, and δ) have also proven important for 
adipocyte differentiation using among other regulators. There are many circulating factors that 
can influence the adipogenic pathway, including fatty acids, insulin, cortisol, catecholamines, IL-
6, and lactate (91). Intriguingly, many of these factors are released during and/or after a session 
of exercise. In fact, preliminary data from our lab demonstrates that human adipocyte precursor 
cells differentiate faster when exposed to serum collected from subjects after a session of 
exercise compared with incubation in serum collected without prior exercise (unpublished data). 
Importantly, an increase in adipogenic capacity may only manifest into a meaningful increase in 
the production of new fat cells under conditions when adipose tissue is stimulated to expand (i.e. 
during episodes of overeating and weight gain). Therefore, assessing the effects of regular 
exercise (versus inactivity) on markers of adipogenesis during periods of overeating may be 
important for determining whether exercise can enhance adipose expandability through 
increasing adipogenesis (thereby relieving hypertrophy-related fibrosis and inflammation). The 
dynamics of hypertrophy and hyperplasia in adipose tissue of course are not independent of 
structural features of the adipose tissue including vasculature and ECM, whose dynamics must 
be considered in any assessment of adipose tissue expansion. 
	
Figure II-3 Outline of key circulating factors released during exercise that have been linked to adipogenesis. 
Exposure of preadipocytes in the adipose tissue to elevated levels of these factors (e.g. catecholamines, fatty acids, 
IGF-1, corticol, IL-6) could increase adipogenic rate and increase the contribution of new, small adipocytes to 
adipose tissue expansion. PPARγ, peroxisome proliferator-activated receptor-γ; C/EBPα, CCAAT/enhancer-binding 
protein-α): key transcriptional regulators of adipogenesis. 
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Adipose Tissue Angiogenesis 
Adipose tissue is highly vascularized, allowing for effective exchange of nutrients and signaling 
molecules between adipose tissue cells and the rest of the body (92). Well-controlled perfusion is 
especially important in adipose tissue because fatty acids are water insoluble and so regulation of 
their exchange between the adipose tissue and vasculature must be facilitated (as outlined in the 
Fatty Acid Storage in Adipose Tissue section of this review). Adipose tissue also plays an 
important role in regulating metabolism by exchanging cytokines and hormones with the 
periphery (93), which also relies on an extensive vasculature. Dramatic increases in adipose 
tissue blood flow occur according to metabolic stimuli such as feeding and exercise, and 
sufficient adipose tissue vasculature is key in regulating these responses (94–96). The adipose 
tissue vasculature can expand in response to metabolic signals through the process of 
angiogenesis: the development of new vessels from existing vasculature. 
Angiogenesis is required for adipose tissue remodeling and expansion, and precedes 
adipogenesis (97); therefore, improving angiogenic capacity could improve adipose tissue 
expandability. While the adipose tissue vasculature expands with obesity (98), it has been 
suggested that adipocyte hypertrophy often exceeds the expansion of adipose tissue vasculature, 
which is thought to be a major cause of the often-observed hypoxia in obese adipose tissue (28). 
There remains some debate over whether increasing adipose tissue angiogenesis improves 
adipose tissue health; but recent genetic rodent models suggest it can attenuate high-fat diet-
related metabolic dysfunction (99,100). In particular, multiple groups found that overexpressing 
vascular endothelial growth factor (VEGFα; considered the master regulator of angiogenesis) 
attenuates glucose intolerance, crown-like structures (a marker of immune cell infiltration), and 
markers of hypoxia during the early stages of weight gain, while adipose-specific ablation or 
inhibition (by Mcr84 antibody administration to decrease VEGF-receptor binding) of VEGF 
exacerbates these pathologies (99,100). Interestingly, adipose VEGF inhibition by Mcr84 in 
“established” obesity (9-week-old ob/ob mice) improved their metabolic phenotype, suggesting 
the role of angiogenesis could be different during “early” weight gain compared with animals 
who are already obese. Steps to ascertain whether pro-angiogenic therapies might have a place in 
treatments of human obesity-related diseases will require a direct assessment of angiogenic 
capacity in humans during weight gain along and establishing targeted approaches to manipulate 
it. 
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Valuable insights into the molecular regulation of angiogenesis have come from settings 
like tumor growth and exercise training in skeletal muscle (17,101,102). However, our 
understanding of adipose tissue angiogenesis is more limited, and whether the same molecular 
regulation occurs with obesogenic adipose tissue expansion is not known. The process of 
angiogenesis involves endothelial cell migration, proliferation, and tubulogenesis (103). It is 
initiated primarily by VEGF binding to the VEGF receptor (VEGF-R; with VEGF-R2 being 
most implicated in existing literature. The detailed regulation of adipose tissue angiogenesis is 
outside the scope of this review; Corvera et al. (104) review the regulation of adipose tissue 
angiogenesis in the context of obesity. In short, existing vasculature is maintained by basal 
inhibition of VEGF, which is overcome by pro-angiogenic stimuli (105). Hypoxia is a classic 
pro-angiogenic signal, but genetic manipulation of hypoxia-inducible factor-1 (HIF1, a key 
transcriptional regulator in the hypoxia response) suggest factors other than hypoxia are 
important regulators of angiogenesis during diet-induced adipose tissue expansion (106). As of 
now, the primary molecular signal(s) responsible for inducing VEGF expression during adipose 
tissue expansion remain unclear but inflammatory pathway activation is also known to activate 
VEGF (107). In fact, sustained inflammation is known to be a trigger for VEGF in several 
tissues, with NF-kB being a major promoter for this process by binding to a response element in 
VEGF (108). VEGF can also be secreted by macrophages, providing more potential for immune 
regulation of angiogenesis during adipose tissue expansion (109,110). In this context, 
chemokines may be important mediators of angiogenesis by altering macrophage secretion of 
VEGF with obesity (104) . Signals associated with energy stress and exercise (AMPK, PGC1α, 
and PPARγ) can also trigger angiogenesis; underscoring the complex regulation of this process 
(104). 
There is very little work assessing the effects of exercise on adipose tissue angiogenesis. 
Walton et al. (42) found that exercise training increased capillarization in the adipose tissue of 
healthy, but not insulin-resistant subjects. However; there are no studies to our knowledge that 
have explored the ability of different exercise stimuli (e.g. varying intensity) to result in adipose 
tissue angiogenesis. Furthermore, there is no work assessing exercise-induced adipose tissue  
angiogenesis during a stimulus for weight gain/adipose tissue expansion in healthy (not yet 
insulin resistant) subjects. There is evidence that exercise activates AMPK, PGC1α, and PPARγ 
within adipose tissue; signals that have been described to upregulate VEGF in other tissues 
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(111). Our group has found that a single session of aerobic exercise increases adipose tissue 
VEGF expression in healthy, weight-stable humans (112) and in rats on a 2-week HFD (113). 
Consistent with the notion that angiogenesis could be an effective therapy to attenuate metabolic 
dysfunction during the early stages of weight gain; it is worth pursuing whether exercising 
during the periods of weight gain that precede insulin resistance could effectively reduce hypoxia 
and enhance adipose expandability by increasing adipose tissue vascularization. It will be 
important to assess this in a physiological setting given evidence that stromal cells (i.e. ECM, 
preadipocytes, and immune cells) are key sources of angiogenic signals, and that ECM 
remodeling (described in the next section) is essential to accommodate capillarization within 
adipose tissue (114). 
	
Figure II-4 Potential links between exercise and adipose tissue angiogenesis. 
The increase in adipose tissue blood flow, catecholamines, and lipolysis in response to exercise could implicate 
several regulators of VEGF (e.g. PPARy, and AMPK; these effects could be dependent or independent on the 
exercise-related increase in fatty acids (FA)). The specific cell types responsible for the upregulation of adipose 
tissue VEGF in response to exercise, and the potential to increase adipose tissue endothelial cell proliferation or 
capillarization have not yet been assessed. PGC1α, peroxisome proliferator-activated receptor gamma coactivator 1-
alpha; PPARγ, peroxisome proliferator-activated receptor-γ; VEGF, vascular endothelial growth factor. 
 
Adipose Tissue ECM Remodeling 
Adipose tissue ECM provides a structural support for the adipose tissue as well as an important 
signaling role for adipocyte growth, differentiation, and continuing response to environmental 
changes (115). The major component of adipose ECM is collagen, though it is a complex 
network of a variety of proteins (e.g. osteopontin, hyaluronan, elastin) outside the scope of this 
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review; for a more detailed review, see Lin et al. (115). ECM forms a basement membrane of 
collagen IV, collagen VIII, heparin sulfate proteoglycans and laminins (116–119). The largest 
component of the pericellular ECM is collagen VI, which directly cross-links adipocytes to the 
basement membrane (76,120). The pericellular ECM is heterogeneous, containing also 
meaningful amounts of Collagens I, III, IV, VI, and VIII, among other proteins (121). The ECM 
communicates with the constantly changing environment within the adipose tissue via 
transmembrane receptors including integrins (with CD11b and CD11c receptors among the most 
abundant), CD44, and CD36, equipping them to regulate key aspects of inflammation and fatty 
acid metabolism – reviewed in (115,122). Therefore, ECM composition could play a unifying 
role in adipose tissue expandability and the signals in response to weight gain. 
The observation of excess extracellular matrix deposition (fibrosis) is one of the most 
consistent findings in high fat diet studies and human obesity (29,123). Genetic ablation of 
Collagen VI in mice has revealed superior adipose tissue expansion (larger fat cells and fat pad 
size) in conjunction with improved glucose tolerance and decreased fibrosis on a high fat diet 
(76). These data support a causal role for ECM deposition in the insulin resistance that is 
commonly correlated with fibrosis in obese humans. It also provides direct support that the ECM 
might limit adipose tissue expansion in obesity, and that removing this limit could improve 
metabolic health. Based on these and other genetic studies in rodents, Lin et al. (115) propose a 
model whereby excessive ECM might physically limit adipocyte hypertrophy, leading to 
adipocyte death; might be part of a pathway distinct and counter to adipose tissue angiogenesis 
thereby inhibiting sufficient vascularization and nutrient exchange of obese adipose tissue; and 
might induce macrophage infiltration by signals downstream of integrin and CD44 receptors. 
Clearly, there is interplay between the structural changes involved in healthy or pathological 
adipose tissue expansion. Furthermore, depot differences (greater fibrosis in visceral versus 
subcutaneous adipose tissue) suggest there are environment-related factors that might prove 
useful for manipulating adipose tissue ECM expandability. 
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Figure II-5 ECM receptors regulate insulin resistance in adipose tissue. 
Unified model through which excessive ECM might (i) physically limit adipocyte hypertrophy, leading to adipocyte 
death; (ii) be part of a pathway distinct and counter to adipose tissue angiogenesis thereby inhibiting sufficient 
vascularization and nutrient exchange of obese adipose tissue; and (iii) induce macrophage infiltration by signals 
downstream of integrin and CD44 receptors. Figure from Lin et al. (115). 
 
Adipose tissue ECM is constantly being turned over and the balance of ECM degradation 
and deposition plays a major role in establishing “healthy” versus fibrotic adipose tissue (124). 
Key factors regulating ECM turnover include but are not limited to matrix metalloproteinases 
(MMPs; degradation); tissue inhibitors of MMPs (TIMPs; inhibit degradation); and secreted 
protein acidic and rich in cytoseine (SPARC; general organization) (32). Humans have 23 
different MMPs whose expression is transcriptionally regulated by stimuli including 
inflammatory cytokines, growth factors, hormones, cell-cell, and cell-matrix interactions 
(reviewed in (125)). The major endogenous inhibitors of MMPs in adipose tissue are TIMPs, and 
activation of the MMPs is largely regulated by TIMP binding to MMPs (126). In general, models 
with higher TIMP or lower MMP expression present protection from disease phenotypes on a 
high-fat diet (127,128), but the complete regulation and function of ECM remodeling in obesity 
and insulin resistance remains unclear and understanding the complex interplay of these 
processes could enhance our understanding of adipose tissue health and expansion. 
There are very few data on the role of exercise in adipose ECM remodeling in humans, 
but Kawanishi et al. (44) provide compelling evidence that exercise training (treadmill exercise 
5d/week) while on a 16 week high-fat diet can attenuate adipose tissue fibrosis (lower Col1a, 
Col3a, TIMP-1 mRNA) in mice compared with mice that did not exercise. The authors linked 
this to an exercise-induced reduction in TGFβ; which is among other anti-inflammatory effects 
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of exercise that can influence adipose tissue expandability (to be discussed in the Adipose Tissue 
Inflammation section of this review). However, the protective role of exercise in weight-gain-
related adipose tissue fibrosis was not corroborated by Pincu et al. (129), who measured adipose 
tissue stromal cell number and ECM gene expression in eWAT from mice that consumed a HFD 
for 8 weeks before and then throughout a 16-week treadmill training protocol. The authors found 
that the HFD and associated weight gain increased adipose stem cell number and expression of 
ECM remodeling genes MMP2, Timp1, Timp2, and Col1a1; but found no difference in this gene 
expression profile (or fibrosis by Sirius red staining) compared with animals that completed 
exercise training. Clearly, we have much to learn about the effects of exercise training on 
adipose tissue structure, especially during episodes of weight gain. Given the potential for 
exercise to alter key components of adipose tissue expandability (i.e. adipogenesis, angiogenesis, 
and ECM remodeling), it could be incredibly informative to directly assess factors regulating 
these processes in response to a controlled exercise stimulus in humans; especially during a 
period of caloric surplus, when adipose tissue is expanding to accommodate the excess energy. 
Importantly, all of these processes have been connected to adipose tissue inflammation; so 
assessing the role of the immune system in conjunction with the structural features of adipose 
tissue remodeling outlined in this section will be fundamental to successfully implementing 
adipose tissue-centric therapies for obesity-related diseases.		
	
Figure II-6 Proposed model linking exercise with reduced adipose tissue fibrosis.	
Work by Kawanishi et al. (44) suggested a reduction in adipose tissue macrophage TGFβ could be responsible for 
the protection from adipose tissue fibrosis in exercise-trained mice on a high-fat diet. While there are many factors 
involved in ECM remodeling that could be implicated in the anti-fibrotic effects of exercise, reduced TIMP-1 
expression represents one potential player to indirectly decrease fibrotic collagen deposition (via reduced MMP 
inhibition). 
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Adipose Tissue Inflammation 
Healthy (lean) adipose tissue has a variety of immune cells that maintain adipocyte health (i.e. 
normal sensitivity to hormonal regulators) (130). This is achieved by the generally anti-
inflammatory/“Th2” state maintained by regulatory T cells and other immune cells (131). In this 
environment, M2 macrophages predominate and maintain adipocyte sensitivity through secretion 
of cytokines like interleukin-10 (132). With weight gain and obesity, there is a dramatic shift in 
immune cell number and phenotype in adipose tissue, which impacts all of adipose tissue fatty 
acid storage, expandability, and insulin sensitivity (13). 
The relationship between obesity and systemic inflammation (133) has  identified the 
immune response as a central piece in the obesity puzzle, giving rise to the field of 
“metainflammation”; the inflammatory response to a metabolic stimulus. The systemic 
inflammation observed with obesity has been largely attributed to the adipose tissue (30), where 
the infiltration of macrophages with a pro-inflammatory phenotype was observed over a decade 
ago (132,134,135). Other immune cell populations are increasingly implicated in this phenotypic 
shift, in particular CD4+ and CD8+ T cells (131). It is now accepted that the adipose tissue 
immune response with obesity is much more complex than a pro-inflammatory macrophage 
polarization, involving a combination of pro- and anti-inflammatory changes across a host of 
immune cells, altogether resulting in insulin resistance among other changes within the adipose 
tissue (86). 
A key mechanism by which adipose tissue inflammation causes insulin resistance is 
through reducing adipocyte sensitivity to insulin; reviewed in (136). TNFα is one of the 
important pro-inflammatory cytokines elevated in adipose tissue from obese humans (30,137). 
TNFα results in serine phosphorylation of the insulin receptor substrate 1 (Irs1) in the adipocyte, 
which impairs insulin signaling (138). Given that insulin is the key hormone regulating the 
suppression of lipolysis, this local insulin resistance exacerbates the excessive adipose tissue 
lipolysis that is characteristic of “overloaded” (obese) adipose tissue. Importantly, there are many 
more pro-inflammatory signaling pathways that have been linked to insulin resistance. The 
Pattern Recognition Receptors (PRR) pathway is another key pro-inflammatory pathway through 
which pathogens (e.g. saturated fatty acids) bind to members of the PRR family, which induce 
transcription of inflammatory genes (e.g. toll-like receptor 4 (TLR4) activates nuclear factor 
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kappa-light-chain-enhancer of activated B cells (NFκB) transcription, which increases 
production of a variety of inflammatory genes) (139). The upstream signals for these immune 
changes in adipose tissue are unclear, but are thought to include a combination of systemic and 
local factors. Key candidate signals include the gut-derived antigen lipopolysaccharide (via 
TLR4 signaling); free fatty acids (via TLR4 or TLR2 signaling); dead adipocytes (via nod-like 
receptor (NLR) signaling); hypoxia; and mechanical adipocyte stress (140). Many of these 
signals have been linked to the adipose tissue expandability “threshold” as outlined in the former 
parts of this review. Given the complexity of these responses, there is a need for creative 
therapeutic approaches to improve adipose tissue expandability and to reduce adipose tissue 
inflammation during weight gain. 
There is preliminary evidence that exercise can attenuate high-fat diet-induced adipose 
tissue inflammation in mice (19,20). Oliveira et al. (20) found the stromovascular fraction from 
epididymal fat pads from rats on a high-fat diet had a more Th1-like profile (more IL-10, less 
TNFα, etc.) after two three-hour swim bouts with a 45-minute break. Using a more feasible 
exercise stimulus, MacPherson et al. (19) found reduced macrophage content (by 
immunofluorescence) in inguinal adipose tissue from high-fat fed mice two hours after a single 
two-hour treadmill exercise session. The authors linked these findings to an increase in exercise-
induced IL-6 and IL-10 expression in the adipose tissue (19). Certainly, the discovery of 
exercise-induced IL-6 secretion from skeletal muscle has yielded much excitement about the 
potential anti-inflammatory effects of exercise (e.g. reduced TNFα) (141,142). However, there 
remains limited understanding of the signals regulating the adipose tissue immune response to 
exercise. Furthermore, no work to-date has directly quantified (i.e. using flow cytometry) 
changes in immune (or other) cell populations in response to a single session of exercise in 
adipose tissue. Assessing the acute signals regulating adipose tissue cellular responses to 
exercise as well as their potential to enhance adipose tissue expandability during a stimulus for 
adipose tissue expansion (i.e. overeating) could reveal very effective targets for therapies for the 




Adipose tissue expands with weight gain by means of sequestering excess energy as triglyceride 
within the adipocyte. Eventually, the capacity for the adipose tissue to sequester fatty acids as 
neutral lipids is exceeded, characterized by excessive FA mobilization and ectopic lipid 
deposition (26,70). This ectopic lipid deposition causes systemic insulin resistance among other 
cardio-metabolic problems (26). 
The physical “limit” to healthy expansion is often called the “adipose tissue expandability 
threshold,” and this threshold is different between people. The expandability threshold depends 
on several key structural features including adipogenic capacity, angiogenic capacity, ECM 
remodeling, as well as interplay with immune cells. There is preliminary evidence that exercise 
might modify these factors, but this has not been directly assessed in human adipose tissue. 
Each exercise session triggers changes that have been identified to modify these 
processes; namely increased adipose tissue blood flow, lipolysis, and IL-6; and the resultant 
increase in fatty acids, PPARγ, AMPK, and PGC1α (proposed model outlined in Figure II-7). 
The stimulus (i.e. exercise intensity and duration) required to elicit these signals in human 
adipose tissue remains unclear. Furthermore, the ability of these signals to result in structural 
changes (cell number, or cumulative remodeling with repeated exercise sessions) is also 
unknown. Importantly, these potential signaling effects of exercise might be most meaningful 
during a stimulus for adipose tissue expansion (i.e. weight gain). Therefore, studies should be 
designed to assess the effects of exercise on key factors regulating adipose tissue expandability 




Figure II-7 Proposed model of exercise-related signals that might regulate adipose tissue expandability. 
(1) Adipogenesis: exercise-induced increases in circulating factors including catecholamines, fatty acids, IGF-1, 
cortisol, and IL-6 could increase preadipocyte differentiation by enhancing transcriptional regulation by PPARγ and 
C/EBPα. (2) Angiogenesis: exercise-induced increases in catecholamines and blood flow result in increased 
adipocyte lipolysis, fatty acids, p-AMPK, and finally PPARγ; a key signal for VEGF, the master regulator of 
angiogenesis. (3) ECM remodeling: exercise-induced reduction in macrophage TGFβ attenuates TIMP-1 release 
from fibroblasts, decreasing adipose tissue fibrosis by indirectly increasing MMP levels. (4) Inflammation: The 
exercise-induced increase in IL-6 levels in adipose tissue might be related to an altered immune environment 
(reduced TNFα, increased IL-10), and a shift towards a Th2, anti-inflammatory profile within the adipose tissue. 
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Chapter III. Project 1  
The Effects of a Single Session of Moderate-intensity and High-intensity Exercise on 
Factors Regulating Adipose Tissue Structure and Metabolic Function 
 
ABSTRACT 
Adipose tissue inflammation and dysfunction are among the primary drivers of insulin resistance 
and metabolic disease. Although very limited information is available regarding the direct effects 
of exercise on adipose tissue, some evidence suggests a session of exercise may upregulate 
factors related to adipose tissue inflammation and structural remodeling.  However, the effects of 
exercise on factors regulating inflammation and remodeling in obese adipose tissue are poorly 
understood. The primary aims of this study were to perform an unbiased analysis of the 
subcutaneous adipose tissue transcriptomic response to acute exercise in obese adults, and to 
assess the effects of different exercise stimuli on this response. We recruited 29 obese adults who 
performed either high-intensity interval exercise (HI; 10x1 min at 90 ± 2 %HRpeak with 1 min 
recovery between intervals; n = 14) or moderate-intensity continuous exercise (MI; 45 min at 71 
± 1 %HRpeak; n = 15). Groups were matched for BMI (HI 33 ± 3 vs. MI 33 ± 4 kg/m2) and there 
was no difference in their fasting blood metabolite or insulin levels at baseline. Adipose tissue 
was collected before and 1 hour after a single session of HI or MI, and samples were processed 
for RNA sequencing. We used Gene Set Enrichment Analysis (GSEA) to assess groups of genes 
that were associated with the response to exercise. Despite the vastly different exercise stimuli in 
HI vs. MI, transcriptional responses to exercise were surprisingly similar between groups (7 out 
of 21 enriched gene sets overlapping). Our major finding was that acute exercise upregulated 
gene sets involved in inflammation (IL6-JAK-STAT3 signaling, allograft rejection, TNFA 
signaling via NFKB, and inflammatory response; FDR q-value < 0.25) by GSEA. Exercise also 
downregulated adipogenic and oxidative metabolism gene sets. Overall, these data suggest genes 
involved in adipose tissue remodeling, and in particular inflammatory signaling, are an important 




In obesity, adipose tissue is often associated with chronic, low-grade inflammation, 
featuring diverse immune cell populations, polarized towards a pro-inflammatory phenotype 
(1,2). Adipose tissue inflammation has been linked to systemic insulin resistance through direct 
action on the adipocyte, where pro-inflammatory cytokines (e.g. TNFα) impair insulin signaling 
at IRS1, which exacerbates the high rates of lipolysis in obesity (3). This in turn results in 
ectopic lipid deposition in metabolically active tissues, causing systemic insulin resistance (4). 
Therefore, interventions that can modify adipose tissue structure to reduce inflammation and 
better accommodate triglyceride storage are essential to improve metabolic health in obesity. 
Participation in regular exercise is known to reduce cardiometabolic disease risk (5), but 
the impact of exercise on adipose tissue structure and function is poorly understood, especially in 
humans. While there is growing interest in the potential for exercise-induced browning of white 
adipose tissue by the release of myokines such as irisin (6), studies in humans have not found 
clear evidence for adipose tissue “browning” after exercise training (7,8). Interestingly, there is 
some evidence that exercise can alter structural components related to adipose tissue storage 
capacity, such as angiogenesis (the formation of new blood vessels), extracellular matrix, and 
inflammation (9–11). However, there has been very little work assessing the signals regulating 
these processes within adipose tissue, particularly in response to exercise in human subjects. 
There is evidence that acute exercise reduces pro-inflammatory macrophage content in 
inguinal white adipose tissue from high-fat diet-fed mice, but there is no work assessing the 
inflammatory signaling response to acute exercise in obese human adipose tissue. Overall, there 
is quite limited work assessing the acute response to exercise in human adipose tissue. The 
majority of work assessing the immune response in the hours after exercise has measured 
circulating immune cells (1–3), with no clear consensus on whether acute exercise is pro- or anti-
inflammatory (4). Despite the lack of clarity regarding the acute effects of exercise on 
inflammatory pathway activation, there is promise for longer-term adaptive responses to exercise 
that could reduce chronic inflammation (5,6). If exercise-induced adaptations to adipose tissue 
structure and vasculature could improve its ability to sequester fatty acids as neutral lipids during 
weight gain and obesity, this could be a mechanism to reduce adipose tissue inflammation and 
improve insulin sensitivity. 
	27	
Adaptations to exercise typically accrue in response to repeated exposure to transient 
exercise-induced transcriptional responses after each exercise session (12). Therefore, 
establishing the signals that occur rapidly after exercise is an important step to understand the 
mechanisms for chronic adaptations to exercise training, and whether this can be manipulated to 
induce favorable adipose tissue remodeling. Furthermore, the intensity of the exercise stimulus is 
known to influence the magnitude of the metabolic adaptations to exercise (13). For example, 
classic work has established that exercise-induced muscle mitochondrial biogenesis is most 
robust in response to high-intensity exercise (7,8). Additionally, cellular stress, blood flow, 
substrate mobilization and fuel selection during/after exercise are also greatly impacted by the 
intensity, duration, and energy expenditure of the exercise session (9–11). Therefore, the purpose 
of this study was two-fold: (1) to perform an unbiased analysis of the subcutaneous adipose 
tissue transcriptomic response to a session of exercise in obese adults, and (2) to examine the 
effects of different exercise stimuli on the transcriptional response to exercise by comparing low-
volume high-intensity interval exercise with more conventional steady-state endurance exercise. 
Expanding our understanding about the adipose tissue transcriptional response to exercise can 




Twenty-nine obese, non-diabetic, weight stable (±3kg for ≥ 6 months) men and women 
participated in this study. Subjects completed a medical history questionnaire, physical 
examination, and resting 12-lead electrocardiogram before entering the study and were excluded 
if they were taking medications that affect lipid or glucose metabolism, had EKG abnormalities, 
or were pregnant/smokers. The study protocol was approved by the University of Michigan 
Institutional Review Board. 
 
Cardiorespiratory fitness testing  
After enrolling in the study, we assessed cardiorespiratory fitness by measuring peak oxygen 
consumption (VO2peak) using an incremental exercise test to exhaustion. The test began with a 4-
min warm-up, followed by an increase in resistance every minute until volitional fatigue. This 
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exercise test was also used to establish heart rate targets during the experimental exercise 
sessions. 
 
Exercise familiarization/short-term training protocol 
Subjects were randomized into either a high-intensity (HI) or moderate-intensity (MI) exercise 
group. In order to avoid the influence of novelty of the exercise stimulus, we measured the 
response to acute exercise after subjects completed 6 weeks of 4 sessions of weekly exercise. For 
the first week, sessions were 25 min steady state exercise in both groups. In the second week, 
participants ramped up to the full experimental protocol shown in Figure III-1A. HI participants 
ramped from 2 to 10 one-minute intervals over the course of week 2, and MI participants 
completed 35 min steady state exercise during week 2. From weeks 3 to 6 (the week of the 
experimental trial), participants performed the full exercise protocol (Figure III-1A): 10x1 min at 
90% HRpeak, with 3 min warmup and cooldown (HI – 25 min, ~150kcal); or steady-state exercise 
at 70% HRpeak for 45min (MI – 45 min, ~250 kcal). Subjects performed their last exercise 
training session 2 days before the experimental trial. 
 
Experimental protocol 
The experimental trial is shown in Figure III-1B. Subjects reported to the laboratory between 
0700-1000h, after an overnight fast. Participants then rested for 20-30 minutes before the Pre-
exercise (Pre) blood and subcutaneous abdominal adipose tissue samples were collected (details 
of the biopsy procedure are provided in Appendix A). Subjects then completed a supervised 
exercise session, identical to one of their typical training sessions (see Figure III-1A). 
Importantly, the two exercise protocols (HI and MI) differed by intensity, duration, and total 
work performed. Immediately post-exercise (IPEX), another blood sample was taken, and 
subjects rested quietly in the lab for one hour before 1h post-exercise (1hPost) blood and fat 
samples were collected from the opposite side of the umbilicus to the Pre biopsy. 
 
Analytical Procedures 
Approximately 200 mg whole adipose tissue was blotted clean with saline and partitioned for 
RNA sequencing and qPCR per below. In both cases, RNA was isolated from ~80 mg tissue 
using a Qiagen RNeasy Plus Universal Mini Kit (cat 73404), with Turbo DNAse treatment (cat 
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AM1907) after RNA isolation. Full RNA isolation and sequencing SOP is provided in Appendix 
B. 
 
RNA-sequencing. Library preparation and sequencing were performed by the University of 
Michigan Advanced Genomics Core. The Lexogen QuantSeq 3’ mRNA library prep (cat 015) 
was used on 100 ng total RNA to generate fragment lengths of ~100 nucleotides. Single-end 
sequencing was performed on the NovaSeq 6000 with 100 cycles and ~10 million reads per 
sample. Data was analyzed in collaboration with the University of Michigan Bioinformatics 
Core. Data passed FastQC analysis and samples had ~80% alignment to the reference genome. 
Differential Expression (DE) analysis was performed on log-CPM values calculated using 
Voom, which were further normalized by the trimmed mean of M-values technique through 
edgeR. Leading edge analysis was used to identify the key genes driving these gene set 
differences. The Limma software package of Bioconductor was used for DE analysis. Gene Set 
Enrichment Analysis (GSEA; Broad Institute) was used to identify gene sets from the Hallmark 
database (Liberzon) that were up- or down-regulated for the same comparisons. This was 
established by Normalized Enrichment Scores (NES), which reflect the degree to which the 
expression of genes from a given gene set are collectively increased or decreased one hour after 
exercise (1hPost) compared with all genes detected in the experiment.  
  
qPCR. Real-time quantitative PCR was used to assess the mRNA expression levels of target 
genes of interest identified by RNA-sequencing. Because there was insufficient RNA remaining 
after library prep for QuantSeq, RNA was isolated from a separate ~80mg piece of adipose tissue 
for qPCR. Predesigned primer and probe sequences were purchased from IDT PrimeTime qPCR 
Assays and are shown in Table III-2. The qPCR data was normalized to the expression of 2 
housekeeping genes (peptidylprolyl isomerase A (PPIA) and beta-2-microglobulin (B2M)) using 
the -∆Ct method (12) and expressed as fold induction (2-∆∆Ct) of mRNA expression compared 
with Pre. 
 
Blood measurements. Plasma was collected in an ice-cold EDTA tube, and serum was collected 
in a silica tube, left to clot for 30 min at room temperature before centrifugation. All samples 
were centrifuged at 2000G, 15min, 4°C and stored at -80°C until analysis. Plasma glucose 
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(Thermo Scientific, Waltham, MA, USA), non-esterified fatty acid (Wako Chemicals USA, 
Richmond, VA, USA), triacylglyceride (Triacylglyceride reagent; Sigma Aldrich), and total- and 
high-density lipoprotein (HDL; Cholesterol E and HDL-Cholesterol E;Wako Chemicals USA) 
concentrations were measured using commercially available colorimetric assay kits. Serum 
insulin concentration was measured by IMMULITE 1000 chemiluminescent assay (Siemens, 
Flanders NJ, USA). Epinephrine and norepinephrine (Abnova, Taipei City, Taiwan; KA1877), 
IL6 (R&D cat HS600C), and cortisol (R&D cat KGE008B) were measured by ELISA. 
Norepinephrine had several undetectable values (below the lowest standard) Pre and 1hPost, so 
statistics were run on the available data with N = 6-7 Pre, N = 13-14 IPEX (full available 
samples), and N = 9 IPEX by a linear mixed model. 
 
Statistics 
Paired student’s t-tests (HI vs. MI) or linear mixed models (group vs. time) were used to analyze 
blood and anthropometric data. IL6, cortisol, NEFA, epinephrine, and norepinephrine 
concentrations were log-transformed to achieve normality prior to analysis. Sidak’s multiple 
comparisons test was performed when an interaction effect was observed. RNA sequencing data 
was analyzed in collaboration with the University of Michigan Bioinformatics Core. DE of 
RNA-sequencing data was fit to a linear model per Smyth (13), and P values of <0.05 after 
multiple comparisons correction by false discovery rate (FDR) per Benjamini (14) were 
considered significant. For GSEA, gene sets found to be enriched with a false discovery rate 
(FDR) < 0.25 were considered significant. Two-way ANOVAs with one factor repetition (time; 
Prism 8.0) were used to assess differences between exercise conditions in qPCR data, following 
log-transformation where normality tests failed. One outlier was excluded from VEGF qPCR 
analysis, identified by Robust regression and Outlier removal (ROUT). Tukey’s post-hoc test 






A total of 29 subjects completed the study: 15 HI (9 women and 6 men) and 14 MI (10 women 
and 4 men). The groups were well matched for age, weight, BMI, and fasting plasma 
concentrations of glucose, insulin, triglycerides, and cholesterol (Table III-2). Samples were 
collected after 6 ± 1 weeks of HI or MI (4 sessions per week) in order to avoid the confounding 
effects of a novel exercise task on the inflammatory response to exercise. 
 
Exercise Response to HI vs. MI Exercise 
During the experimental exercise session, MI subjects exercised at an intensity eliciting 71 ± 1% 
of their HRpeak (132 ± 7 bpm) for 45 minutes, while HI subjects exercised at an intensity eliciting 
90 ± 2% of their HRpeak (163 ± 8 bpm) during their 10 x 1 minute high-intensity intervals. After 
exercise, plasma concentrations of epinephrine, norepinephrine, cortisol, IL6, and NEFA were all 
elevated above pre-exercise levels in both MI and HI (main effect for exercise, all P≤0.01; 
Figure III-2). In addition, the increase in plasma cortisol concentration was significantly greater 
in HI vs. MI, while the increase in plasma NEFA concentrations was significantly greater in MI 
vs. HI (both P=0.03; Figure III-2). 
 
Effects of Exercise on Adipose Tissue Gene Expression 
Targeted analysis of gene expression for factors regulating adipose tissue remodeling. Based on 
previous findings from our lab (15,16) and others (6,17), we used qPCR to assess gene 
expression of 6 a priori targets related to adipose tissue remodeling. Consistent with our 
previous work, we found a trend for exercise to increase VEGFA gene expression (P = 0.07; 
Figure III-3). We also found an increase in TIMP1 mRNA after exercise (main effect P < 0.01; 
Figure III-3) and IL6 mRNA increased 2.5-fold after HI (P < 0.01), but not MI (Figure III-3). 
 
Untargeted analysis of the effects of exercise on adipose tissue gene expression. Using QuantSeq 
RNA sequencing, 12077 total genes were detected in this experiment. We found 17 DE genes in 
adipose tissue collected one hour after HI compared with before exercise (10 upregulated, 7 
downregulated – Table III-3, Figure III-4A), while in MI, there were 10 DE genes (8 
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upregulated, 2 downregulated – Table III-3, Figure III-4B). Surprisingly, there was no overlap in 
DE genes between HI and MI – the full list is provided in Table III-3. 
We used qPCR to validate a total of 4 genes (ANGPTL4, MMP7, CXCL5, CISH) with 
among the highest log fold-change (logFC) after exercise, and three additional genes (CXCR2, 
NFKBIA, ADAMTS1) central to the regulation of adipose tissue remodeling that exhibited a 
trend for DE (adjusted P < 0.1, Figure III-5). Of this panel of seven genes (Figure III-5), we 
found small, yet significant main effects of exercise for only ANGPTL4 and MMP7 (both 
P≤0.01), but the increase in MMP7 mRNA after exercise by qPCR was actually in contrast to the 
reduction in MMP7 found with RNA sequencing.  The relatively large mean increase in CXCR2 
did not reach statistical significance (P = 0.68). Overall, our qPCR analysis did not corroborate 
our DE analysis. 
 
Gene Set Enrichment Analysis. Given the inconsistencies between RNA-sequencing and qPCR 
analyses, we used GSEA for its power to identify gene set-level changes in cases where 
individual gene expression changes may not be robust (18). We identified 13 pathways that were 
affected by HI (5 increased, 8 decreased), and 15 pathways affected by MI (10 increased, 5 
decreased; Figure III-6 and Table III-4). We found that 7 of these gene sets changed in the same 
direction between HI and MI (4 upregulated and 3 downregulated; Figure III-6B). Individual 
enrichment plots for these 7 gene sets are shown in Figure III-6C. Interestingly, the four 
pathways that were upregulated after exercise were all related to immune function (IL6-JAK-
STAT3 signaling, allograft rejection, TNFA signaling via NFKB, and inflammatory response), 
whereas the three downregulated pathways were broadly related to metabolism (oxidative 
phosphorylation, adipogenesis, and peroxisome). 
 
DISCUSSION 
A key finding from this project was that acute exercise rapidly alters the adipose tissue 
transcriptome (i.e. 1 hour after exercise). In addition, despite HI and MI representing distinct 
exercise stimuli, we found similar gene sets were altered one hour after exercise in both groups. 
Specifically, pathways related to inflammation were upregulated after both HI and MI exercise, 
while pathways related to adipogenesis and oxidative metabolism were downregulated. These 
data suggest that gene set-level increases in inflammatory signaling pathways are likely an 
	33	
important component of the early response in adipose tissue after a session exercise – while 
reductions in metabolic pathways may reflect downregulation during the early-phase recovery in 
response to exercise. 
The intensity of exercise is known to have profound impact on the metabolic response during 
the exercise session (10,19) and for at least the few hours afterwards (20). Furthermore, there is 
now a large body of literature suggesting that high-intensity interval training (HIIT) can induce 
similar adaptations to more conventional moderate-intensity continuous training (MICT) despite 
a lower time commitment, which may certainly be attributed to the high intensity stimulus, but 
could also be due to other factors associated with the HIIT protocol such as the pulsatile nature 
of the stimulus (21). Much of this previous work examining the effects of HIIT vs. MICT has 
focused on whole-body responses and changes within skeletal muscle (19), with very little 
information available regarding effects on signaling responses within adipose tissue. In our 
study, the greater adrenergic/cortisol response after HI indicated that we did indeed achieve 
distinct metabolic stimuli between the two exercise protocols. However, despite robust 
differences in exercise intensity, as well as differences in exercise duration and energy 
expenditure between HI and MI, the gene expression responses were remarkably similar. 
Strikingly, all gene sets that were upregulated after exercise were inflammation-related, while 
most of the gene sets that were downregulated were related to metabolic control, in both HI and 
MI. 
Our finding that acute exercise upregulated gene sets involved in inflammation just one hour 
after exercise suggests that inflammatory signaling may be an important early-phase post-
exercise response within human subcutaneous abdominal adipose tissue. This is consistent with 
recent work in lean participants reporting that the top upregulated gene ontology (GO) pathways 
in subcutaneous adipose tissue collected four hours after exercise were inflammation-related 
(22). Acute exercise has mixed effects on immune cells in circulation and tissues including 
spleen and liver (4,23,24); but the effects of exercise on immune cells in obese human adipose 
tissue remain unclear. The gene sets enriched in our adipose tissue samples after exercise 
included several genes involved in chemoattraction (e.g. CCR2, CCL5), as well as genes 
encoding for cytokines and inflammatory signaling molecules (lists in full in Appendix D). This 
suggests there are signals for the recruitment of immune cells and/or immune cell activation 
within adipose tissue as quickly as only one hour after exercise, which is in agreement with the 
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hypothesis that exercise-induced inflammatory signaling within adipose tissue could result in a 
phenotypic shift in immune cell populations after exercise. Among the inflammatory gene sets 
upregulated by GSEA in this cohort, the IL6-JAK-STAT signaling pathway had the greatest 
normalized enrichment score (NES), indicating this pathway exhibited the most robust collective 
upregulation of genes within the overall transcriptome. This is consistent with the work by 
MacPherson et al. (17), who reported an increased IL6-signaling in inguinal adipose tissue 
samples collected two hours after exercise from high-fat diet mice (17), as well as the well-
established role of IL6 as an exercise-induced myokine (25). Together, these data support a key 
role of immune signaling (including IL6 signaling) in the early adipose tissue response to 
exercise in obese humans. It is important to consider that IL6 is among inflammatory cytokines 
with potential pro- and anti-inflammatory effects (26). Therefore, these results should be 
considered in the context that immune signaling is complex, and assessment of specific signaling 
pathways over the several hours and even day(s) after a session of exercise or over days and 
weeks of repeated exercise is required to achieve a better understanding of the impact of this 
general regulation of immune signaling. Furthermore, because the magnitude of the 
inflammatory gene response to a session of exercise is quite modest (Appendix D), especially 
when compared with a classic inflammatory insult such as sepsis or even exercise-induced 
muscle damage, measurable changes at the protein-level and/or changes in biological function 
may only be evident after several weeks of repeated exercise. 
The increased gene expression of TIMP1 and trend for elevated VEGFA we found only one 
hour after exercise supports the notion that exercise may quickly elicit signals capable of 
modifying key structural components in subcutaneous adipose tissue. VEGFA is the master 
regulator of angiogenesis, and we have previously reported increased VEGFA expression in 
subcutaneous adipose tissue one hour after a session of exercise (15), and immediately after 
exercise in rats (16). Exercise training has been found to increase adipose tissue capillarization 
(measured histologically) (27), and our recent finding of greater CD31 (an endothelial cell 
marker) in subcutaneous adipose tissue samples from regular exercisers compared with sedentary 
controls (15) further supports this finding that angiogenic signals in adipose tissue stemming 
from each exercise session may lead to increased vascularization after chronic exercise training. 
A single session of exercise also may trigger signals related to ECM remodeling in adipose 
tissue. The fibrotic network of adipose tissue ECM is primarily modified by a family of matrix 
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metalloproteinases (MMPs), whose function of cleaving collagenous proteins is regulated 
transcriptionally, post-translationally, and by the tissue inhibitor of MMP (TIMP) protein family. 
TIMP 1, thereby, modifies the ECM in its role as an MMP inhibitor, and our finding that TIMP1 
expression was increased after exercise suggests that exercise may upregulate factors involved in 
ECM remodeling. A better understanding of the factors involved in the remodeling of adipose 
tissue angiogenesis and ECM remodeling in response to exercise will require measurements over 
several hours after exercise, and assessment of related structural changes after weeks/months of 
exercise training. However, these qPCR data suggest that exercise can activate key players in 
these processes. 
Our GSEA finding that the adipogenic gene set was downregulated after a session of exercise 
is consistent with previous work (28,29). This reduction in adipogenic signaling one hour after 
exercise is not surprising given that adipogenesis is usually triggered by conditions of energy 
surplus, and our participants had just expended ~200-300 kcals during the exercise session. 
Importantly, this finding does not preclude the possibility that factors released during and/or 
immediately after a session of exercise (e.g. catecholamines, IL6, growth factors, NEFA) may 
augment adipogenic capacity when energy availability is high; as suggested by some preliminary 
findings from our lab (30). Furthermore, our finding that several gene sets related to oxidative 
metabolism in adipose tissue were downregulated one hour after exercise may also reflect 
adipose tissue responses during the “recovery phase” after the exercise session. Specifically, this 
downregulation in oxidative metabolism genes within adipose tissue may be a compensatory 
response for the increased energy demands experienced during the exercise session. This acute 
down regulation of gene expression of oxidative metabolic pathways may be transient, because 
subcutaneous adipose tissue oxidative capacity and mitochondrial biogenesis have been 
suggested to remain stable with chronic exercise training in human subjects (31–33). Together, 
these data suggest the metabolic response to long-term exercise training is distinct from this 
rapid (1 hour) response. A thorough assessment of the time course of changes in gene expression 
and protein level responses will be required to elucidate the mechanisms for exercise-induced 
metabolic adaptations in adipose tissue. 
There are several limitations to consider in interpreting these data. It is possible the very 
small number of differentially expressed genes after exercise was a consequence of the timing of 
our sample collection (i.e. 1 hour after exercise). Work by Fabre et al. (22) identified ~350 DE 
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genes in lean, trained subjects when measured 4h after exercise. Our decision to collect adipose 
tissue samples one hour after exercise was based on our interest in the rapid signals induced in 
adipose tissue after exercise. The use of GSEA allowed us to identify that this response, though 
mild at the individual gene level, is consistent at the gene set level. Furthermore, to detect 
individual gene expression changes in this complex tissue may require analysis in single cell 
populations, but the objective of this work was to perform exploratory analysis on whole tissue 
to provide some direction on which novel transcripts are impacted by acute exercise. While the 
adipose tissue immune response to weight gain is different between males and females (34), the 
analyses in this project reveal pathways that are up/downregulated with both sexes pooled, 
providing insight to consistent exercise-induced signals that are triggered in both sexes – which 
is important for practical exercise prescription. Finally, while the central focus of this project was 
to expand our understanding of exercise induced adaptations to subcutaneous adipose tissue that 
could improve its storage capacity, thereby reducing ectopic lipid deposition and inflammation in 
visceral adipose tissue during periods of weight gain, there are well known regional differences 
among adipose tissue depots. Therefore, the findings reported here may not translate to the 
response in visceral adipose tissue, or even gluteal/femoral subcutaneous adipose tissue. 
In summary, our key findings indicate that one hour after a session of exercise there was an 
upregulation of gene sets involved in inflammation, and a downregulation of gene sets related to 
oxidative metabolism and adipogenesis in adipose tissue from obese adults. Furthermore, our 
findings support the notion that genes involved in adipose tissue structural remodeling are altered 
one hour after a session of exercise. These data suggest that an upregulation in inflammatory 
pathways is an important part of the immediate response to regular acute HI and MI exercise. 
This provides new evidence suggesting immune signaling in adipose tissue from obese subjects 
could be a key early trigger for the purported long-term adipose tissue adaptations to exercise 
training such as reduced pro-inflammatory macrophage content (17). Finally, our findings 
indicate that low-volume, high-intensity exercise evokes similar adipose tissue transcriptomic 
responses to more conventional moderate-intensity exercise (consistent with most standard 
exercise guidelines (36)), despite meaningful differences in energy expenditure and time 
commitment between these two exercise protocols.  
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Figure III-1 Experimental Design. 
(A) Subjects completed a single bout of MI (45 min at ~70% HRpeak) or HI (10x1 min at ~90% HRpeak with 1 min 
recovery in 25 min total). HI: high-intensity exercise; MI: moderate-intensity exercise. (B) Sample collection was 




Figure III-2 Exercise Response of Circulating Factors. 
Plasma samples were collected Pre, IPEX, and 1hPost for analysis of hormones/NEFA. (A) Epinephrine 
concentration - significantly greater IPEX v. Pre and 1hPost (P < 0.01); main effect for time (P < 0.01). N = 12-14. 
(B) Plasma norepinephrine concentration – main effect for time (P < 0.01). N = 6-14. (C) Cortisol concentration – 
main effect for time (P = 0.01), and main effect for group (P = 0.03). N = 13-15. (D) Plasma IL-6 concentration – 
main effect for time (P < 0.01). N = 13-15. (E) Plasma NEFA concentration: main effect for time (P < 0.01) and 
main effect for group (P = 0.03). N = 13-15. IPEX: immediate post-exercise; NEFA: non-esterified fatty acids. Data 




Figure III-3 Gene Expression for Factors Regulating Adipose Tissue Remodeling. 
Fold-change of a priori transcripts related to adipose tissue remodeling in whole adipose tissue samples. There was 
a trend for exercise to increase VEGFA expression (P = 0.07). There was a main effect of group on IL6 expression 
(P = 0.04), wherein post-hoc analyses determined IL6 was increased in the HI group only (P < 0.01). There was a 
trend for a group effect on TGFB expression (P = 0.06), and there was an exercise effect on TIMP1 expression (P < 
0.01). N = 9-15. Data are Mean ± SD. *P < 0.05 for exercise effect; †P < 0.05 for group effect. ME: main effect. 
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Figure III-4 Differentially Expressed Transcripts within HI and MI. 
(A) Adjusted P-value vs. log2(Fold-Change) for transcripts from Pre-HI vs. 1hPost-HI. Positive Fold-Change 
represents an upregulation 1hPost. (B) Adjusted P-value vs. log2(Fold-Change) for transcripts from Pre-MI vs. 
1hPost-MI. Points above the dashed lines were DE at an FDR adjusted P < 0.05. DE: differentially expressed; FDR: 
false discovery rate. N = 12 per group. 
	42	
	
Figure III-5 qPCR Validation. 
Fold-change of targets that were differentially expressed by RNA-sequencing in HI (dark) and MI (light). There was 
a main effect for exercise to increase ANGPTL4 and MMP7 gene expression (P <0.01). N = 12-15. Data are Mean ± 




Figure III-6 Gene Set Enrichment Analysis. 
(A) Heat map depicting the NES for gene sets from the Hallmark database. * denotes FDR q-val < 0.25. NES: 
normalized enrichment score; FDR: fase discovery rate. (B) Venn diagram presenting common gene set enrichment 
between HI and MI. Gene sets that were enriched 1hPost are shown in red; Gene sets that were enriched Pre (i.e. 
downregulated) are shown in blue. Seven pathways falling into immune or metabolic function were common 
between all comparisons. (C) Enrichment plots for these common immune (top) and metabolism (bottom) pathways. 
N = 12 per group. 
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TABLES 
Table III-1 qPCR targets in the subcutaneous adipose tissue. 
 Gene 














angiopoietin-like 4 (ANGPTL4) 
matrix metallopeptidase 7 (MMP7) 
cytokine inducible SH2 containing protein (CISH) 
C-X-C motif chemokine ligand 5 (CXCL5) 
C-X-C motif chemokine receptor 2 (CXCR2) 
nuclear factor of kappa-B inhibitor alpha (IκBα) 
A disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAMTS1) 
vascular endothelial growth factor (VEGF) 
interleukin 6 (IL6) 
transforming growth factor beta 1 (TGF-β1) 
monocyte chemotactic protein 1 (MCP1) 
tissue inhibitor of matrix metalloproteinases 1 (TIMP1) 





Table III-2 Physical characteristics of subjects 
 
   
 
HI MI P 
Age (years) 32 ± 6 29 ± 5 0.13 
Body mass (kg) 97.2 ± 13.7 96.5 ± 11.4 0.89 
BMI (kg/m2) 33.2 ± 2.9 33.4 ± 3.6 0.85 
Fasting glucose (mg/dL) 84 ± 9 86 ± 9 0.46 
Fasting insulin (uIU/mL) 18 ± 12 13 ± 6 0.29 
Triglycerides (mg/dL) 104 ± 62 114 ± 61 0.65 
Total Cholesterol (mg/dL) 149 ± 30 155 ± 33 0.61 
HDL Cholesterol (mg/dL) 34 ± 7 34 ± 8 0.95 
LDL Cholesterol (mg/dL) 116 ± 33 122 ± 37 0.64 
	
BMI: body mass index, HDL: high density lipoprotein, LDL: low density lipoprotein. n = 14-15 per group. Data are 
Mean ± SD. 
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Table III-3 Differentially expressed genes in HI and MI 
 
Genes are divided by upregulated (1hPost > Pre; top) and downregulated (1hPost < Pre; bottom). Expression 
represents mean normalized logCPM per group. Bolded genes were validated by qPCR. Expression represents the 
mean expression level for that group. logFC: log2(fold change); adj.P: adjusted P value for false discovery rate. N = 
12 per group. 
 
  
Gene logFC adj.	P Gene logFC adj.	P
Pre Post Pre Post
ST6GALNAC3 7.2 12.1 0.76 0.00 ANGPTL4 159.2 254.5 0.71 0.00
SPATA6 16.5 21.6 0.42 0.02 CISH 13.6 31.8 1.21 0.03
FANCM 16.0 20.0 0.38 0.02 S100A12 2.4 9.0 1.58 0.03
CXCL5 6.1 40.4 1.52 0.03 ADM 151.9 202.6 0.45 0.03
SLC20A2 5.1 7.5 0.58 0.03 COX14 161.1 196.5 0.27 0.03
FAM126B 70.8 90.4 0.29 0.03 SERTAD4 18.0 24.3 0.44 0.03
GALNT15 122.4 148.2 0.35 0.03 ADRB1 32.4 48.9 0.60 0.03
FAM107A 118.3 138.2 0.32 0.04 RAPGEF3 28.9 37.6 0.36 0.04
NUB1 107.8 121.3 0.19 0.04
KLF10 36.4 45.1 0.38 0.05
Downregulated
Gene logFC adj.	P Gene Expression logFC adj.	P
Pre Post Pre Post
MMP7 7.2 1.9 -1.63 0.00 SESN1 60.1 47.4 -0.32 0.03
SLC5A3 355.2 267.0 -0.35 0.00 ZNF518A 65.0 53.6 -0.28 0.04
AHDC1 30.0 22.6 -0.39 0.02
NCEH1 28.5 14.2 -0.80 0.03
FABP5 112.8 85.7 -0.33 0.03
CDK6 96.4 80.0 -0.26 0.03










Table III-4 Gene Set Enrichment Analysis for samples collected before (Pre) vs. after (1hPost) exercise 
 
Only pathways with FDR q-val < 0.25 are shown. Size represents the number of genes in the listed gene set. A 
negative normalized enrichment score (NES) represents enrichment in the Pre condition. ES: enrichment score; 
NES: normalized enrichment score; FDR q-val: false-discovery rate-adjusted significance score. N = 12 per group. 
Gene	Set	Name Size ES NES FDR	q-val.
HALLMARK_IL6_JAK_STAT3_SIGNALING 63 0.44 1.97 0.001
HALLMARK_TNFA_SIGNALING_VIA_NFKB 158 0.33 1.72 0.014
HALLMARK_HEME_METABOLISM 153 0.30 1.57 0.035
HALLMARK_INFLAMMATORY_RESPONSE 134 0.28 1.44 0.075
HALLMARK_ALLOGRAFT_REJECTION 140 0.27 1.41 0.074
HALLMARK_OXIDATIVE_PHOSPHORYLATION 180 -0.51 -2.27 0.000
HALLMARK_MYC_TARGETS_V1 190 -0.46 -2.04 0.000
HALLMARK_FATTY_ACID_METABOLISM 132 -0.42 -1.78 0.011
HALLMARK_ADIPOGENESIS 184 -0.38 -1.69 0.056
HALLMARK_PEROXISOME 81 -0.43 -1.69 0.057
HALLMARK_CHOLESTEROL_HOMEOSTASIS 62 -0.44 -1.69 0.059
HALLMARK_MYC_TARGETS_V2 50 -0.45 -1.64 0.102
HALLMARK_MTORC1_SIGNALING 185 -0.36 -1.61 0.144
HALLMARK_IL6_JAK_STAT3_SIGNALING 63 0.47 2.07 0.000
HALLMARK_ALLOGRAFT_REJECTION 140 0.37 1.81 0.005
HALLMARK_INTERFERON_GAMMA_RESPONSE 173 0.34 1.75 0.006
HALLMARK_INTERFERON_ALPHA_RESPONSE 89 0.38 1.73 0.005
HALLMARK_INFLAMMATORY_RESPONSE 134 0.34 1.66 0.011
HALLMARK_COMPLEMENT 154 0.31 1.56 0.020
HALLMARK_KRAS_SIGNALING_DN 63 0.35 1.53 0.022
HALLMARK_TNFA_SIGNALING_VIA_NFKB 158 0.26 1.30 0.130
HALLMARK_ESTROGEN_RESPONSE_EARLY 141 0.26 1.28 0.129
HALLMARK_MYC_TARGETS_V2 50 0.30 1.22 0.194
HALLMARK_OXIDATIVE_PHOSPHORYLATION 180 -0.39 -1.76 0.022
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION163 -0.35 -1.55 0.120
HALLMARK_WNT_BETA_CATENIN_SIGNALING 36 -0.44 -1.49 0.151
HALLMARK_PEROXISOME 81 -0.37 -1.46 0.160






Chapter IV. Project 2 
The Effects of Acute Moderate-intensity Exercise on Adipose Tissue Cellular 
Composition and Function in Obese Humans 
 
ABSTRACT 
Adipose tissue pathology in obese patients often features impaired adipogenesis, angiogenesis, 
and chronic low-grade inflammation, all of which are processes that are regulated in large part by 
adipose tissue stromal vascular cells (SVC; i.e. non-adipocyte cells within adipose tissue 
including preadipocytes, endothelial cells, and immune cells). Exercise activates many processes 
in adipose tissue, such as lipolysis and adipokine secretion, but the impact of exercise on the 
individual adipose tissue SVCs has not been explored. The purpose of this study was to assess 
the effects of a session of exercise on changes in preadipocyte, endothelial cell, macrophage, and 
T cell content in human subcutaneous adipose tissue. We collected abdominal subcutaneous 
adipose tissue samples from ten obese regular exercisers (BMI 33 ± 3 kg/m2, body fat 41 ± 7 %) 
the morning (12h) after 60 min endurance-type exercise (80 ± 3 %HRpeak) versus quiet rest in the 
laboratory. SVCs were isolated by collagenase digestion and stained for flow cytometry. We 
found exercise reduced preadipocyte content (38 ± 7 vs. 30 ± 13 %SVC; P = 0.04). The 
reduction was driven by an exercise-induced decrease in CD34hi preadipocytes (18 ± 5 vs. 13 ± 6 
%SVC; P = 0.002), a subset of preadipocytes that generates high lipolytic rate adipocytes ex 
vivo. Exercise did not alter endothelial cell content, suggesting the exercise signal for endothelial 
cell migration may take longer to accrue. Exercise did not change total immune cell number, or 
macrophage or T cell content, and future work should assess subpopulations of these cells. We 
conclude that exercise may rapidly regulate the subcutaneous adipose tissue pre-adipocyte pool 




The ability of adipose tissue to expand and store excess energy during weight gain and obesity is 
important for maintaining tissue and systemic insulin sensitivity. While the adipocyte is the main 
site for fatty acid storage, the adipose tissue stromal vascular cell (SVC) composition is 
heterogeneous and includes adipocyte precursor cells (preadipocytes), immune cells (e.g. 
macrophages, T cells, dendritic cells), and endothelial cells – among others. These cells play a 
key role in regulating the overall “metabolic health” of adipose tissue. For example, impairments 
in the ability of these cells to (i) differentiate into new adipocytes; (ii) maintain an anti-
inflammatory immune environment; and (iii) propagate angiogenesis to maintain sufficient tissue 
oxygenation and tissue crosstalk are some of the main maladaptive features commonly found in 
adipose tissue from obese, insulin resistant adults (1).   
 Preadipocytes are self-renewing SVCs that can differentiate into mature adipocytes. 
These cells can play a key role during periods of growth/weight gain by differentiating into new 
adipocytes in response to adipogenic stimuli including insulin, fatty acids, catecholamines, and 
cortisol (2).  While the contribution of adipogenesis to mature adipocytes in obesity is relatively 
low (~8% new cells per year (3)), there is evidence that adipogenic rate can be 
altered/accelerated in vivo, which might enhance adipose tissue storage capacity by providing 
more small fat cells to sequester bioactive fatty acids as triglycerides (4). Furthermore, the recent 
identification of preadipocyte subtypes that differentiate into adipocytes with distinct metabolic 
phenotypes (5) highlights the potential for these cells to impact adipose tissue function. 
Insufficient adipose tissue angiogenesis in expanding adipose tissue in obesity is thought 
to result in hypoxia of their hypertrophic adipocytes (6). Endothelial cells (EC) are the primary 
component of adipose tissue vasculature, and EC migration to the tip of capillary sprouts is a key 
step in angiogenesis (7). Therefore, signals that could improve endothelial cell migration and 
function during periods of weight gain could minimize adipose tissue hypoxia and the ensuing 
chronic low-grade inflammation. 
While “healthy” adipose tissue function is maintained by a variety of anti-inflammatory 
immune cells (e.g., T regulatory cells and M2-like macrophages), adipose tissue hypoxia, 
pathogen-associated molecular patterns (e.g. LPS), and adipocyte death are among the triggers 
for a shift towards chronic low-grade inflammation in obesity. This pro-inflammatory 
environment impairs adipose tissue storage and insulin action by increasing pro-inflammatory 
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cytokine production (8). In turn, adipose tissue inflammation and insulin resistance can 
exacerbate the high rates of fatty acid release and cytokine production from obese adipose tissue, 
contributing to systemic insulin resistance. 
Acute exercise increases signals in adipose tissue that impact adipogenesis, angiogenesis, 
and inflammation (9,10), suggesting unique potential for exercise to coordinately regulate the 
stromal cell composition of obese adipose tissue. Although visceral adipose tissue is often a 
predominant site of obesity-related inflammation, this is often a consequence of impairments in 
subcutaneous adipose tissue storage capacity that result in ectopic lipid deposition in visceral 
adipose tissue as well as other tissues such as the liver and skeletal muscle. Therefore, the goal of 
this study was to quantify changes in preadipocytes, ECs, macrophages, and T cells in abdominal 





Ten obese adults (3 men, 7 women) participated in the study. All participants were regular 
exercisers (≥ 3 days/wk of 30-60min moderate/vigorous endurance-type exercise) in order to 
avoid the confounding effect a novel exercise stress can impart on unaccustomed exercisers. 
Participants with elevated blood pressure (i.e., > 140/90 mmHg), history of cardiovascular or 
metabolic disease, and regular use of medications known to affect metabolism or inflammation 
were excluded. All women were pre-menopausal, with regularly occurring menses. The study 
protocol was approved by the University of Michigan Institutional Review Board. 
 
Preliminary testing 
Subjects were screened for physical activity status, cardiovascular disease risk, and medical 
history by questionnaires. Resting blood pressure, weight, height, body composition (DEXA; GE 
Lunar DPX) and peak oxygen consumption (VO2peak) were also measured during screening. 
The VO2peak test began with a warm up at a moderate running speed individualized for each 
subject, after which the incline of the treadmill was increased every 1-2 minute(s) until volitional 
fatigue. During a separate visit, we performed an oral glucose tolerance test (OGTT) after an 
overnight fast (12 h).  Because all subjects were regular exercisers, to avoid the robust influence 
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General study design. All subjects completed two separate experimental trials. The only 
difference between the two trials was whether they exercised (EX) or remained sedentary (SED) 
in the evening before adipose tissue samples were collected the next morning. Each trial required 
subjects to visit the laboratory in the evening for supervision of the study treatment (EX or SED), 
and again the next morning for blood and adipose tissue sample collection (see Figure IV1 and 
protocol details below). All participants were required to perform their last regular exercise 
session exactly 2 days before beginning their experimental trial (3 days before sample 
collection). On the day of their first evening visit, participants recorded everything they ate that 
day in order to replicate this diet on the day before their second experimental trial. The order of 
the EX and SED trials was randomized. 
 
Evening before sample collection. Subjects arrived to the laboratory at approximately 1800h.  
After resting quietly for 30 min, participants either: 1) 60 min exercise (EX) at 80 ± 3% HRpeak 
(152 ± 8 bpm) – or 2) remained sedentary (SED) by resting quietly in the laboratory (in 
randomized order). EX was completed on a treadmill, except for one participant who used a 
cycle ergometer. Fifteen minutes after completing the hour of SED/EX, participants were 
provided with a standardized meal: 33% daily energy expenditure calculated by the Mifflin St. 
Jeor equation (11). The meal was composed of ~55% carbohydrate, 30% fat, and 15% protein. 
Participants then abstained from exercise, food and drink (other than water) overnight.  
 
Morning of sample collection. Participants returned to the laboratory at approximately 0645h. 
After resting quietly for 30 minutes, we collected a baseline blood sample by venipuncture. We 
then collected the abdominal subcutaneous adipose tissue sample by needle aspiration (see 
details of adipose tissue biopsy procedure in Appendix A). After completion of all sample 





Adipose tissue stromal vascular cell isolation. Two grams of adipose tissue were collected into 
FACS buffer (Hank’s Balanced Salt Solution (HBSS) with calcium and magnesium) and 
processed by collagenase digestion for isolation of the SVCs. Full SVC isolation protocol is 
available in Appendix D. In short, large pieces within the aspirated sample were minced by hand 
with sterile scissors before incubating the samples in 3 mg/mL Collagenase Type I (Worthington 
cat NC9633623) in FACS buffer (~30 mg/g tissue), while rocking at 37oC for ~45 minutes until 
samples became slurry. This slurry was passed through a 300 µm filter to isolate the SVCs. 
Following centrifugation, this cell pellet was treated with a red blood cell lysis buffer (recipe in 
Appendix D), and SVCs were subsequently washed, pelleted, and counted with a 
hemocytometer. SVCs were then stained and fixed for flow cytometry. 
 
Flow cytometry. SVCs were stained for flow cytometry as described previously (12) with minor 
modifications (detailed protocol in Appendix D). Briefly, ~1E6 cells were used for full stain and 
fluorescence minus one controls (FMO’s; controls to identify the signal of a given fluorochrome 
in the context of the full remaining panel of fluorochromes), and ~0.2E6 cells were used for 
single stain/unstained controls. Details regarding cell surface markers and fluorophores used in 
this study are provided in Table IV-1. Sample tubes were incubated in Fc block (for nonspecific 
binding to Fc receptors of immune cells) for 5 minutes prior to staining. Cells were incubated in 
conjugated antibodies (Table IV-1) for 30 minutes at 4°C (dark), washed with 2mL PBS, 
pelleted, and resuspended in PBS for analysis. Samples were analyzed on the LSR Fortessa at the 
University of Michigan Flow Cytometry Core (details in Appendix D). FlowJo® software was 
used to quantify cell populations from human SVCs, which were gated according to Figure IV-2. 
As shown, after selecting for single cells, excluding debris, and selecting live cells, T cells 
(CD45+CD3+), macrophages (CD45+CD64+CD206+), and dendritic cells (DC; CD45-CD64-
CD11c+) were gated off of CD45+ total immune cells. Endothelial cells (EC; CD45-
CD34+CD31+) and preadipocytes (CD45-CD31-CD29+) were selected from the CD45- non-
hematopoeitic fraction. Given the variability in sample size obtained with the needle aspiration 
technique, all cell populations were normalized to the total number of live cells analyzed. The 
gating strategy is depicted in Figure IV-2. 
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Blood measurements. Plasma glucose (Thermo Scientific, Waltham, MA, USA), non-esterified 
fatty acid (Wako Chemicals USA, Richmond, VA, USA), triacylglyceride (Triacylglyceride 
reagent; Sigma Aldrich), and total- and high-density lipoprotein (HDL; Cholesterol E and HDL-
Cholesterol E; Wako Chemicals USA) cholesterol concentrations were measured using 
commercially available colorimetric assay kits. Plasma insulin concentration was measured with 
a chemiluminescent immunoassay (Siemens IMMULITE 1000, Flanders NJ, USA). Matsuda 
insulin sensitivity index (ISI) was calculated as described by Matsuda & DeFronzo (13). 
 
Statistics 
Paired student’s t-tests, were performed to assess differences between SED and EX. Two-way 
repeated measures ANOVAs (repeated for exercise and preadipocyte subtype) were used to 
assess differences in preadipocyte subpopulations, with Sidak’s multiple comparison test used 
when required. Statistical significance was defined as P<0.05. 
 
RESULTS 
Baseline subject characteristics 
Seven obese women and three obese men completed the study (Table IV-2). All subjects were 
regular exercisers (4 ± 1 sessions of moderate/vigorous exercise per week) in order to avoid the 
confounding influence of a novel exercise task on inflammation. Despite being regular 
exercisers, all subjects were classified having impaired glucose regulation/insulin resistance, 
based on their Matsuda ISI (14), which was measured after abstaining from exercise for three 
days (Table IV-2). 
 
Exercise effects on fasting blood profile  
Fasting plasma concentrations of non-esterified fatty acids, triglycerides, Total-, HDL-, and LDL 
cholesterol were not affected by the exercise session performed the previous day (SED vs. EX; 
Table IV-3).  Similarly, fasting plasma glucose and insulin concentrations were nearly identical 
between EX and SED (Table IV-3). There was also no change in circulating cytokine 




Effects of exercise on stromal cell number 
The exercise session (performed 12 hours before adipose tissue collection) did not affect the 
proportion of CD45-CD31+CD34+ endothelial cells, total CD45+ immune cells, or any of the 
other immune cell populations we measured (i.e. CD45+CD64-CD11c+ dendritic cells, 
CD45+CD3+ T cells, and CD45+CD64+CD206+ macrophages) (Figure IV-4). In contrast, 
exercise reduced the proportion of total preadipocytes in the SVC fraction (P = 0.04; Figure IV-
5A). 
We stratified preadipocytes into three subtypes according to CD34 and CD29 expression 
as previously outlined by Raajendiran et al. (5). In Figure IV-2D, we refer to these three 
populations as CD34hi (CD29+CD34hi), CD34lo (CD29+CD34lo), and CD34- (CD29+CD34-). 
These populations also express variable CD29 expression, with the CD34- population expressing 
the highest level of CD29 (Figure IV-2D). Interestingly, the reduction in the preadipocytes in the 
SVC appeared to be due to a reduction in the proportion of the CD34hi subtype (P=0.002), while 
CD34- and CD34lo preadipocytes were not different in SED vs. EX (Figure IV-4B).  There was 
no effect of exercise on preadipocyte subtypes expressed as a proportion of total preadipocytes 
(P = 0.59). By t-test, there was a trend for CD34hi to decrease as a proportion of total 
preadipocytes (P = 0.08), and CD34lo preadipocytes increased (P = 0.04), while there was no 
change in CD34- preadipocytes relative to total SVC or preadipocytes. 
 
Assessing the influence of blood contamination on stromal vascular cell quantification 
It was important to establish the influence of blood contamination on our SVC quantification, 
because traces of blood are very common in the adipose tissue samples collected using the lipo-
aspirate procedure. In Figure IV-6, panels A-F present whole blood stained with the same 
antibody panel as the adipose tissue SVC’s. T cell (Figure IV-6B) and DC (Figure IV-6C) gating 
show considerable presence of blood cells, and therefore the quantification presented in  
Figure IV-4 should be considered to reflect adipose tissue T cell/DC numbers including local 
tissue blood cells. Despite this potential for blood contamination in the T cell and DC 
quantification, contamination was likely uniform in samples collected in the EX and SED visits, 
and therefore it likely doesn’t affect the interpretation of our findings. There was no positive 
endothelial cell (Figure IV-6E) or preadipocyte (Figure IV-6F) staining on the whole blood 
control. Using an anti-CD206 antibody, we were able to identify adipose tissue-specific 
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macrophages. Figure IV-6H shows the CD206 FMO on SVC’s confirming the presence of 
CD206hi and CD206lo macrophages. Figure IV-6C shows that there is a large population of blood 
cells that stain positive for CD64, a typical macrophage marker. Therefore, we relied on CD206 
to exclude these potential contaminating blood cells (likely monocytes), because Figure IV-6D 
identifies the majority of these cells to be CD206-. Figure IV-6H (CD206 FMO on SVCs) shows 
that the CD206- population of blood contamination was distinct from a population of CD206lo 
macrophages (which has been previously reported; (15)). 
 
DISCUSSION 
This is the first study to assess changes in stromal cell composition in human subcutaneous 
adipose tissue after an acute session of endurance-type exercise. A key finding of this study was 
that preadipocyte content in the SVC fraction of subcutaneous adipose tissue was reduced twelve 
hours after a session of exercise. Importantly, this reduction in preadipocyte content was driven 
by a reduction in CD34hi preadipocytes – a population of adipocyte precursor cells that has been 
linked to the formation of an adipocyte phenotype with elevated lipolytic rate (5). In contrast to 
these exercise induced changes in preadipocytes, there were no effects of acute exercise on total 
immune cell number, immune cell subtypes (macrophages, T cells, and dendritic cells), or 
endothelial cell number in subcutaneous adipose tissue. Therefore, these data suggest that a 
single session of exercise may provide a stimulus to remodel the preadipocyte pool within human 
subcutaneous adipose tissue, without altering immune cell or endothelial cell number 12h after 
exercise. 
Preadipocytes are most often identified by the expression of CD34 (16), which is a 
transmembrane phosphoglycoprotein typically associated with hematopoietic stem/progenitor 
cells. However, CD34 expression is not exclusive to these cells and its function is not well-
described beyond some role in cytoadhesion, proliferation, and differentiation (reviewed in (17)). 
Preadipocytes are now commonly described to express CD29, Sca-1, and CD24 (on Lin- cells), 
with CD24 in particular linked to adipocyte commitment (18). The most reliable preadipcoyte 
cell surface markers remain unresolved, particularly in human adipose tissue, but CD34 (in 
combination with CD45+/CD31+ exclusion) is the primary marker used in most studies. 
Recently, Raajendiran et al. (5) isolated 3 distinct CD45-CD31-CD29+ preadipocyte populations 
based on the abundance of CD34 (CD34-, CD34lo, CD34hi), and reported these preadipocyte 
	56	
subpopulations feature unique metabolic properties ex vivo. In particular, CD34hi preadipocytes 
differentiate into adipocytes with markedly elevated lipolytic rate, and high rates of lipolysis 
have been clearly linked with impaired insulin sensitivity (19,20). Along these lines, CD34hi 
preadipocytes are more prevalent in adipose SVCs from people with diabetes compared with 
non-diabetic controls (5). Our finding that exercise lowered the proportion of CD34hi cells in the 
SVC suggests that the proportion of preadipocyte subtypes in human subcutaneous adipose tissue 
is plastic, and exercise may lead to a shift towards a more favorable preadipocyte phenotype, 
primed to generate adipose tissue with a lower average lipolytic rate. 
The session of exercise did not affect the relative abundance of CD34- cells, a subset of 
preadipocytes with high CD29 expression that that has been reported to generate beige-like 
adipocytes (5,21). It has been suggested that exercise may induce a beige-like phenotype in white 
adipose tissue via adrenergic signaling and myokine release from skeletal muscle (22). Our 
finding that exercise did not alter the abundance of CD34- (CD29hi) preadipocytes could be 
interpreted to suggest that the exercise session did not remodel the preadipocyte pool towards 
beige-like precursors, which is consistent with several studies indicating that exercise training 
does not induce a beige-like phenotype within subcutaneous adipose tissue (23–25). Tsiloulas et 
al. (23) surmised that insufficient CD29+ precursors could explain their observation that exercise 
training did not induce “beiging” within subcutaneous abdominal adipose tissue from obese 
subjects - although they did not assess CD29+ progenitor content in their study. The 
identification of CD34- (CD29hi) preadipocytes as about one third of total preadipocytes in our 
cohort of obese regular exercisers suggests that the presence of CD29+ preadipocytes in human 
subcutaneous adipose tissue may not be a limiting factor for the beiging potential of exercise in 
healthy obese adults. However, longer-term exercise training studies would be required to 
ascertain whether regular exercise alters the CD34-CD29hi preadipocyte pool thereby creating an 
environment with higher capacity for beiging. 
Adipose tissue is a primary source of circulating inflammatory factors in obesity (26–28), but 
the effects of acute exercise on changes in adipose tissue immune cell composition have not been 
directly measured. Using transcriptomic analysis, Fabre et al. reported an increased expression of 
macrophage genes in human subcutaneous adipose tissue from previously untrained lean adults 4 
h after a single session of exercise (29). In contrast, using immunofluorescence, MacPherson et 
al. (30) found reduced F4/80+CD11c+ cells (representing pro-inflammatory macrophages) in 
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inguinal white adipose tissue from HFD mice two hours after completing a two hour treadmill 
exercise session. Unfortunately, neither of these methodologies directly quantifies macrophage 
number from the adipose tissue, so the phenotype of adipose tissue macrophages cannot be 
determined from these studies. Our study is the first work to our knowledge to quantify adipose 
tissue macrophage content after acute exercise in subcutaneous adipose tissue from human 
subjects using flow cytometry. Contrary to our hypothesis, we found no change in macrophage 
number 12 hours after a session of exercise in this obese cohort. It is possible that an exercise-
induced change in adipose tissue macrophage number is transient, and we may have missed this 
change in our samples collected 12 hours after exercise. It is also possible that acute exercise 
may not change macrophage number, but may modify the macrophage phenotype instead, 
consistent with the gene expression-level changes observed by Fabre et al. (29). In attempt to 
stratify macrophage subtypes, we used surface markers CD11c and CD206, but we were unable 
to achieve consistent separation of macrophage subtypes between cytometer runs. As well as 
being unable to quantify macrophage subtypes, we observed that most macrophages were 
CD11c+CD206+, which is in contrast with some previous studies assessing human subcutaneous 
adipose tissue macrophages (15); therefore, further clarification on the response of different 
macrophage subtypes to exercise needed. 
To assess the ability of exercise to signal cellular remodeling of the broader adipose tissue 
immune environment, we also quantified dendritic cell and T cell content. While T cells (in 
particular TRegs and Th2 cells) are important for maintaining adipose tissue health in lean 
subjects, T cell accumulation in adipose tissue has been shown to precede macrophage 
infiltration; indicating that these cells are an important player in the early adipose tissue immune 
response. Furthermore, there is some data linking CD11c-expressing adipose tissue DC’s to 
immune cell recruitment, and specifically to T cell phenotype (Th17 vs. Th1 polarization; (31)). 
However, there are not much data assessing the contribution of DC’s identified by markers truly 
distinguishing them from adipose tissue macrophages, as typical DC markers share overlap with 
macrophages and other cells (32). Using the general T cell marker CD3, and a specific DC 
marker CD64-CD11c+ (33), we found that total T cell and DC numbers did not change 12h after 
exercise. Similar to adipose tissue macrophages, this does not preclude the possibility that 
sampling 12 hours after the exercise session omits changes that may have occurred earlier (or 
later); or that exercise induces a phenotypic shift within these cell populations. Furthermore, 
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given the importance of these immune cell populations in the response to adipocyte hypertrophy, 
the effects of exercise on these cell populations may only be apparent during periods when 
adipose tissue is undergoing dynamic change (i.e., periods of weight gain or weight loss). For 
example, Kawanishi et al. (2010) reported that mice that exercised while actively gaining weight 
on a high fat diet (HFD) were largely protected from the large increase in inflammatory 
cytokines and markers of pro-inflammatory macrophage infiltration commonly found in adipose 
tissue from sedentary mice that gained the same amount of weight on the HFD. 
Previous work from our lab and others (9,34) suggests that exercise may augment 
subcutaneous adipose tissue angiogenesis, a process that is required for effective adipose tissue 
remodeling. Because endothelial cells are central to the process of angiogenesis, we 
hypothesized that exercise would increase the abundance of these cells in adipose tissue. 
Contrary to this hypothesis, we did not detect a measurable increase in endothelial cell number in 
adipose tissue collected 12 hours after exercise. However, based on evidence that 12 weeks of 
exercise training increased adipose tissue capillarization (Walton, et al), along with cross-
sectional findings from our lab reporting elevated expression of CD31 in regular exercisers 
compared with sedentary control subjects, we contend it may take longer to detect changes in 
endothelial cell number. 
Among the limitations to this study are that we did not power the study to explore sex 
differences, and we were unable to assess depot differences. While differences in adipose tissue 
metabolism are known to exist between men and women, we anticipate that these sex related 
differences may be rather subtle compared with the robust effects of exercise on our measures. In 
addition, because we were interested here in studying exercise-mediated signals within 
subcutaneous adipose tissue after each exercise session in order to assess the potential for 
exercise to improve the capacity for lipid storage within this depot, our findings may not 
translated to responses in other adipose tissue depots (e.g. visceral or gluteofemoral adipose 
tissue). While we did not find a change in immune or endothelial cell content, it remains possible 
that these cell populations may change earlier after exercise than we measured, or that the 
exercise-induced signals related to inflammation and angiogenesis might be more potent in a less 
healthy population that the participants in our study. While our experiments do not identify a 
specific mechanism for the reduction in preadipocytes, the preferential reduction in CD34hi 
preadipocytes suggests future work should continue to explore these three preadipocyte subtypes 
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(CD34hi, CD34lo, and CD34-) to measure transcriptional/function changes related to 
differentiation or proliferation. This may be important in the quest to understand how exercise 
can regulate preadipocyte function as well as to identify pathways for the independent regulation 
of these progenitor subtypes. 
The most novel finding from these experiments was the exercise-induced reduction in 
preadipocyte number, and this was achieved by a reduction in the abundance of CD34hi 
preadipocytes, which in turn differentiate into mature adipocytes with high lipolytic rates. Given 
that high adipose tissue lipolytic rate is linked to insulin resistance (19,35), this phenotype could 
lead to improved adipose tissue and whole body metabolism. Our finding that there was no 
change in immune cell, macrophage, T cell, or dendritic cell content in this cohort of obese, 
regular exercisers suggests that immune cell number is unchanged 12h after exercise in obese 
regular exercisers. Furthermore, the lack of change in endothelial cell number 12 h after the 
endurance-type exercise session likely indicates that adipose tissue angiogenesis takes several 
repeated exercise exposures to accrue. Overall, these data suggest the rapid effects of exercise on 
adipose tissue stromal cell number feature a remodeling of the preadipocyte pool that could lead 
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Figure IV-1 Experimental Design. 
All participants completed an evening and morning visit for both exercise and sedentary control collections, in 




Figure IV-2 Representative flow cytometry gating scheme. 
A) CD45+/- cell populations were gated off of single cellsàscatteràlive cell selection. From CD45+ (immune 
cells): CD3+ T cell selection is shown (2B); as well as total macrophages, CD64+ with the addition of a subsequent 
CD206- exclusion (2C). From CD45- (non-immune cells): EC’s were selected as CD31+CD34+. Preadipocyte 




Figure IV-3 Plasma cytokine concentrations. 
There was no change in circulating plasma cytokine concentrations of IL6 (P = 0.86; A) or TNFα (P = 0.91; B). N = 




Figure IV-4 Stromal vascular cell content of adipose tissue samples following SED and EX visits. 
(A) Immune cells as CD45+ and non-immune cells as CD45-; (B) Subsets selected from CD45+ or CD45- parent 
populations. SVC: stromal vascular cells; EC: endothelial cells; DC: dendritic cells; Macs: macrophages. All cell 




Figure IV-5 Preadipocyte phenotype. 
SVC: stromal vascular cells. (A) Total preadipocytes in the stromalvascular fraction decreased in EX (P = 0.04). (B) 
CD34hi preadipocytes decreased as % SVC (P = 0.002; interaction between exercise and preadipocyte subtype P = 
0.046). (C) Relative to total preadipocyte content: CD34hi preadipocytes trended to increase in EX (P = 0.08), 
CD34lo preadipocytes decreased (P = 0.04), and CD34- preadipocytes did not change (P = 0.86). N = 10. Data are 




Figure IV-6 Assessment of the influence of blood contamination in SVC quantification. 
(A-F) Whole blood control to assess the presence of blood cells within tissue SVC gating. (G-H) CD206-based 
selection of a total macrophage population clean from blood cells (blood sample with same gating in 6D). All plots 





Table IV-1 Flow cytometry antibodies 
Marker Color Clone Supplier 
Live/Dead Live/Dead Fix Yellow N/A Thermo Fisher Scientific L34967 
CD45 e450 HI30 eBiosciences 48-0459-41 
CD64 APC 10.1.1 BioLegend 305013 
CD34 Percp-Cy5.5 581 BioLegend 353521 
CD31 APC-Cy7 WM59 BioLegend 303119 
CD11c PE-Cy7 3.9 BioLegend 301608 
CD29 PE TS2/16 BioLegend 303004 
CD3 FITC OKT3 BioLegend 317305 
CD206 BV650 19.2 BD Optibuild 740598 





Table IV-2 Baseline characteristics 
Age (years) 26 ± 5 
Body mass (kg) 96 ± 11 
BMI (kg/m2) 33 ± 3 
% Body Fat (DEXA) 41 ± 7 
Fat mass (kg) 39 ± 7 
Fat free mass (kg) 56 ± 7 
VO2peak (L/min) 
Matsuda ISI 
3.0 ± 0.5 
4.1 ± 1.4 





Table IV-3 Exercise effects on fasting blood profile 
 
SED EX P 
NEFA (mg/dL) 344 ± 70 346 ± 71 0.97 
Triglycerides (mg/dL) 82 ± 40 66 ± 25 0.30 
Total Cholesterol (mg/dL) 145 ± 27 137 ± 29 0.10 
HDL Cholesterol (mg/dL) 36 ± 13 34 ± 9 0.27 
LDL Cholesterol (mg/dL) 109 ± 26 101 ± 24 0.21 
Fasting glucose (mg/dL) 78 ± 10 79 ± 10 0.76 
Fasting insulin (uIU/mL) 12 ± 5 11 ± 6 0.90 
NEFA: non-esterified fatty acids; HDL: high density lipoprotein; LDL: low density lipoprotein. n = 10. Data are 
Mean ± SD. 
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Chapter V. Project 3 
Effects of Habitual Exercise on Adipose Tissue Responses to Overeating 
ABSTRACT 
Overeating and the resultant weight gain have been linked to the ectopic lipid deposition and 
inflammation that underlie many obesity-related diseases. Effective storage of excess energy in 
subcutaneous adipose tissue during periods of overeating may help reduce weight-gain-related 
insulin resistance. Furthermore, exercise can alter the expression of genes involved in regulating 
adipose tissue storage capacity. The aim of this study was to assess changes in the expression of 
factors regulating adipose tissue storage capacity and inflammation in response to a brief 
exposure of overeating in non-obese adults who are either regular exercisers (EX) or non-
exercisers (nonEX). Eleven EX and 11 nonEX who were well matched for BMI (22 ± 2 vs. 23 ± 
3 kg/m2) ate 30% above their estimated daily energy requirements for one week. Fasting blood 
and abdominal subcutaneous adipose tissue samples were collected before and after the 
overeating intervention. Both EX and nonEX gained ~1 kg (P<0.01), and Matsuda ISI was 
reduced ~15% in both groups (P=0.04), with no difference in the response to overeating between 
EX and nonEX. Similarly, gene expression of factors involved in lipid metabolism (HSL, ATGL, 
DGAT, PPARγ) and angiogenesis (HIF1α, KDR) were increased (P<0.05), with no differences 
observed between EX and nonEX. The modest overeating stimulus did not increase markers of 
inflammation in the systemic circulation (plasma C-reactive protein; P = 0.30) or adipose tissue 
(pERK/ERKtot P = 0.33; MCP-1 P=0.85). Overall our findings indicate that short exposure to a 
modest overeating stimulus can impair insulin sensitivity and upregulate genes involved in 
regulating adipose tissue storage capacity, with no major differences in responses between 




Obesity afflicts over one third of Americans, and is a leading cause of insulin resistance and 
the associated comorbidities (1,2). Obesity typically develops over months and years, as a result 
of episodic overeating (i.e., energy intake > energy expenditure), which requires adipose tissue to 
expand considerably in order to store the excess energy as triglycerides within the adipocytes. 
Unfortunately, with excessive weight gain, the capacity of adipose tissue to expand 
effectively/healthfully is often surpassed, which can lead to pathological features within the 
tissue, including hypoxia and fibrosis (3). Therefore, understanding the regulation of the 
processes involved in enhancing adipose tissue storage capacity during overeating is a crucial 
step for developing targeted therapies for adipose tissue (and systemic) insulin resistance. 
Exercise is known to rapidly improve systemic insulin resistance, but its effects on adipose tissue 
are not well explored. Understanding the effects of exercise on factors regulating adipose tissue 
storage capacity during episodes of overeating could reveal new mechanisms for improving 
metabolic health in obesity. 
Healthy adipose tissue expansion requires several remodeling processes including 
adipogenesis (the formation of new adipocytes), angiogenesis (the formation of new blood 
vessels) and extracellular matrix (ECM) remodeling. Increased adipogenesis is thought to 
support healthier adipose tissue expansion by providing more small adipocytes for storing excess 
energy, which may attenuate the hypoxia that can result from extensive adipocyte hypertrophy 
(4). Similarly, it has been proposed that adipose tissue vascularity in obesity may be insufficient 
to provide oxygen to the hypertrophic adipocytes (5), and interventions designed to increase 
adipose tissue angiogenesis have been found to improve systemic glucose metabolism in mice 
(6–8). Furthermore, overexpression of HIF1α (the master regulator of hypoxic signaling) in mice 
triggers dramatic ECM fibrosis and inflammation (9). Chronic low-grade inflammation is a 
hallmark of obese adipose tissue, and can directly impair local and systemic insulin resistance by 
inhibiting insulin signal transduction. Immune cell expansion within adipose tissue can develop 
within days in mice on a high fat diet (10), though the onset of inflammation during weight gain 
in humans is not well established. Together, better understanding the regulation of key factors 
linked to enhancing adipose tissue storage capacity (e.g., angiogenesis, ECM remodeling, and 
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inflammation) in response to overeating, could identify mechanisms to improve healthy adipose 
tissue expansion and mitigate the negative consequences of weight gain and obesity. 
Exercise can alter the expression of genes that have been shown to increase adipogenesis, 
angiogenesis, and ECM remodeling (11–14), suggesting that exercise may trigger events that 
could lead to enhanced storage capacity in adipose tissue. In fact, exercise training studies in 
mice have demonstrated animals that exercise while gaining weight on a high fat diet were 
protected from adipose tissue fibrosis and inflammation, compared with sedentary mice that 
gained the same amount of body fat on the same high fat diet (12,15). There is also evidence that 
exercise training can trigger adipose tissue angiogenesis in humans (16). Importantly, to test the 
effects of exercise on factors regulating adipose tissue storage capacity it is best to conduct 
longitudinal experiments while adipose tissue is stimulated to expand (i.e., during periods of 
sustained overeating). This project sought to determine the effects of exercise on factors related 
to adipose tissue storage capacity (e.g. angiogenesis, ECM remodeling, immune response) in 
response to one-week of overeating. Our hypothesis was that brief overeating would trigger 






We recruited two cohorts of health adults; one group of regular exercisers (EX; a least 4 days/wk 
of ≥30 min aerobic exercise of moderate-vigorous intensity for ≥6 months) and one group of 
non-exercisers (nonEX; no regularly planned exercise for at least 6 months). In total, 11 EX and 
11 nonEX completed the study and the groups were well matched for body mass index (BMI; 
20-30 m/kg2). All subjects were non-smokers and weight-stable (±3 kg for at least 6 months). 
Exclusion criteria included blood pressure > 140/90 mmHg, history of cardiovascular or 
metabolic disease, or regular use of medications known to affect metabolism. The study protocol 





Preliminary testing included measurement of weight, height, blood pressure, and peak oxygen 
consumption (VO2peak) to assess aerobic capacity/fitness. VO2peak was determined using a 
graded exercise test to exhaustion on either a stationary bike or treadmill, beginning with a 4-
minute warm up, followed by an increasing workload every 1-2 minutes until volitional fatigue. 
 
Experimental protocol 
Experimental visit. Subjects completed two experimental visits; one immediately before (Pre) 
and another immediately after (Post) the one-week overeating intervention. The study design is 
depicted in Figure V-1. The evening before the experimental trial, EX completed an exercise 
session at 1630h (45 min at ~65% VO2peak, monitored by heart rate). All subjects were provided 
with strict guidelines for dinner to ensure standard macronutrient composition (33% of daily 
energy expenditure; 55% carbohydrate, 30% fat, 15% protein). This meal was consumed by 
2100h, after which subjects fasted until arriving for their experimental trial the next morning.  
Subjects arrived to the laboratory at 0700h the next morning, at which time, body weight 
and resting blood pressure were collected, and an intravenous catheter was inserted for blood 
sampling. Then an abdominal subcutaneous adipose tissue sample was obtained by needle 
aspiration at 0800h (details of adipose tissue biopsy procedure are provided in Appendix A – and 
details of adipose tissue processing are provided below). Subjects then completed an oral glucose 
tolerance test (OGTT), with blood samples collected every 15 min for 2 hours after drinking a 
75g dextrose drink (Azer Scientific). The Post overeating experimental trial was identical to the 
Pre trial. 
 
Overeating intervention. For one week, subjects overate ~30% excess calories per day above 
their estimated daily energy expenditure based on fat free mass from underwater weighing: [{370 
+ (21.6 x fat free mass)} x 1.5] x 1.3 (17).  To achieve this daily energy surplus, subjects 
consumed their normal diets to reach energy balance requirements, and supplemental calories 
were provided in the form of Boost Plus® (50% carbohydrate, 35% fat, and 15% protein) or other 
snacks with the same macronutrient composition if participants had dietary restrictions that 
precluded the use of Boost Plus®. Diet and exercise were monitored daily using MyFitnessPal 
and subjects also reported daily to a study team member: (1) consumption of their supplemental 
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calories; (2) detailed exercise information, and (3) body weight, taken at the same time each day. 
Importantly, EX were required to eat more than nonEX (i.e. to replace energy expended during 
exercise) in order for both groups to be in 30% caloric excess each day. On the final evening of 
the overeating intervention (the night before the “Post” trial), subjects consumed the same meal 
for dinner that they consumed the evening before the “Pre” trial. 
 
Analytical procedures 
Adipose tissue processing. Adipose tissue biopsies were immediately saline-rinsed, and divided 
for analysis. Approximately 300 mg was flash frozen for RNA and protein analysis. The 
remaining ~1-1.5 g was immediately digested in collagenase for separation of the SVCs and 
mature adipocytes; full protocol in Appendix E. Mature adipocytes were washed and allocated 
for ex vivo lipolysis (see below). 
 
Lipolysis assay. An ex vivo lipolysis assay was performed on freshly extracted cells to assess 
basal and stimulated lipolytic rates of isolated mature adipocytes (200µL per well). Samples 
were incubated for two hours (rocking at 37 °C) in Krebs-Ringer Bicarbonate Buffer + 4% BSA, 
5mM glucose, 200 nM adenosine, 20nM 2-phenylisopropyl adenosine, and 1U/mL adenosine 
deaminase in a sterile 96-well plate. Stimulated samples were also exposed to: 1x10-8 mM 
isoproterenol and 1x10-6 mM isoproterenol during this incubation. Immediately after the 2-hour 
incubation, the assay plate was placed on ice to arrest lipolysis, and media was collected to 
determine lipolytic rate as [glycerol] by colorimetric assay (Sigma Free Glycerol Reagent). 
 
Adipose tissue mRNA expression. Gene expression was measured using qPCR (full protocol in 
Appendix F). Briefly, RNA was isolated by chloroform separation following homogenization in 
1 mL RNA Stat-60 (Tel-Test Inc., Friendswood, TX). Reverse transcription was performed with 
200 ng RNA input, using Life Technologies reverse transcriptase (4368813, Life Technologies, 
Grand Island, NY). Predesigned primer and probe sequences were purchased from IDT 
PrimeTime qPCR Assays and are listed in Table V-1. The qPCR data was normalized to 
expression of 2 housekeeping genes (peptidylprolyl isomerase A (PPIA) and beta-2-
microglobulin (B2M)) using the -∆Ct method (18) and expressed as fold induction (2-∆∆Ct) of 
mRNA expression compared with  before overeating. 
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Western blotting. Western blotting was performed to assess protein content of a subset of genes 
whose expression was found to change using qPCR. Protein content was measured by loading 
15-20 ug protein from subcutaneous adipose tissue homogenate (full details in Appendix G). All 
nitrocellulose membranes were stained with Memcode Reversible Protein Stain 
(ThermoScientific cat 24580) after transfer, and this total protein stain was quantified by 
AlphaView and used as a loading control in our quantification of protein abundance. Primary 
antibodies were purchased from Cell Signaling and incubated overnight. As noted above, protein 
content (AU) was normalized to total protein content from that subject’s lane (Memcode) to 
correct for variability in loading, as well as an internal standard (pooled adipose tissue 
homogenate) that was loaded into each gel to correct for differences in running and transferring 
when multiple membranes were combined. 
 
Plasma/serum concentration measurements. Blood samples were centrifuged at 2000rpm 
at 4oC for 15 minutes and stored at -80 °C until analysis; serum samples were left to clot at room 
temperature for 30 min before centrifugation. Plasma glucose (Thermo Scientific, Waltham, MA, 
USA), fatty acid (Wako Chemicals USA, Richmond, VA, USA), triacylglyceride 
(Triacylglyceride reagent; Sigma Aldrich), and total- and high-density lipoprotein (HDL; 
Cholesterol E and HDL-Cholesterol E;Wako Chemicals USA) concentrations were measured 
using commercially available colorimetric assay kits. Serum insulin concentration was measured 
with a chemiluminescent immunoassay (Siemens IMMULITE 1000, Flanders NJ, USA). Plasma 
C-reactive protein was measured by a high-sensitivity ELISA (Calbiotech, CR120C). A panel of 
circulating inflammatory markers (IFN-γ, IL-10, IL-13, IL1Rα, IL-1α, IL-1β, IL-6, IL-8, MCP-1, 
TNFα, IL-4, VEGF) was measured by multiplex (Luminex L200, Luminex, Austin, TX, USA) 
using a kit purchased from Millipore (#HCVD3-67CK, Milliplex MAP Kit, Millipore, Billerica, 
MA, USA).  
 
Calculations 
Glucose and insulin concentrations during the OGTT were used to calculate insulin sensitivity 





A student’s t-test was used to determine baseline differences between EX and nonEX. A 2-way 
mixed model ANOVA (overeating x exercise) was used to assess the response to overeating 
within, and between the groups. A P-value of < 0.05 was considered statistically significant. 
 
RESULTS 
Baseline subject characteristics 
As designed, EX and nonEX were well matched for age, body weight, and BMI (Table V-2).  
Also, as anticipated, VO2peak was nearly 25% greater in EX vs. nonEX (p = 0.03; Table V-2), 
reflecting the expected enhanced aerobic capacity/fitness in EX. Baseline insulin sensitivity (as 
assessed by the Matsuda ISI) was greater in EX vs. nonEX (p = 0.01; Table V-2), and there was 
a trend for fasting plasma triglyceride concentrations to be higher in nonEX vs. EX (p = 0.06; 
Table V-2) but all other baseline blood lipid measures were similar between groups (Table V-2). 
 
Whole-body metabolic responses to overeating 
After our one-week overeating intervention, body weight increased by ~1 kg in both EX (75.1 ± 
10 to 75.9 ± 11 kg) and nonEX (75.0 ± 16 to 75.9 ± 16 kg) (both p < 0.01). Importantly, weight 
gain was identical between groups (p = 0.99). Matsuda ISI was reduced by ~10% after 
overeating (p = 0.04), and this impairment in insulin sensitivity was similar between groups 
(Figure V-2). The one-week overeating intervention did not significantly alter any of the 
measured blood lipid markers or C-reactive protein in either group (Table V-3). 
 
Adipose tissue responses to overeating 
Adipocyte size, lipolysis, and inflammation. The very modest (~1 kg) weight gain from the one-
week overeating intervention did not translate to a measurable increase in average adipocyte area 
in either EX (4268 ± 1252 to 4346 ± 1178 µm2) or nonEX (5078 ± 1251 to 5284 ± 1873 µm2). 
Overeating also did not alter basal or stimulated ex vivo lipolytic rate in isolated adipocytes in 
either group (Figure V-3), suggesting our overeating intervention did not impact the primary 
function of adipocytes. The one-week overeating intervention did not appear to affect a measure 
of tissue inflammatory status, ERK phosphorylation (Figure V-4). Unfortunately, 9 of the 10 
cytokines measured by Luminex (see METHODS) were not detectable in the healthy subjects 
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enrolled in this study. MCP-1 was the only measureable cytokine, and it was not affected by 
overeating in either group (P ≥ 0.85; data not shown). 
 
Factors regulating adipose tissue metabolism and remodeling. In agreement with our ex vivo 
adipocyte lipolytic measurements, overeating did not alter the protein abundance or 
phosphorylation state of factors regulating lipolysis or esterification (Figure V-4). There was a 
significant main effect for the abundance of HSL and ATGL between EX and nonEX (P < 0.05; 
Figure V-4), but again this did not translate to differences in lipolysis (Figure V-3).  
 
In contrast to protein abundance measures, the mRNA expression of several key factors 
regulating lipolysis and lipid storage (Figure V-5A) as well as angiogenesis (Figure V-5B) were 
upregulated after overeating. This suggests that the overeating stimulus triggered signals to 
augment these processes, but the stimulus may not have been robust enough (or long-lasting 
enough) to translate to a measurable increase at the protein level. Unlike the increased gene 
expression of lipid metabolism and angiogenic factors, mRNA expression of some of the 
important factors involved in ECM remodeling did not change (Figure V-5C). Contrary to our 
hypothesis, we also did not observe any measurable differences in gene expression in response to 
overeating between EX and nonEX. 
 
DISCUSSION 
Major findings from our study indicate that even a modest overeating stimulus can impair 
insulin sensitivity after one week in healthy adults, and regular exercise did not protect against 
this rapid maladaptive response to overeating. In contrast to the decline in insulin sensitivity, 
overeating did not significantly affect blood lipid profile, adipocyte lipolysis, or markers of 
inflammation in adipose tissue or plasma. Interestingly, overeating did increase gene expression 
for factors regulating lipid metabolism and angiogenesis in adipose tissue, but this did not evoke 
changes in the abundance of their respective proteins. Therefore, while systemic insulin 
sensitivity may decline rapidly after even mild overeating, it may take a more robust overeating 
stimulus (duration of overeating and/or magnitude of weight gain) for other clinical and 
subclinical measures to respond. 
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Overeating can rapidly impact key markers of metabolic health (20–23). Our finding that 
insulin sensitivity was impaired after just one week of overeating aligns with previous work 
demonstrating a relatively rapid decline in insulin sensitivity with overeating (20,24–27). The 
mechanism(s) underlying the rapid reduction in insulin sensitivity with overeating are not clear, 
but may be due to several factors, including: oxidative stress (24), ectopic lipid deposition (liver, 
visceral adipose tissue; (28)), and tissue and/or systemic inflammation (10). It has been 
suggested that regular exercise may help protect against the insulin resistance that often 
accompanies overeating (25,27). For example, Walhin et al. (25) reported that in subjects 
required to overeat 50% more than their calculated energy needs for 1 week, glucose tolerance 
was impaired in those who reduced their daily physical activity to low levels (<4000 steps/day), 
but not in subjects who remained physically active. In contrast, here we found insulin sensitivity 
declined similarly in regular exercisers and non-exercisers. This discrepancy may be due in part 
to the relatively modest overeating stimulus employed in our study (30%) compared with 
previous studies (≥50%). Perhaps even more notable, in previous studies (25,27), subjects who 
exercised while overeating gained a bit less weight or body fat during the intervention than those 
who remained sedentary, and this difference in body weight/fat gain could have a profound 
impact on their metabolic outcomes. In our study, exercisers and non-exercisers were tightly 
matched for weight gain during our intervention, suggesting that when controlling for weight 
gain, exercise may not provide additional protection against systemic insulin resistance in 
response to brief exposure to overeating. Furthermore, the “inactive” groups in previous studies 
(25,27) were required to markedly reduce their habitual physical activity behaviour in addition to 
overeating, and this simultaneous change confounds the interpretation of their findings - whereas 
here we assessed the effects of maintained habitual physical activity status in our subject. 
During periods of overeating and weight gain, the vast majority of the excess energy is stored 
in adipocytes in the adipose tissue. Correspondingly, weight gain can increase the abundance of 
factors regulating lipolysis and lipid storage in the expanding subcutaneous adipose tissue (29). 
For example, overfeeding studies have reported changes in proteins involved in regulating 
adipose tissue esterification (DGAT2) and lipolysis (pHSL, PLIN, ATGL) after 8 weeks of 
weight gain in mice and humans (30,31). Our observation that the gene expression of many of 
these same factors were increased after only one week of overeating suggests that the signaling 
events triggering these adaptive responses in adipose tissue occur rather quickly in response to an 
	79	
energy surplus. We surmise that the lack of change in the abundance of corresponding proteins 
may have been largely due to the short exposure of a relatively modest overeating stimulus in our 
study, although other factors, such as the effects of overeating on adipose tissue endoplasmic 
reticulum (ER) stress (32) may contribute as well.  The ER is the primary site of protein 
synthesis, so ER stress, and a resultant disruption in ER function may attenuate protein 
translation. 
Adipose tissue expansion during periods of weight gain requires not only adipocyte 
hypertrophy, but also accommodation by the surrounding anatomical environment. For example, 
if expanding adipocytes do not experience a compensatory increase in angiogenesis/vascularity, 
insufficient capillarization may contribute to tissue hypoxia/inflammation, as well as tissue and 
systemic insulin resistance (33,34). Although angiogenic capacity has been reported to increase 
in response to overeating and weight gain (35), adipocyte capillary density is still often found to 
be compromised in obesity (6,7). Our findings expand on these data by demonstrating that even a 
very modest overeating stimulus in human subjects can trigger a pro-angiogenic response, as 
evidenced by our observed increase in the expression of several pro-angiogenic genes. 
Interestingly, this included HIF1a gene expression, which could suggest increased hypoxic 
signaling; but unfortunately we did not have sufficient tissue to establish HIF1a localization 
(HIF1a nuclear content would be a better index of HIF1a activation). It appears that the pro-
angiogenic signalling we observed did not translate to a measurable increase in adipose 
vascularity, as noted by the lack of change the gene expression of CD31 or protein abundance of 
VEGFα (both markers of an adaptive response in angiogenesis). 
Contrary to our hypothesis, exercise did not further augment this angiogenic response to 
overeating. This is in apparent contrast with recent findings from our lab that adipose tissue 
VEGFA mRNA expression increased in the hour(s) after exercise (11,36), which we interpreted 
to suggest that angiogenic signaling is upregulated in the few hours after each session of 
exercise. This discrepancy could be a factor of the timing of the measurements (12h after 
exercise in the present study vs. 1-3 hours after exercise in previous work). Alternatively, it is 
possible that the pro-angiogenic effects of overeating we observed in both EX and nonEX may 
have overwhelmed the more subtle effects of exercise in our study.  
Although obesity-related insulin resistance is often linked with increased systemic and/or 
adipose tissue inflammatory response (37–42), we found no increase in tissue or systemic 
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inflammation in response to overeating. This aligns with some human studies dissociating 
impaired insulin sensitivity from changes in circulating pro-inflammatory cytokines and adipose 
tissue macrophages in the early stages of weight gain (24,43).  Development of insulin resistance 
with an accompanying pro-inflammatory response likely requires more robust alterations in 
adipose tissue morphology than our 1 week overeating intervention would provide (reviewed in 
(44)). For example, Muir et al. (10) reported that in overfed mice, peak CD11c+ adipose tissue 
macrophage infiltration was observed when adipocytes hypertrophied to their peak size. 
Therefore, while increased circulating inflammatory factors and an increase in adipose tissue 
inflammatory pathway activation may indeed contribute to impaired insulin action in obesity, 
they may not be required for the onset of insulin resistance during the early stages of weight 
gain. This is consistent with other work in mice suggesting that early diet-induced insulin 
resistance is linked to lipid overload and lipid toxicity in skeletal muscle and liver, rather than 
inflammation (45). Notably, cytokine concentrations are often well below the clinical range in 
healthy adults (46), and even overeating for one week did not bring many of these adipose tissue 
cytokines into the measurable range in our healthy subjects (Luminex, data not shown). 
Although our findings indicate regular exercise did not protect against insulin resistance or 
alter the changes in adipose tissue we found in response with this brief exposure to overeating, it 
is still quite possible that exercise might modify the adaptive responses to longer-term overeating 
and weight gain. Along these lines, an overwhelming amount of epidemiological evidence 
demonstrates improved markers of metabolic health outcomes and fewer incidences of metabolic 
disease in those who live physically active lives vs. sedentary adults (47,48). Several factors may 
underlie the long-term health benefits of exercise, including improved weight maintenance with 
exercise (49), but much of the health benefits of a physically active lifestyle remain even when 
controlling for body weight/body fat. Because most people experience at least some weight gain 
throughout adulthood (50), it is possible that at least a portion of the long-term metabolic health 
benefits of regular exercise may be due to exercise-mediated modifications in adipose tissue 
structure and metabolic function as people experience episodes of weight gain throughout their 
lifetime. 
Conducting controlled overeating experiments in human subjects presents considerable 
challenges, and several limitations exist. This experiment was conducted in free-living 
conditions, and although subjects’ diets were tightly monitored, we were not able to directly 
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control dietary adherence. All subjects gained weight after the one-week intervention supporting 
the prospect that they were indeed overeating, and importantly, weight gain was tightly matched 
between EX and nonEX. In addition, our study was designed to test the effects of overeating in 
healthy adults to assess consequences of early stages of weight gain, but it is possible that the 
response to a similar overeating challenge in obese adults may be different from what we 
observed here. Also, we only collected samples from abdominal subcutaneous adipose tissue in 
our study, due to its major role in fatty acid delivery to the systemic circulation (51), but it is 
important to consider that adipose depot differences likely exist in the response to overeating. In 
particular, visceral adipose tissue typically develops more inflammation than subcutaneous 
adipose tissue, and so the responses to overeating might be different in visceral fat. Furthermore, 
there are differences in the adipose tissue immune response to overeating between males and 
females (52). While we anticipate that these sex-based differences in the response to overeating 
may be rather subtle, it is important to acknowledge that the study was not powered to assess sex 
differences in this response. Finally, all samples were collected in the overnight fasted state, so 
the responses presented here do not reflect the overeating effects in postprandial conditions. 
In summary, our main findings indicate that a brief and modest overeating intervention 
triggered an increase in the expression of genes involved in lipid metabolism and angiogenesis in 
abdominal subcutaneous adipose tissue. These early adaptive responses to overeating and weight 
gain could lead to long-term alterations in adipose tissue lipid storage capacity. Future work 
aimed at understanding the regulation of angiogenesis, adipogenesis, and ECM remodeling in 
response to more extensive weight gain will be very impactful. This study also provided a free-
living, practical model to suggest that brief overeating (inducing just ~1 kg weight gain) 
significantly impaired insulin sensitivity in healthy adults, without affecting ex-vivo lipolytic 
rate, or markers of adipose tissue and systemic inflammation. This suggests that the early 
induction of insulin resistance with weight gain is likely independent of adipose tissue or 
systemic inflammation, and (consistent with previous work) could result from ectopic lipid 
deposition. Importantly, we found no difference in the response to overeating in regular 
exercisers vs. non-exercisers, suggesting exercise may not protect against the negative 
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Figure V-1 Overeating study design. 
The day before the study visits, subjects consumed identical diets, with the addition of supplemental kcal during the 
intervention. Visit 1 was identical to Visit 2, as subjects reported to the lab following an overnight fast for collection 
of adipose tissue and blood samples. Overeating was performed in free-living conditions and monitored daily. 
OGTT: oral glucose tolerance test.	  
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Figure V-2 Insulin sensitivity response to overeating. 
ISI: insulin sensitivity index *P<0.05 for effect of exercise. †P<0.05 for effect of overeating. N = 9-11 per group. 




Figure V-3 Ex Vivo Adipocyte Lipolysis. 
Basal lipolysis (no isoproterenol), low-dose isoproterenol-stimuled lipolysis, and high-dose isoproterenol-stimulated 




Figure V-4 Adipose Tissue ERK Protein. 
Representative images and quantified protein content for ERKtot, pERK, and pERK/ERKtot as a marker of ERK 





Figure V-5 Adipose Tissue Lipolysis/Esterification Proteins. 
No change in the content of eight proteins involved in lipolysis or esterification in response to overeating. Inset: 
representative images for all proteins measured, with representative Memcode total protein image at right. *P<0.05 




Figure V-6 Gene expression. 
mRNA was upregulated in response to overeating in a panel of genes involved in lipolysis and lipid storage (A) and 
angiogenesis (B), but there was no change in the expression of genes involved in extracellular matrix remodeling 
(C). †P<0.05 for effect of overeating. N = 8-10. Data are Mean ± SD.	
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TABLES 
Table V-1 qPCR targets in the subcutaneous adipose tissue 
	Gene 





















hormone-sensitive lipase (HSL) 
adipose triglyceride lipase (ATGL) 
diacylglyceride acyltransferase 1 (DGAT1) 
glycerol-3-phosphate Acyltransferase-1 (GPAT1) 
CCAAT enhancer binding protein alpha (CEBPα) 
proliferator-activated receptor gamma (PPARγ) 
sterol regulatory element-binding protein 1 (SREBP1c) 
1-acylglycerol-3-phosphate O-acyltransferase (ABHD5) 
vascular endothelial growth factor (VEGF) 
hypoxia inducible factor 1 alpha (HIF1α) 
cluster of differentiation 31 (CD31) 
vascular endothelial growth factor receptor 1 (VEGFR1) 
vascular endothelial growth factor receptor 2 (VEGFR2) 
angiopoietin-2 (ANGPT2) 
angiopoietin-like 4 (ANGPTL4) 
collagen alpha-1 (VI) chain (COL6A1) 
collagen alpha-1 (I) chain (COL1A1) 
transforming growth factor beta 1 (TGF-β1) 
tissue inhibitor of matrix metalloproteinases 1 (TIMP1) 





Table V-2 Baseline characteristics of subjects 
   
 
EX NONEX P 
Age (years) 22 ± 2 23 ± 3 0.70 
Body mass (kg) 75.1 ± 9.9 75.0 ± 15.6 0.99 
BMI (kg/m2) 24.6 ± 2.9 24.6 ± 2.3 0.99 
VO2peak (ml/kg FFM/min) 3.2 ± 0.7 2.6 ± 0.6* 0.03 
Matsuda ISI 11.1 ± 5.3 6.0 ± 3.6* 0.02 
Triglycerides (mg/dL) 54 ± 22 80 ± 35 0.06 
Total Cholesterol (mg/dL) 138 ± 24 131 ± 31 0.59 
HDL Cholesterol (mg/dL) 46 ± 12 38 ± 10 0.13 
LDL Cholesterol (mg/dL) 92 ± 25 93 ± 28 0.94 
BMI: body mass index, ISI: insulin sensitivity index, HDL: high density lipoprotein, LDL: low density lipoprotein. 
* P<0.05 compared with EX. n = 9-11 per group. Data are Mean ± SD. 
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(mg/dL) 54 ± 22 61 ± 40 80 ± 35 75 ± 32 0.12 0.87 0.39 
Total Cholesterol 
(mg/dL) 138 ± 24 129 ± 18 131 ± 31 139 ± 34 0.89 0.99 0.08 
HDL Cholesterol 
(mg/dL) 46 ± 12 48 ± 10 38 ± 10 41 ± 9 0.07 0.22 0.93 
LDL Cholesterol 
(mg/dL) 92 ± 25 81 ± 14 93 ± 28 98 ± 36 0.41 0.58 0.11 
Fasting NEFA 
(uM) 395 ± 191 270 ± 133 336 ± 205 337 ± 210 0.96 0.10 0.09 
CRP (mg/L) 1.7 ± 1.3 1.8 ± 1.6 1.6 ± 1.3 2.0 ± 1.4 0.94 0.30 0.58 
BMI: body mass index, ISI: insulin sensitivity index, HDL: high density lipoprotein, LDL: low density lipoprotein, 
NEFA: non-esterified fatty acids, CRP: high-sensity C-reactive protein. n = 9-11 per group. Data are Mean ± SD.
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Chapter VI. Overall Discussion 
	
Together, the projects of my dissertation shed light on some pathways through which exercise 
modifies adipose tissue in ways that could impact metabolic health. In this chapter, I will 
summarize the key findings from all of my dissertation projects and provide an integrated 
interpretation of the results. Then, I will outline some ensuing questions that could help move 
these findings towards understanding the signals that regulate adipose tissue and systemic 
inflammation and insulin resistance in humans. 
 
SUMMARY OF KEY FINDINGS 
Project 1: The effects of a single session of moderate-intensity and high-intensity exercise on 
factors regulating adipose tissue structure and metabolic function 
In Project 1, I used RNA-sequencing and qPCR analyses to explore changes in the 
subcutaneous adipose tissue transcriptome in obese adults after an exercise session of either high 
intensity interval training (HIIT) or moderate intensity continuous training (MICT). 
Subcutaneous abdominal adipose tissue samples were collected before exercise and one hour 
after exercise. 
Key Findings: 
• HIIT and MICT resulted in similar upregulation of gene sets related to the inflammatory 
response (IL6-JAK-STAT3 Signaling, Allograft Rejection, TNFA Signaling via NFKB, 
and Inflammatory Response) 
• Gene sets involved in Oxidative Phosphorylation, Peroxisome, and Adipogenesis were 
downregulated one hour after exercise 
• The expression of several genes involved in adipose tissue remodeling (VEGFA, IL6, 
ANGPTL4, TIMP1) were increased after exercise 
• The rapid gene set response to a single exercise session appears to be largely independent 
of exercise intensity 
	93	
Overall, this project identified the coordinated upregulation of inflammatory genes to be the 
major adipose tissue signaling response one hour after a single session of HIIT or MICT. 
 
Project 2: The effects of acute moderate-intensity exercise on adipose tissue cellular 
composition and function in lean and obese humans 
Project 2 used flow cytometry to assess changes in the cellular composition of the adipose tissue 
stromal vascular fraction from obese adults collected 12 h after exercise (60 min at 80 ± 3% 
HRpeak; EX) compared with a within-subject sedentary control (SED). 
Key Findings: 
• Exercise decreased both total preadipocyte number, and CD34hi preadipocytes, without a 
corresponding change in CD34- and CD34lo preadipocytes 
• There were no changes in adipose tissue EC’s, total (CD45+) immune cells, DC’s, T 
cells, or adipose tissue macrophages in SED vs. EX 
The decrease in CD34hi preadipocytes after exercise suggests a shift towards a preadipocyte 
phenotype that may confer a healthier whole adipose tissue metabolic profile (i.e. lower lipolytic 
rate). 
 
Project 3: The effects of habitual exercise on adipose tissue responses to overeating 
In Project 3, habitual exercisers (≥30 min planned exercise, ≥5 days/week) and non-exercisers 
(no planned weekly exercise) consumed ~30% more calories than that required for weight 
maintenance.  They gained ~1kg (matched between exercisers and non-exercisers) over one 
week, while maintaining regular exercise or inactivity. Subcutaneous abdominal adipose tissue 
biopsies were collected before and after overeating to assess ex vivo lipolytic rate (isolated 
adipocytes), gene expression, and protein content of factors related to adipose tissue remodeling. 
Peripheral insulin sensitivity was calculated by Matsuda insulin sensitivity index (ISI) from a 3 h 
oral glucose tolerance test before and after overeating. 
Key Findings: 
• One week of modest overeating impaired ISI in healthy adults by 10%  
• Regular exercise did not protect against this rapid maladaptive response to overeating 
• Overeating did not alter blood lipid profile, adipocyte lipolysis, or tissue/systemic 
inflammation 
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• Overeating increased gene expression of factors regulating lipid metabolism and 
angiogenesis (HSL, ATGL, DGAT, PPARγ, HIF1A, KDR) in adipose tissue, without 
changing the corresponding proteins 
Together, the brief overeating exposure (1 week) resulted in a similar reduction in insulin 
sensitivity and tissue gene expression changes in exercisers and non-exercisers, without 
impacting other tissue and circulating markers of metabolic health/inflammation. 
 
INTEGRATED INTERPRETATION OF RESULTS 
 
Rapid adipose tissue inflammatory response to exercise 
A key novel finding from my dissertation was the upregulation of inflammatory signaling 
genes one hour after exercise in adipose tissue from obese adults (Project 1). However, our 
observation in Project 2 that adipose tissue total immune cell number, macrophage, T cell, and 
dendritic cell content did not change 12 hours after exercise in adipose tissue samples from a 
similar cohort of obese, regular exercisers suggests this transcriptional response may not increase 
immune cell number within the adipose tissue, at least in this timeframe. It is well-documented 
that blood leukocyte number increases during exercise, biased towards cytotoxic/effector and 
mature/differentiated cells; cells with tissue migration phenotypes; and cells with a higher 
adenoreceptor/glucocorticoid receptor expression (reviewed in Simpson et al. (149)). After 
exercise, lymphocyte number decreases (lymphocytopenia), and there is an increase in neutrophil 
number relative to pre-exercise baseline, which has been suggested to reflect leukocyte egress to 
tissues like the spleen, lungs, and gut (151). However, despite accelerating interest/appreciation 
in adipose tissue’s role as an immunological tissue, there is essentially no work examining the 
effects of exercise on changes in adipose tissue immune cells in human subjects.  My dissertation 
projects were designed in part to expand our understanding in this regard. Characterizing the 
adipose tissue immune response to exercise could provide a novel understanding of the signals 
regulating adipose tissue inflammation, and inform therapeutic strategies to attenuate the chronic 
low-grade inflammation characteristic of obesity. 
My observation from Project 2 indicating that immune cell number was stable 12 h after 
exercise suggests the leukocytes mobilized by exercise may not be migrating to adipose tissue in 
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the several hours after exercise. Therefore, it is more likely that exercise may trigger a change in 
macrophage or other immune cell phenotype (i.e. transcriptional profile of a given cell 
population), independently of cell number. For example, MacPherson et al. (19) reported a 
reduction in pro-inflammatory (F4/80+CD11c+) macrophages, but no change in total (F4/80+) 
macrophage content 2h post-exercise in mouse inguinal adipose tissue – suggesting exercise 
might regulate macrophage phenotype independent of total number. Given the time course of 
monocyte differentiation within tissue (i.e. days), an acute exercise-induced change in 
macrophage phenotype would likely occur via transcriptional changes within resident adipose 
tissue macrophages (rather than influx and differentiation of circulating monocytes). However, 
monocytes and neutrophils could be rapidly recruited to adipose tissue in response to exercise, 
but I was unable to quantify these cells in this dissertation due to tissue limitations. Therefore, 
future projects could expand on this work by measuring these other immune cell populations, as 
well as immune cell subtypes (e.g. CD11c+/- macrophages) to more completely define the 
adipose tissue response to exercise. 
 
Effects of exercise on adipose tissue angiogenesis and vascularization 
Our findings that VEGFA gene expression increased (trend P = 0.07) one hour after exercise 
(Project 1), with no change in endothelial cell content 12 hours after exercise (Project 2) suggest 
that even though each exercise session may upregulate pro-angiogenic genes, this does not 
trigger endothelial cell migration by 12 hours after exercise. Understanding if and how exercise 
induces angiogenesis could have important therapeutic implications because angiogenesis is 
essential for tissue oxygenation, paracrine function, and fatty acid transport – all of which 
typically become pathologic in the context of adipose tissue expansion. Angiogenesis is 
necessary for adipogenesis (77), implicating this process as central in adipose tissue expansion. It 
has also been suggested that insufficient angiogenesis to accommodate adipocyte hypertrophy 
can drive adipose tissue inflammation and fibrosis through the resulting hypoxic signaling (161). 
Min et al. (193) recently reported that exercise protected against the reduction in adipose tissue 
capillary density normally observed with weight gain in mice on a high fat diet. This suggests 
that exercise may help maintain vascularity in obese adipose tissue, but this will need to be 
explored with a model of overeating long enough to achieve functional changes in human 
adipose tissue vasculature. While we did not collect samples for histology in Project 3, there was 
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no change in adipose tissue CD31 mRNA expression, which provided a crude indication that the 
angiogenic signaling from this modest one-week overeating stimulus did not increase adipose 
tissue vascularity. 
 
Effects of exercise on adipose tissue extracellular matrix (ECM) remodeling 
ECM remodeling is regulated in part by the cumulative balance of matrix metalloproteinases 
(MMPs) and tissue inhibitors of MMPs (TIMPs) in the local adipose tissue environment. 
Although we did not perform an exhaustive assessment of ECM remodeling factors, we found an 
increase in TIMP1 one hour after HIIT/MICT (Project 1), but no difference in COL1 or COL6 
gene expression between non-obese exercisers and non-exercisers (Project 3). Future work 
would merit from more functional measures of adipose tissue ECM remodeling factors in 
response to acute and chronic exercise, such as zymography and histological analyses. 
Furthermore, Marcelin et al. (204) recently showed that PDGFRα signaling regulates the 
proportion of CD9hi progenitors that are linked to a pro-fibrotic phenotype in mice and humans, 
suggesting regulation of the progenitor pool could alter adipose tissue fibrosis. Although we did 
not comprehensively assess the impact of exercise on progenitors within adipose tissue, Project 2 
did identify a change in preadipocyte phenotype and number within adipose tissue 12 hours after 
exercise, suggesting exercise-related signals can influence at least a subset of the progenitor 
populations in human subcutaneous adipose tissue. 
When we addressed the effects of regular exercise on the angiogenic and ECM remodeling 
signaling responses to overeating in adipose tissue, there was no difference in the response 
between exercisers and non-exercisers (Project 3). However, our finding that angiogenic factors 
increase within one week of overeating while ECM remodeling factors do not, suggests that 
angiogenesis may be triggered more rapidly than ECM remodeling; at least in response to 
overeating. Overall, overeating/weight gain and the result increased stimulus for triglyceride 
storage is likely a much more robust signal for these remodeling processes in adipose tissue 
compared with exercise alone, given that these processes are typically triggered to support 
adipocyte hypertrophy/hyperplasia. Therefore, assessing the effects of exercise in the context of 
more robust adipose tissue expansion and energy surplus may shed light on its ability to regulate 
angiogenesis and ECM remodeling. 
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Effects of exercise on adipose tissue metabolism 
One of the most compelling findings from my dissertation was a decrease in total 
preadipocyte content 12 hours after a single exercise session (Project 2). This was observed 
along with a rapid downregulation of the hallmark adipogenic gene set one hour after exercise 
(Project 1). We speculate here that the rapid downregulation of adipogenic genes in response to 
exercise is likely distinct from longer-term adaptations that might feature enhanced adipogenesis, 
given preliminary findings from our lab suggesting that incubating preadipocytes in exercise 
serum increases the rate of adipogenesis (154). It is unclear from the reduction in preadipocytes 
in Project 2 whether this decrease results from increased adipogenesis, reduced proliferation, or 
increased apoptosis. However, given the time course of in vivo preadipocyte differentiation (~8% 
per year (79)), it is likely one of the latter. Overall, the broad takeaway from the observed 
decrease in preadipocyte content (driven by CD34hi preadipocytes) is that the preadipocyte 
phenotype can be modified rapidly. Therefore, better understanding the mechanisms regulating 
the exercise-induced decrease in preadipocytes (e.g. regulation of proliferation and apoptosis) 
could elucidate the potential for therapeutic regulation of these cells by exercise or 
pharmacological means. Importantly, Raajendiran et al. (166) demonstrated that distinct 
preadipocyte subtypes secrete different proteins and differentiate into adipocytes with different 
lipolytic rates. Therefore, exploring the relationship between preadipocyte phenotype and in vivo 
adipose tissue function (e.g. lipolytic rate or secretome) would inform whether manipulating this 
cell population could alter whole adipose tissue metabolic function.  
 
Assessing the adipose tissue structural response to overeating requires robust energy surplus 
A key working hypothesis at the outset of this dissertation was that regular exercise protects 
against the negative consequences of weight gain within adipose tissue. While Projects 1 and 2 
identified some immune and progenitor cell responses to acute exercise in obese regular 
exercisers, Project 3 found no difference in the adipose tissue responses (gene expression, 
protein content, ex vivo lipolytic rate) to short-term overeating between regular exercisers and 
non-exercisers. These data suggest that in non-obese adults, exercise may not impact the adipose 
tissue response to brief and modest overeating. However, the 1 kg weight gain induced by 
overeating did not correspond to an increase in adipocyte size, which is the key demand for 
structural remodeling within adipose tissue. Therefore, although genes involved in adipose tissue 
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metabolism and angiogenesis were upregulated by overeating in Project 3, it was not surprising 
that there were no changes in gene expression of extracellular matrix remodeling factors, or 
protein content of the key fat storage and angiogenic proteins we measured – and in fact this 
informs a model wherein some minimum adipocyte hypertrophy is required to trigger 
measureable structural changes within adipose tissue. That threshold may be dependent on 
baseline adipocyte size or adipose tissue composition, and so working with an obese population 
may also be important to capture the remodeling response that is relevant to pathological adipose 
tissue. 
 
DIRECTIONS FOR FUTURE RESEARCH 
	
Time course of the adipose tissue immune response to exercise 
Findings from Project 1 suggests immune signaling is rapidly upregulated following each 
session of exercise, but in Project 2 I found no change in immune cell number (total, 
macrophages, T cells, and dendritic cells) 12 hours after exercise. To my knowledge, no work to 
date has measured the changes in immune cell abundance between 0-12 hours after exercise, 
when changes in circulating immune cell numbers are known to be dynamic (149). Therefore, 
obtaining a time course of immune cell changes in adipose tissue (e.g. 1, 4, 8, and 12 hours after 
exercise) would help elucidate the short-term dynamics of immune cells in adipose tissue. 
Importantly, the inflammatory signaling response to exercise could result from a phenotypic 
change in immune cells, rather than a change in cell number. Collecting sorted cells and/or 
imaging tissue samples could be a key step to assess phenotypic shifts in immune cell 
populations in response to exercise. Further exploring these changes will be important to identify 
the exercise related signals that may influence adipose tissue health during weight gain and 
obesity. 
 
Effects of exercise on adipose tissue structural remodeling during weight gain 
My dissertation projects have helped to expand our understanding about the effects of 
exercise on signaling and cell population profile in adipose tissue – as well as attempts to 
examine the effects of exercise on adipose tissue during a brief exposure to overeating and 
weight gain. However, to assess whether these effects of exercise may truly modify adipose 
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tissue in ways to protect against the negative health consequences of weight gain, we must 
employ a longer, more robust overeating/weight intervention.  In rodents, longer-term high fat 
diet interventions do indeed demonstrate protective effects of exercise on adipose tissue fibrosis 
(44), macrophage infiltration (43) and angiogenesis (193); but there have been no well-controlled 
long-term overeating interventions in humans to establish whether exercise could be an effective 
tool to mitigate adipose tissue dysfunction. Importantly, in order to assess the direct effects of 
exercise on adipose tissue in response to weight gain, it is imperative to match weight gain (more 
importantly match the gain in body fat mass) between exercisers and non-exercisers.  In these 
types of overeating experiments, exercisers must eat more than non-exercisers in order to 
compensate for the energy expended during exercise.  If not, the exercisers will gain less weight 
and it will be impossible to discern the direct effects of exercise on changes in adipose tissue 
structure, inflammation, function, etc, from the indirect effects of just gaining less body fat. The 
inclusion of more functional measurements into these experiments would also better characterize 
the effects of exercise on the structural response to overeating. For example, conducting ex vivo 
measurements of angiogenic capacity (205) in addition to histological assessments of adipose 
tissue capillarization and protein and mRNA measures of factors regulating angiogenesis; would 
provide a more comprehensive evaluation of the effects of exercise on angiogenesis. Similarly, 
the addition of adipose tissue histology paired with more functional assays such as co-culture of 
decellularized adipose tissue with other cells (e.g. preadipocytes) would provide more 
comprehensive assessment of influence of exercise while overeating on ECM function and 
composition. For example, co-culture of preadipocytes and decellularized adipose tissue from 
exercisers and non-exercisers who undergo weight gain could reveal whether the ECM from 
exercisers might promote adipogenesis better than non-exercisers following a period of tissue 
expansion. Together, these experiments would help to (1) more thoroughly characterize the 
changes during the early response to overeating in human adipose tissue, and (2) identify 






Adipose tissue dysfunction is central to the development of obesity-related metabolic 
dysfunction. Hallmarks of adipose tissue dysfunction include hypertrophic adipocytes, 
accompanied by adipose tissue hypoxia, fibrosis, and chronic low-grade inflammation, which are 
all associated with tissue and systemic insulin resistance. Overall, Projects 1 and 2 of this 
dissertation provided some of the first evidence that acute exercise can signal changes in 
inflammatory gene expression and stromal vascular fraction composition within subcutaneous 
adipose tissue from obese humans. In particular, the remodeling of the adipocyte progenitor pool 
after acute aerobic exercise provides novel evidence that exercise can rapidly impact adipose 
tissue composition. Collectively, Projects 1 and 2 contribute to our working knowledge of the 
rapid post-exercise (1h and 12h) adipose tissue responses to exercise (conceptual model in 
Figure VI-1). Project 3 demonstrated that brief, modest overeating resulted in increased 
angiogenic and lipid metabolism gene expression in adipose tissue from non-obese people, with 
no accompanying structural changes during the brief overeating exposure. Furthermore, there 
was no difference in the signaling response between regular exercisers and non-exercisers in 
response to this mild and brief overeating stimulus. These data suggest that perhaps some 
minimum adipocyte hypertrophy may be required to trigger structural adaptations in the adipose 
tissue stroma. Therefore, future work measuring the impact of long-term weight gain or weight 
loss resulting in appreciable changes in cell size could shed light on the potential for the signals 
associated with regular exercise to influence adipose tissue remodeling (angiogenesis, ECM 
remodeling, and inflammation). This has important implications for effectively using exercise as 
a therapeutic intervention, and more globally for understanding the coordinated signals 
regulating adipose tissue remodeling during the episodes of weight gain that most people in 
developed countries experience throughout adulthood. 
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Figure VI-1 Conceptual Model.  
Novel acute exercise-induced signals in adipose tissue include (1) decreased total and CD34hi preadipocytes;  
(2) decreased oxidative metabolism pathways; (3) no change in endothelial cell content; and (4) increased 
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APPENDICES 
Appendix A – Subcutaneous Adipose Tissue Aspiration Biopsy 
• The anterior abdominal wall in the periumbilical area will be cleaned with betadine 
• All the following procedures performed using aseptic technique 
• Create sterile field around biopsy site and inject 10cc of 1% lidocaine (no epinephrine) 
with 25g needle, to infiltrate biopsy site (at least 5cm lateral to the umbilicus) 
• Inject up to 10cc of 0.5% lidocaine to supplement anesthesia, and to add more saline 
volume to the biopsy area (*Lidocaine administration should not exceed 4.5mg/kg body 
weight) 
• Make small incision (2-3mm) in anesthetized biopsy site with tip of #11 scalpel blade 
• Insert Coleman aspiration needle into incision site (~3-5cm), blunt needle “cheater” is 
inserted into syringe to hold vacuum in syringe (blocking the plunger from retracting) 
during the aspiration process 
• With needle inserted, one hand lightly pinches the surface of the biopsy site, while the 
other hand gentle maneuvers the biopsy needle under the skin for ~60 seconds to extract 
tissue. 
• Remove aspiration needle from incision site and eject tissue onto abdominal pad for 
cleaning with saline 
• Aspiration procedure is then repeated in the same incision, but the needle will be directed 
to a slightly different “track” within the anesthetized area in order to avoid tissue 
collection within exactly the same area. 
• Aspiration procedure is repeated ~10 times. 
• After completion of all tissue extraction, biopsy site will be cleaned with alcohol, steri-
strip placed to close the small incision, and tegaderm bandage placed over the steri-strips 
• Ice will be applied to biopsy site (as desired) for 10-20 min 
• Participant is instructed to keep the bandages on for 5 days. 
 
As an alternative approach, a 1.5in x 16g needle may be used for tissue aspiration instead of the 
Spirotri cannula, under the same conditions as described above. 
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Appendix B – RNA Sequencing Sample Preparation and Interpretation Tools 
Prep/optimization 
• Meet with RNA sequencing/bioinformatics core to create a project plan 
• Run some test samples through RNA QC to determine if isolation with the kit of choice 
provided sufficient yield/quality of RNA – in our case, the Qiagen RNeasy Plus 
Universal Mini Kit + Turbo DNAse treatment had good quality and purity based on RIN, 
260/230, and DNA Qubit – note quality scores are generally lower for fatty tissues 
• Then did the same with our real samples before forwarding to sequencing core – i.e. 
created original submission with final samples as QC only; with a note that the samples 
would be forwarded for sequencing only after QC was discussed with the core. 




• Prep: cool tissue lyser blocks and centrifuge, acquire dry ice for chipping/homogenizing, 
reconstitute kit reagents for RNeasy kit, clean all supplies, gloves, and bench top with 
RNAse-away (repeat as needed throughout procedureàessential for RNA purity and 
yield), label tubes: 
o 1 set round bottom 2mL homogenization tubes 
o 1 set 0.6mL or smaller for Turbo purification 
o 3x1.5mL microcentrifuge tubes - label the final set with genomics core ID’s (need 
to create online submission before isolation) if applicable 
• Chip 40-60mg adipose tissue using clean scalpel in mortar with liquid nitrogen (blood 
contamination becomes a problem with larger pieces) 
• Store samples in eppendorf tubes on dry ice until immediately before lysing in Cartee lab 
tissue lyser 
• Prep 2mL heavy-duty round-bottom eppendorf tubes with 2 steel ball bearings (RNAse-
cleaned) and 1mL RNA-Stat 60 on RNAse-cleaned ice bucket 
• Add samples to RNA-Stat 60 quickly and lyse 60 seconds (max speed) on Cartee lab 
tissue lyseràcheck for homogenous slurryàrepeat for 30-60 seconds as needed until 
sample is homogenous 
• Spin samples at 12 000G, 10 min, 4C to separate fat to top 
• Carefully waste top fat layer if too thick to access infranatant without contamination 
• Transfer infranatant (avoiding pelleted waste) into new 1.5mL eppendorf, entering 
through middle of sample to avoid lipid contamination 
• Proceed to step 5 of RNeasy Plus Universal Mini Kit Protocol (Qiagen Cat 73404) - 
adjustments are noted here, but see kit protocol for full details:
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o Add 100uL gDNA eliminator solution (proportional to starting volume - in this 
case ~900uL starting volume), securely cap the tube containing the homogenate, 
and shake it vigorously for 15s (vortex). Addition of gDNA eliminator solution 
will effectively reduce genomic DNA contamination fo the aqueous phase; but 
contrary to the kit protocol, an additional DNAse treatment has been found to 
be necessary in our hands 
o Add 180uL chloroform. Securely cap the tube containing the homogenate, and 
shake it vigorously for 15 s (vortex). Thorough mixing is important for 
subsequent phase separation. 
o Place the tube containing the homogenate on the benchtop at room temperature 
for a full 3 min - we have occasionally observed insufficient separation following 
the spin; if this happens, mix samples and re-spin. 
o Centrifuge at 12000G for 15 min at 4C. After centrifugation, heat the centrifuge 
to room temperature for subsequent steps. 
o Transfer the upper aqueous phase (~500uL) to a new microcentrifuge tube 
o Add one volume (e.g. 500uL) of 70% ethanol, mix thoroughly by pipetting, do 
not centrigure; proceed to next step immediately 
o Transfer up to 700uL of the sample to an RNeasy mini spin column placed in a 
2mL collection tube (supplied) by ejecting straight into the tube (no need to have 
the tip right on the membrane). Close the lid gently and centrifuge for 15s at 
≥8000G at room temp. Discard the flow through (DO NOT BLEACH WASTE) 
o Repeat with the remainder of the sample (can use suction to discard flow through 
for efficiency in large batch processing) 
o Add 700uL buffer RWT to the RNeasy spin column: angle the tip and inject into 
the column inner rim; should be able to see the solutions swirl down and into the 
column using this technique; do not need to touch the tip to the rim in order to 
expedite by enabling the same tip throughout. Close lid gently and centrifuge for 
15 s at ≥8000G to wash the membrane. Discard flow through. 
o Add 500uL buffer RPE, cap, spin at same settings, discard flow through 
o Add 500uL buffer RPE, cap, spin for 2 min, discard flow through 
o Place the spin column in a new 2mL collection tube and discard the old tube with 
the flow through. Close the lid gently, centrifuge at full speed (kept at 8000G 
here) for 1 min to avoid flow through/RPE carryover. 
o Place the RNeasy spin column in a new 1.5mL collection tube and add 30uL 
RNAse free water directly to the spin column membrane (pipet with tip close to 
membrane - can touch membrane if needed, but if not can use same tip 
throughout). Ensure accurate pipet especially for this step! Cap and elute RNA by 
spinning for 1 min at ≥8000G - stop at this step due to typically low yields. 
• Proceed to Turbo DNAse treatment. Could add an on-column DNAse treatment to the 
steps above, but we had to clean already isolated RNA and therefore used the Turbo 
DNA-free kit for post-isolation DNA cleanup: Invitrogen cat AM1907. See kit protocol 
for cleanup, adjusted protocol outlined here: 
o Warm incubator to 37C 
o Transfer RNA to 0.6mL tubes or smaller for sufficient supernatant recvoery 
o Add 0.1x final volume 10X Turbo DNAse buffer and 1uL of Turbo DNase 
enzyme to the RNA and mix gently; final volume can be 10-100uL; typically: 
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§ 30uL RNA (based on availability from isolation procedure) 
§ 1uL DNase (constant) 
§ 3.4uL buffer (10% of final volume) 
§ 34.4uL total 
o Incubate at 37C for 30 min 
o Resuspend the DNAse inactivation reagent by flicking or vortexing 
o Add resuspended DNase inactivation reagent (2uL or 0.1 volume - whichever is 
greater - 3.4uL in this case) and mix well  
o Incubate for 5 min at room temperature and flick 2-3 times during the incubation 
period to redisperse the DNase inactivation reagent 
o Centrifuge samples (10000G, 1.5 min, room temp) and carefully transfer the 
supernatant containing the RNA to a fresh tube (labeled for genomics core if 
needed); do not disturb the pellet of DNase inactivation reagent - this is the final 
purified RNA specimen 
• Send 5uL to core for QC – or for proper sequencing samples, send the full 30uL to the 
core for QC and this means the tubes will have to have submission ID’s on them and the 
tubes will get freeze-thawed one additional time following the QC discussion – this is not 
a big problem in the big picture – RNA quality has been stable for a couple freeze-thaws 
in our hands. 
 
Library Prep 
• QuantSeq library prep (by Lexogen) was run by Melissa Coon (uniqname ricotta) 
• QC (by bioanalyzer) was emailed to us as a PDF (on SML drive) 
• qPCR was performed to confirm these results (all by sequencing core). Melissa 
confirmed that QC looked good after library prep. 
 
Analysis 
• Data was then organized and processed and run through the pipeline by Grace Kenney 
(grkenney) - see report from core on the drive 
• QC for alignment to the reference genome was performed by FastQC - see multiQC 
report on the drive - most important outcome is overall alignment (overall ~80%) 
• LogCPM values were filtered for variance stabilization and removal of low/unexpressed 
genes 
• edgeR normalization was performed using trimmed mean of M values technique prior to 
fitting the data 
• Dispersion plot confirms that variation is not tightly linked to expression as a final check 
before fitting the data 
• The linear model is described here, with the addition of paired variables used for each 
individual; the limma package of Bioconductor was used for fitting the model differential 
expression was assessed with sample-level quality weights used: 
https://www.bioconductor.org/packages/release/bioc/vignettes/limma/inst/doc/usersguide
.pdf 
• FDR p-value was used 
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• GSEA analysis was performed (BROAD institute) - steps outlined here: 
GSEA analysis performed following user guide from the GSEA website: 
http://software.broadinstitute.org/gsea/doc/GSEAUserGuideFrame.html 
 
1. Download GSEA to run online via JAVA (there are various slightly different versions, I 
use the easiest one to launch, which runs online) 
2. Prepare 2 key files: 
a. Expression dataset – I created in excel (for ease of sorting groups) and saved as a 
tab-delimited .txt - can follow existing template 
b. Phenotype labels – I created in excel and saved as .cls – see previous examples or 
user guide for formatting guidelines - first # = #samples, second # = #distinct 
groups, third # always 1. To save as .cls file: 
i. Save as tab-delimited text file 
ii. On a Mac: in the finder window, right click -> select “Get Info” 
iii. Name + extension 
iv. Uncheck hide extension 
v. Manually change .txt to .cls 
3. Gene sets – can choose from the MSigDb – I used: 
i. GO - biological processes 
ii. Hallmark 
iii. Curated KEGG 
iv. Curated Reactome 
v. GO molecular function 
vi. GO cellular component 
Note: I had challenges running e.g. “GO - all” because I think it was too 
many gene sets combined for the processing of the computer (error 
message = JAVA heap space) 
4. Run GSEA: 
a. Only need to use one expression data set as it works with both phenotype labels 
b. Gene sets database - toggle between the list above (or other options) 
c. Number of permutations - start with 10 to test the input; then run with 1000 as 
default 
d. Toggle between both phenotype labels: pre/post and hiit/mict (any of the hiit/mict 
comparisons can be made with that phenotype label sheet) depending on the 
comparison being run 
e. Note that the same “feature” i.e. gene or probe identifiers need to be used across 
all these files; I used the default from the data from the core, which didn’t work 
with “collapse data to symbols” set at True - I had to change it to false 
f. Permutation type did not work with Phenotype; I had to change it to gene_set 
g. Chip annotations – I used NCBI by default 
 




• GSEA goal = determine whether members of a gene set are randomly distributed 
throughout a list (which ranks genes by DE, with no minimum threshold) or whether they 
tend to occur toward the top or bottom; indicating if a gene set is related to the phenotype 
(e.g. pre vs. post exercise) 
• Key outcome = Enrichment Score (ES) - reflects this degree to which a gene set is 
overrepresented at the extremes (top/bottom) of an entire ranked gene list - calculated by 
walking down the full list of genes and counting a running sum statistic upon 
encountering a gene from the gene set - or decreasing it when encountering a gene not in 
this gene set - so ES is the max deviation from 0 and corresponds to a weighted 
Kolmogorov-Smirnov-like statistic 
o Positive score = gene set enrichment at the top of the ranked list; increased by the 
intervention/disease phenotype 
o Negative score = enrichment at the bottom; decreased by the intervention/disease 
phenotype 
• Significance level of ES is based on comparing to ES’s of a ton of permutations of either 
phenotype labels or random gene sets - considered in the nominal p value - limited value 
because not corrected for multiple comparisons 
• FDR is also calculated as the estimated probability that a given normalized ES 
(normalized for the size of the gene set) represents a false positive  - computed by 
comparing the tails of the observed and null distributions for NES - so this is what we 
want to go by because it accounts for multiple comparisons 
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Appendix C – Leading Edge Genes from GSEA 










PIM1 39 0.35023 0.042094 Yes 
MAP3K8 258 0.246771 0.056007 Yes 
IRF1 263 0.246124 0.087523 Yes 
TNFRSF1B 268 0.244102 0.118777 Yes 
A2M 282 0.238903 0.148615 Yes 
PF4 283 0.238839 0.179519 Yes 
ACVR1B 316 0.233403 0.207074 Yes 
TNFRSF1A 356 0.227495 0.233287 Yes 
STAT3 412 0.219341 0.257123 Yes 
TYK2 422 0.217919 0.284576 Yes 
IL17RA 483 0.210238 0.30682 Yes 
IL1R2 563 0.201182 0.326322 Yes 
LTB 673 0.191081 0.342038 Yes 
CSF2RB 716 0.188037 0.362898 Yes 
CSF3R 790 0.181934 0.380406 Yes 
ITGB3 830 0.178058 0.400222 Yes 
PTPN1 907 0.172388 0.416246 Yes 
IL18R1 989 0.166961 0.431155 Yes 
IL4R 1109 0.158119 0.44178 Yes 
TLR2 1419 0.136729 0.433934 Yes 
IL10RB 1492 0.132801 0.445167 Yes 
PIK3R5 1536 0.129842 0.458414 Yes 
BAK1 1614 0.1248 0.468198 Yes 
IL2RG 1626 0.124225 0.483363 Yes 
IL2RA 1682 0.121277 0.49451 Yes 
CCR1 2025 0.103775 0.479673 Yes 
CD14 2084 0.101401 0.488 Yes 
TGFB1 2102 0.100768 0.499633 Yes 
ITGA4 2252 0.093426 0.499408 Yes 
PTPN2 2268 0.092617 0.510152 Yes 
CNTFR 2345 0.089186 0.515411 Yes 
SOCS3 2779 0.070914 0.488801 No 
CD44 2824 0.068896 0.49408 No 
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IL13RA1 3244 0.052716 0.466273 No 
CXCL9 3284 0.051116 0.469663 No 
CXCL10 3290 0.050857 0.475831 No 
PLA2G2A 3479 0.044581 0.466062 No 
GRB2 3504 0.043988 0.46977 No 
HMOX1 4354 0.015867 0.401658 No 
ACVRL1 4782 0.002849 0.366737 No 
STAT1 5339 -0.01321 0.322496 No 
JUN 5523 -0.01781 0.309676 No 
FAS 5978 -0.03021 0.276064 No 
TNFRSF21 6129 -0.03416 0.268087 No 
PTPN11 6240 -0.03696 0.263779 No 
STAT2 6430 -0.04194 0.253586 No 
IRF9 6500 -0.04371 0.253539 No 
IFNGR2 6743 -0.05066 0.240094 No 
IFNAR1 6795 -0.05196 0.242602 No 
PDGFC 7191 -0.06215 0.217998 No 
CBL 8258 -0.09011 0.141559 No 
IL15RA 8270 -0.0906 0.152373 No 
CD9 8282 -0.09092 0.163227 No 
HAX1 8360 -0.0934 0.168949 No 
MYD88 8475 -0.09729 0.172115 No 
CD36 8583 -0.10021 0.176239 No 
CSF1 8596 -0.10059 0.188262 No 
OSMR 8710 -0.10427 0.192416 No 
IL1R1 8925 -0.1109 0.18908 No 
IL6ST 9526 -0.13086 0.156425 No 
LEPR 9633 -0.13514 0.16515 No 
IFNGR1 10342 -0.16569 0.128077 No 












CCR2 161 0.273351 0.003238 Yes 
CCND3 204 0.262347 0.015705 Yes 
CCL5 265 0.245956 0.025677 Yes 
PF4 283 0.238839 0.038793 Yes 
HLA-E 294 0.237077 0.052384 Yes 
ELF4 307 0.234343 0.065642 Yes 
EGFR 378 0.224706 0.07349 Yes 
IFNAR2 408 0.219636 0.08444 Yes 
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SPI1 411 0.219397 0.097621 Yes 
BCL3 418 0.218644 0.110423 Yes 
LY75 546 0.202693 0.112191 Yes 
TLR1 581 0.199413 0.121494 Yes 
LTB 673 0.191081 0.12555 Yes 
CFP 674 0.191069 0.137174 Yes 
LYN 677 0.190784 0.148614 Yes 
HCLS1 707 0.188488 0.157668 Yes 
PTPRC 713 0.188202 0.168702 Yes 
APBB1 720 0.187452 0.179606 Yes 
CD1D 740 0.185949 0.189338 Yes 
SRGN 791 0.181817 0.196241 Yes 
GBP2 794 0.181486 0.207115 Yes 
PRKCB 913 0.172171 0.207774 Yes 
MAP4K1 971 0.168024 0.213255 Yes 
IL16 976 0.167751 0.223128 Yes 
LCP2 1000 0.165986 0.231313 Yes 
NCF4 1054 0.162273 0.236776 Yes 
TAP1 1100 0.158569 0.24268 Yes 
IL4R 1109 0.158119 0.251634 Yes 
TLR6 1203 0.151238 0.253099 Yes 
TAPBP 1239 0.14855 0.259225 Yes 
ITGAL 1247 0.148209 0.26766 Yes 
PTPN6 1252 0.147826 0.27632 Yes 
TRAF2 1253 0.147807 0.285312 Yes 
CD3G 1401 0.137756 0.281466 Yes 
TLR2 1419 0.136729 0.28837 Yes 
CSK 1521 0.131294 0.287956 Yes 
JAK2 1525 0.130903 0.29567 Yes 
CD2 1551 0.128763 0.301424 Yes 
ICOSLG 1567 0.127834 0.307954 Yes 
HIF1A 1584 0.126683 0.31433 Yes 
IL2RG 1626 0.124225 0.318477 Yes 
IL2RA 1682 0.121277 0.32128 Yes 
CCL19 1691 0.120851 0.327967 Yes 
WAS 1720 0.119089 0.332883 Yes 
CD247 1745 0.117995 0.338065 Yes 
B2M 1766 0.117205 0.343531 Yes 
RPL39 1780 0.116504 0.349538 Yes 
CD96 1830 0.113469 0.352365 Yes 
CCR1 2025 0.103775 0.342542 Yes 
CTSS 2045 0.102894 0.347222 Yes 
GLMN 2064 0.102235 0.351944 Yes 
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TGFB1 2102 0.100768 0.354997 Yes 
HLA-A 2157 0.098282 0.356485 Yes 
IRF7 2180 0.096929 0.360551 Yes 
PRF1 2189 0.096619 0.365764 Yes 
HLA-
DOA 2343 0.089241 0.358467 Yes 
CD74 2346 0.089176 0.363726 Yes 
GZMB 2370 0.08827 0.367183 Yes 
NPM1 2476 0.083262 0.363515 No 
FGR 2563 0.07965 0.361208 No 
CD86 2656 0.075952 0.358176 No 
ACVR2A 2836 0.068484 0.347454 No 
F2R 2974 0.063265 0.339908 No 
GPR65 3059 0.059966 0.33657 No 
EIF3A 3102 0.058042 0.336607 No 
GZMA 3206 0.054607 0.331362 No 
CXCL9 3284 0.051116 0.328068 No 
HLA-
DRA 3289 0.050917 0.330832 No 
HLA-
DMB 3323 0.050056 0.331133 No 
FCGR2B 3854 0.031497 0.288967 No 
RPS9 4142 0.02246 0.266462 No 
TIMP1 4254 0.019041 0.258388 No 
BCL10 4294 0.017611 0.256216 No 
ICAM1 4401 0.014576 0.248286 No 
ST8SIA4 4488 0.011639 0.241841 No 
IL27RA 4491 0.011527 0.242376 No 
HLA-
DQA1 4590 0.008873 0.234765 No 
PSMB10 4882 -5.08E-04 0.210592 No 
IGSF6 4934 -0.0021 0.206478 No 
TAP2 5008 -0.00432 0.200669 No 
GCNT1 5203 -0.00928 0.185098 No 
STAT1 5339 -0.01321 0.174673 No 
RPS19 5507 -0.01733 0.161837 No 
FLNA 5539 -0.01822 0.160368 No 
ABI1 5643 -0.02139 0.153102 No 
STAB1 5805 -0.02536 0.141254 No 
CD47 5870 -0.02705 0.137576 No 
FAS 5978 -0.03021 0.130514 No 
IKBKB 6050 -0.03186 0.126547 No 
EIF3D 6210 -0.03632 0.115532 No 
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RPL9 6252 -0.03733 0.114393 No 
CD4 6267 -0.03784 0.11553 No 
KLRD1 6325 -0.03917 0.113172 No 
CCL13 6328 -0.03922 0.115392 No 
WARS 6355 -0.03993 0.115658 No 
UBE2D1 6406 -0.0414 0.114018 No 
IFNGR2 6743 -0.05066 0.089154 No 
ITGB2 6778 -0.05156 0.089463 No 
LY86 6921 -0.05482 0.080987 No 
MMP9 7044 -0.05808 0.074374 No 
MAP3K7 7336 -0.06586 0.054176 No 
EIF4G3 7345 -0.06603 0.057528 No 
TPD52 7573 -0.07123 0.042981 No 
HLA-
DMA 7973 -0.08193 0.014779 No 
IL15 7993 -0.08239 0.018211 No 
C2 8177 -0.08745 0.00831 No 
RIPK2 8192 -0.08773 0.012483 No 
RPS3A 8224 -0.08877 0.015305 No 
DEGS1 8533 -0.09873 -0.00431 No 
CSF1 8596 -0.10059 -0.00334 No 
RARS 8659 -0.10257 -0.00226 No 
INHBB 8690 -0.10373 0.001554 No 
CCL4 8744 -0.10548 0.003563 No 
TGFB2 8807 -0.1076 0.004951 No 
EIF3J 8863 -0.10896 0.007005 No 
DARS 8866 -0.10903 0.013472 No 
CCL2 8870 -0.10908 0.019858 No 
AARS 8898 -0.11005 0.024307 No 
THY1 8997 -0.11332 0.02305 No 
TLR3 9009 -0.11386 0.029062 No 
CD28 9031 -0.11445 0.034278 No 
CAPG 9056 -0.11524 0.039292 No 
MTIF2 9112 -0.11698 0.041834 No 
CCND2 9543 -0.13165 0.014078 No 
BCAT1 9703 -0.13808 0.009254 No 
CD40 9710 -0.13828 0.017167 No 
NME1 9906 -0.1465 0.00986 No 
GALNT1 10206 -0.15896 -0.00534 No 
IFNGR1 10342 -0.16569 -0.00649 No 
NCK1 10415 -0.16876 -0.00221 No 
IRF8 10480 -0.17181 0.002921 No 
ETS1 10688 -0.18286 -0.00317 No 
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EIF5A 10897 -0.19538 -0.00859 No 
ABCE1 11423 -0.23605 -0.03789 No 
BRCA1 11443 -0.23774 -0.02501 No 
MRPL3 11560 -0.25048 -0.01942 No 
AKT1 11588 -0.25375 -0.00623 No 
UBE2N 11782 -0.28175 -0.00514 No 
SOCS5 11856 -0.29412 0.00668 No 
HDAC9 11916 -0.30719 0.020461 No 
 










IER3 14 0.402595 0.018994 Yes 
ZC3H12A 16 0.395612 0.038722 Yes 
RNF19B 21 0.383896 0.057613 Yes 
NFIL3 30 0.364614 0.075205 Yes 
EHD1 74 0.317851 0.08754 Yes 
SERPINB8 86 0.308278 0.102061 Yes 
REL 88 0.305275 0.117265 Yes 
KLF10 120 0.289926 0.129201 Yes 
NINJ1 184 0.266677 0.137307 Yes 
KDM6B 248 0.248453 0.144501 Yes 
MAP3K8 258 0.246771 0.156109 Yes 
IRF1 263 0.246124 0.1681 Yes 
CCL5 265 0.245956 0.180334 Yes 
IER2 302 0.234982 0.189102 Yes 
NR4A2 363 0.225825 0.195412 Yes 
MXD1 383 0.224009 0.205047 Yes 
BCL3 418 0.218644 0.213164 Yes 
SLC2A3 439 0.215758 0.222302 Yes 
PTPRE 440 0.215469 0.233092 Yes 
IL7R 471 0.211884 0.241204 Yes 
YRDC 551 0.202178 0.244747 Yes 
NAMPT 554 0.202081 0.2547 Yes 
CEBPB 668 0.191321 0.254868 Yes 
BTG2 682 0.190508 0.263325 Yes 
DUSP4 694 0.18975 0.271911 Yes 
DDX58 701 0.18888 0.28087 Yes 
RELA 843 0.177197 0.277998 Yes 
BHLHE40 899 0.172826 0.282071 Yes 
SNN 930 0.171236 0.288147 Yes 
CCNL1 948 0.169946 0.295241 Yes 
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CFLAR 1065 0.161145 0.293648 Yes 
TANK 1066 0.161049 0.301713 Yes 
TAP1 1100 0.158569 0.306904 Yes 
RELB 1124 0.157228 0.312862 Yes 
LITAF 1147 0.155674 0.318825 Yes 
MAP2K3 1151 0.155437 0.326359 Yes 
IFIT2 1245 0.148274 0.326037 No 
TLR2 1419 0.136729 0.318473 No 
ICOSLG 1567 0.127834 0.31263 No 
HES1 1569 0.127701 0.318941 No 
BIRC3 1759 0.117654 0.309089 No 
ATP2B1 1782 0.116478 0.31309 No 
DUSP5 1861 0.11116 0.312159 No 
TGIF1 1910 0.109159 0.313627 No 
PPP1R15A 1928 0.108454 0.317642 No 
FOSL2 2137 0.099309 0.305289 No 
ZBTB10 2160 0.098208 0.308374 No 
MCL1 2227 0.094797 0.307623 No 
JUNB 2235 0.09419 0.311757 No 
ABCA1 2341 0.089301 0.307482 No 
F3 2355 0.08877 0.310845 No 
PFKFB3 2501 0.082248 0.302885 No 
SDC4 2534 0.080734 0.304262 No 
EFNA1 2630 0.076859 0.300198 No 
SOCS3 2779 0.070914 0.291421 No 
PDE4B 2808 0.069623 0.292575 No 
CD44 2824 0.068896 0.294775 No 
DENND5A 2891 0.066235 0.292595 No 
TNFAIP6 2956 0.064195 0.290478 No 
TNC 2966 0.063684 0.292917 No 
SLC2A6 2987 0.062886 0.294401 No 
PLEK 2996 0.06261 0.296869 No 
SMAD3 3255 0.052328 0.277999 No 
CXCL10 3290 0.050857 0.277713 No 
GADD45A 3309 0.0504 0.278738 No 
PDLIM5 3352 0.049091 0.277698 No 
KLF9 3367 0.048396 0.278955 No 
B4GALT1 3423 0.046745 0.276714 No 
SAT1 3442 0.046065 0.277522 No 
SOD2 3488 0.044359 0.275995 No 
ZFP36 3540 0.042564 0.273878 No 
PLK2 3645 0.03837 0.267136 No 
TRIP10 3957 0.02803 0.242634 No 
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GPR183 3986 0.026971 0.241652 No 
SPSB1 4119 0.02299 0.231808 No 
TSC22D1 4145 0.022317 0.230843 No 
GFPT2 4161 0.021907 0.230691 No 
TNFAIP8 4305 0.017105 0.219635 No 
TNIP1 4318 0.01671 0.219473 No 
VEGFA 4380 0.015145 0.21515 No 
B4GALT5 4395 0.01477 0.214723 No 
ICAM1 4401 0.014576 0.215037 No 
TRAF1 4517 0.010914 0.206004 No 
PMEPA1 4533 0.010568 0.205284 No 
FOS 4598 0.008663 0.200386 No 
KYNU 4756 0.003582 0.187488 No 
PLAUR 5005 -0.00427 0.167044 No 
MAFF 5040 -0.00508 0.164466 No 
DRAM1 5190 -0.00889 0.152499 No 
BTG3 5205 -0.00932 0.1518 No 
ID2 5261 -0.01087 0.147763 No 
BIRC2 5278 -0.01148 0.147005 No 
JUN 5523 -0.01781 0.127572 No 
BCL2A1 5541 -0.01825 0.12707 No 
BMP2 5576 -0.01927 0.125203 No 
NFE2L2 5652 -0.02152 0.120033 No 
IRS2 5918 -0.02866 0.099394 No 
TRIB1 5937 -0.02915 0.099354 No 
ACKR3 5938 -0.02915 0.100814 No 
RCAN1 5979 -0.03021 0.098995 No 
IFNGR2 6743 -0.05066 0.037975 No 
PHLDA1 7077 -0.05893 0.013187 No 
TNFAIP2 7157 -0.06116 0.009669 No 
CDKN1A 7289 -0.06459 0.001992 No 
ETS2 7440 -0.06851 -0.00707 No 
STAT5A 7525 -0.0702 -0.01055 No 
PLAU 7599 -0.07198 -0.01303 No 
MYC 7606 -0.07212 -0.00992 No 
CEBPD 7622 -0.07244 -0.00754 No 
DNAJB4 7722 -0.07504 -0.01203 No 
TIPARP 7732 -0.0753 -0.00901 No 
RHOB 7788 -0.07677 -0.00975 No 
IFIH1 8001 -0.08262 -0.02327 No 
RIPK2 8192 -0.08773 -0.0347 No 
LAMB3 8243 -0.08958 -0.03438 No 
IL15RA 8270 -0.0906 -0.03201 No 
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EGR3 8428 -0.09555 -0.0403 No 
MSC 8497 -0.0978 -0.04107 No 
KLF4 8499 -0.09781 -0.03625 No 
CSF1 8596 -0.10059 -0.03921 No 
PTGER4 8655 -0.10248 -0.03891 No 
TNIP2 8656 -0.10248 -0.03378 No 
CCND1 8668 -0.10305 -0.02954 No 
SQSTM1 8709 -0.10426 -0.02765 No 
PNRC1 8729 -0.10494 -0.02398 No 
CCL4 8744 -0.10548 -0.01986 No 
CCL2 8870 -0.10908 -0.02481 No 
EIF1 8965 -0.11224 -0.02702 No 
TUBB2A 9167 -0.11857 -0.03783 No 
NFAT5 9190 -0.11934 -0.03368 No 
CD83 9348 -0.12488 -0.04051 No 
KLF2 9525 -0.13084 -0.04862 No 
IL6ST 9526 -0.13086 -0.04206 No 
PANX1 9581 -0.13319 -0.03989 No 
DUSP1 9745 -0.13983 -0.04647 No 
KLF6 9917 -0.14697 -0.05335 No 
SERPINE1 10028 -0.15133 -0.05494 No 
GADD45B 10211 -0.15906 -0.06213 No 
MARCKS 10219 -0.1595 -0.05473 No 
SGK1 10244 -0.16047 -0.04869 No 
EDN1 10297 -0.16336 -0.04484 No 
PHLDA2 10346 -0.16579 -0.04054 No 
ATF3 10507 -0.17301 -0.0452 No 
HBEGF 10658 -0.18115 -0.04862 No 
G0S2 10669 -0.18164 -0.04036 No 
NFKB2 10783 -0.18742 -0.04039 No 
EGR1 10921 -0.19696 -0.04194 No 
SPHK1 11094 -0.20906 -0.0458 No 
BTG1 11135 -0.21265 -0.03848 No 
IER5 11179 -0.21556 -0.03127 No 
NFKB1 11234 -0.21946 -0.02478 No 
JAG1 11275 -0.22356 -0.01691 No 
TNFAIP3 11314 -0.22708 -0.00871 No 
LDLR 11658 -0.26305 -0.02411 No 
BCL6 11689 -0.26717 -0.01323 No 
CCRL2 11793 -0.28362 -0.0076 No 
NFKBIA 12095 -0.38042 -0.01363 No 













RAF1 116 0.29082 0.007594 Yes 
ADM 211 0.259639 0.015169 Yes 
IRF1 263 0.246124 0.025518 Yes 
CCL5 265 0.245956 0.040013 Yes 
TNFRSF1B 268 0.244102 0.054315 Yes 
ACVR1B 316 0.233403 0.064242 Yes 
CD55 317 0.233291 0.07807 Yes 
FFAR2 375 0.224862 0.08666 Yes 
MXD1 383 0.224009 0.099355 Yes 
RASGRP1 419 0.218449 0.109393 Yes 
PROK2 433 0.216515 0.121146 Yes 
PTPRE 440 0.215469 0.133419 Yes 
IL10RA 461 0.213037 0.144383 Yes 
IL7R 471 0.211884 0.156194 Yes 
KCNA3 487 0.209764 0.16738 Yes 
CCR7 553 0.202094 0.173955 Yes 
NAMPT 554 0.202081 0.185933 Yes 
TLR1 581 0.199413 0.195591 Yes 
IFITM1 587 0.198972 0.206969 Yes 
FPR1 597 0.197512 0.217928 Yes 
TNFSF10 663 0.191865 0.223896 Yes 
LYN 677 0.190784 0.234124 Yes 
BTG2 682 0.190508 0.245083 Yes 
SELL 724 0.187377 0.252781 Yes 
CSF3R 790 0.181934 0.258161 Yes 
ITGB3 830 0.178058 0.265473 Yes 
PTAFR 832 0.177936 0.275936 Yes 
RELA 843 0.177197 0.285608 Yes 
IL18R1 989 0.166961 0.28345 Yes 
LCP2 1000 0.165986 0.292457 Yes 
SEMA4D 1103 0.158442 0.293369 Yes 
CD82 1105 0.158325 0.30267 Yes 
IL4R 1109 0.158119 0.311792 Yes 
TAPBP 1239 0.14855 0.309873 Yes 
AQP9 1285 0.145308 0.314745 Yes 
TLR2 1419 0.136729 0.311793 Yes 
PIK3R5 1536 0.129842 0.309845 Yes 
ICOSLG 1567 0.127834 0.314928 Yes 
HIF1A 1584 0.126683 0.321107 Yes 
ATP2B1 1782 0.116478 0.311634 No 
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CD14 2084 0.101401 0.292621 No 
C5AR1 2092 0.101165 0.298036 No 
IRF7 2180 0.096929 0.296548 No 
SLC7A2 2196 0.096397 0.301015 No 
ABCA1 2341 0.089301 0.294337 No 
RHOG 2348 0.08903 0.299115 No 
F3 2355 0.08877 0.303878 No 
RNF144B 2398 0.08714 0.305552 No 
CD48 2523 0.08109 0.30005 No 
NMI 2589 0.078581 0.299304 No 
EIF2AK2 2742 0.072418 0.29096 No 
PDE4B 2808 0.069623 0.289683 No 
ACVR2A 2836 0.068484 0.291498 No 
ADRM1 2856 0.067442 0.293916 No 
CMKLR1 2912 0.065556 0.293229 No 
TNFAIP6 2956 0.064195 0.293459 No 
P2RX7 3071 0.059359 0.2875 No 
LY6E 3210 0.054324 0.279248 No 
CXCL9 3284 0.051116 0.276209 No 
CXCL10 3290 0.050857 0.278808 No 
GABBR1 3581 0.040881 0.257123 No 
MMP14 3701 0.036164 0.249373 No 
GPR183 3986 0.026971 0.227362 No 
TPBG 4158 0.021967 0.214449 No 
LPAR1 4185 0.021263 0.213548 No 
TIMP1 4254 0.019041 0.209023 No 
RGS16 4376 0.015255 0.199868 No 
ICAM1 4401 0.014576 0.198737 No 
SCN1B 4433 0.013358 0.196952 No 
PSEN1 4573 0.00934 0.18595 No 
PLAUR 5005 -0.00427 0.150373 No 
AHR 5010 -0.00441 0.150302 No 
SLC7A1 5292 -0.01185 0.127644 No 
FZD5 5427 -0.01518 0.117404 No 
ABI1 5643 -0.02139 0.100798 No 
STAB1 5805 -0.02536 0.088917 No 
SGMS2 6234 -0.03676 0.055515 No 
MET 6725 -0.05014 0.017752 No 
SLC31A2 6733 -0.05038 0.020157 No 
IFNGR2 6743 -0.05066 0.022411 No 
KIF1B 6773 -0.05146 0.02305 No 
DCBLD2 6786 -0.05168 0.025116 No 
IFNAR1 6795 -0.05196 0.027531 No 
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TACR1 6934 -0.05514 0.019326 No 
NMUR1 6936 -0.0553 0.022521 No 
EMP3 7041 -0.05798 0.017312 No 
CDKN1A 7289 -0.06459 6.07E-04 No 
AXL 7425 -0.06813 -0.00658 No 
SLC4A4 7451 -0.06868 -0.00459 No 
P2RX4 7523 -0.07015 -0.00633 No 
GNAI3 7543 -0.07065 -0.00372 No 
MYC 7606 -0.07212 -0.0046 No 
CYBB 7777 -0.07639 -0.01421 No 
HRH1 7991 -0.08235 -0.02703 No 
IL15 7993 -0.08239 -0.02223 No 
PCDH7 8123 -0.08605 -0.02786 No 
RIPK2 8192 -0.08773 -0.02831 No 
SLC31A1 8202 -0.08803 -0.02384 No 
PTGER2 8249 -0.0898 -0.02234 No 
IL15RA 8270 -0.0906 -0.01863 No 
BST2 8494 -0.09776 -0.03138 No 
MSR1 8579 -0.10011 -0.03243 No 
CSF1 8596 -0.10059 -0.0278 No 
PTGER4 8655 -0.10248 -0.02654 No 
OSMR 8710 -0.10427 -0.02485 No 
CCL2 8870 -0.10908 -0.0316 No 
GNA15 8917 -0.11066 -0.02887 No 
IL1R1 8925 -0.1109 -0.02288 No 
TLR3 9009 -0.11386 -0.02303 No 
C3AR1 9063 -0.11551 -0.02059 No 
MARCO 9186 -0.11915 -0.02367 No 
CHST2 9436 -0.12786 -0.03679 No 
PVR 9501 -0.13014 -0.0344 No 
CD40 9710 -0.13828 -0.04349 No 
ITGA5 9738 -0.13954 -0.03747 No 
GPC3 9751 -0.14004 -0.03016 No 
KLF6 9917 -0.14697 -0.03517 No 
SERPINE1 10028 -0.15133 -0.03534 No 
HAS2 10150 -0.15631 -0.03614 No 
SRI 10229 -0.15974 -0.03315 No 
EDN1 10297 -0.16336 -0.02904 No 
SCARF1 10555 -0.17571 -0.03999 No 
ATP2A2 10559 -0.1758 -0.02982 No 
HBEGF 10658 -0.18115 -0.02723 No 
SLC11A2 10721 -0.18467 -0.02144 No 
APLNR 10823 -0.19011 -0.01857 No 
	135	
CALCRL 10909 -0.1962 -0.014 No 
SPHK1 11094 -0.20906 -0.01691 No 
NFKB1 11234 -0.21946 -0.01546 No 
LDLR 11658 -0.26305 -0.03503 No 
ATP2C1 11707 -0.26932 -0.02306 No 
CCRL2 11793 -0.28362 -0.01331 No 
CX3CL1 12056 -0.35892 -0.01382 No 












BCKDHA 510 0.206071 -0.03271 No 
IDH3B 1339 0.14176 -0.09503 No 
DLST 1836 0.113003 -0.13102 No 
RHOT2 3006 0.062327 -0.2256 No 
CPT1A 3250 0.052453 -0.24337 No 
NDUFA5 3292 0.050849 -0.24436 No 
ATP6V0C 3494 0.04425 -0.25902 No 
UQCRFS1 3659 0.03768 -0.2709 No 
MRPS12 3781 0.034167 -0.27937 No 
PMPCA 3810 0.033022 -0.28012 No 
MRPS30 3892 0.030418 -0.28543 No 
MRPL11 3990 0.026741 -0.29225 No 
PDK4 4089 0.023726 -0.29929 No 
TIMM10 4097 0.023351 -0.29876 No 
TCIRG1 4205 0.020563 -0.30671 No 
ATP6V1G1 4256 0.018959 -0.30997 No 
ETFB 4454 0.012729 -0.3258 No 
ATP6V0B 4462 0.012646 -0.32578 No 
TIMM50 4543 0.010234 -0.33197 No 
IDH2 4638 0.007704 -0.33945 No 
MTRF1 4644 0.007492 -0.3395 No 
GRPEL1 4703 0.005416 -0.34409 No 
GPI 4737 0.004133 -0.34664 No 
ABCB7 4753 0.003614 -0.34772 No 
NDUFS2 4758 0.003491 -0.34789 No 
COX4I1 4823 0.001543 -0.35316 No 
NDUFV1 5082 -0.0061 -0.37439 No 
NDUFA6 5147 -0.00781 -0.37936 No 
UQCRC1 5184 -0.00877 -0.38195 No 
CASP7 5248 -0.01059 -0.3867 No 
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NDUFA2 5249 -0.0106 -0.38619 No 
ATP6V1C1 5297 -0.0121 -0.38954 No 
NQO2 5320 -0.01267 -0.39077 No 
VDAC3 5336 -0.01308 -0.39139 No 
NDUFS6 5528 -0.01793 -0.40647 No 
MFN2 5618 -0.02048 -0.41292 No 
HADHA 5730 -0.02346 -0.42106 No 
NDUFC2 5759 -0.02421 -0.42224 No 
NDUFS8 5771 -0.02452 -0.42199 No 
SURF1 5775 -0.02464 -0.42106 No 
SLC25A4 5810 -0.02544 -0.42268 No 
AIFM1 6143 -0.03455 -0.44874 No 
POR 6273 -0.03794 -0.45769 No 
COX6B1 6278 -0.03816 -0.4562 No 
COX10 6289 -0.03829 -0.4552 No 
PDHA1 6360 -0.04001 -0.45913 No 
UQCRQ 6513 -0.04402 -0.46971 No 
UQCRC2 6666 -0.04811 -0.4801 No 
UQCRB 6719 -0.04991 -0.48205 No 
GLUD1 6738 -0.05057 -0.48114 No 
ECHS1 6835 -0.05277 -0.48662 No 
ACAA1 6885 -0.0539 -0.48814 No 
RHOT1 6908 -0.05459 -0.48736 No 
PDP1 6971 -0.05611 -0.48985 No 
COX15 7052 -0.05821 -0.49375 No 
NDUFA9 7137 -0.06061 -0.49786 No 
PHYH 7251 -0.06375 -0.50424 No 
HSPA9 7311 -0.06516 -0.50605 Yes 
ATP6AP1 7337 -0.06588 -0.50499 Yes 
NDUFV2 7356 -0.06628 -0.50332 Yes 
LDHB 7428 -0.06816 -0.50599 Yes 
PHB2 7437 -0.06836 -0.50339 Yes 
OPA1 7506 -0.06987 -0.50572 Yes 
TIMM9 7540 -0.07054 -0.50511 Yes 
COX7C 7571 -0.0712 -0.50421 Yes 
NDUFS4 7582 -0.07147 -0.50162 Yes 
MPC1 7614 -0.07234 -0.50075 Yes 
SUPV3L1 7674 -0.0738 -0.50215 Yes 
ATP6V1E1 7685 -0.07417 -0.49944 Yes 
OXA1L 7749 -0.07566 -0.50108 Yes 
VDAC1 7754 -0.07586 -0.49779 Yes 
PDHX 7778 -0.07647 -0.49605 Yes 
NDUFS1 7794 -0.0769 -0.49363 Yes 
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CYB5R3 7798 -0.07705 -0.49019 Yes 
ISCA1 7805 -0.07721 -0.487 Yes 
ECI1 7823 -0.07766 -0.48471 Yes 
AFG3L2 7961 -0.08149 -0.49225 Yes 
IDH3G 8098 -0.08536 -0.49952 Yes 
NDUFS7 8133 -0.08632 -0.49823 Yes 
RETSAT 8138 -0.0864 -0.49443 Yes 
ETFDH 8139 -0.08642 -0.4903 Yes 
SUCLA2 8201 -0.088 -0.49118 Yes 
COX6A1 8245 -0.08962 -0.49049 Yes 
CS 8255 -0.09004 -0.48694 Yes 
ACAA2 8263 -0.09029 -0.4832 Yes 
MRPS15 8281 -0.0909 -0.48028 Yes 
MRPL35 8356 -0.09332 -0.48199 Yes 
FXN 8390 -0.09409 -0.48025 Yes 
MDH1 8435 -0.09591 -0.47933 Yes 
ECH1 8438 -0.09595 -0.47491 Yes 
ATP6V0E1 8449 -0.09642 -0.47114 Yes 
DECR1 8471 -0.09723 -0.46824 Yes 
COX11 8488 -0.09766 -0.46491 Yes 
SLC25A3 8532 -0.09872 -0.46378 Yes 
NDUFB1 8629 -0.10172 -0.46693 Yes 
NDUFB8 8731 -0.10497 -0.47034 Yes 
VDAC2 8788 -0.10685 -0.46991 Yes 
CYC1 8825 -0.1079 -0.46775 Yes 
IDH1 8960 -0.11195 -0.47358 Yes 
UQCR11 9044 -0.11485 -0.47502 Yes 
ACADSB 9075 -0.11581 -0.47199 Yes 
GPX4 9076 -0.11582 -0.46645 Yes 
LRPPRC 9078 -0.11588 -0.46099 Yes 
ISCU 9085 -0.11606 -0.45595 Yes 
COX6C 9106 -0.11678 -0.45203 Yes 
TIMM13 9174 -0.11877 -0.45195 Yes 
LDHA 9177 -0.11887 -0.44643 Yes 
COX7A2 9197 -0.11942 -0.44231 Yes 
ACADM 9346 -0.12477 -0.4487 Yes 
ATP6V1F 9375 -0.1259 -0.44501 Yes 
SUCLG1 9539 -0.13158 -0.45233 Yes 
DLAT 9562 -0.13257 -0.44783 Yes 
COX5B 9577 -0.13308 -0.44263 Yes 
NDUFB4 9601 -0.13403 -0.43815 Yes 
UQCRH 9674 -0.13691 -0.43761 Yes 
MDH2 9724 -0.13896 -0.43506 Yes 
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TIMM17A 9867 -0.14476 -0.43999 Yes 
NDUFB7 9881 -0.14536 -0.43412 Yes 
DLD 9891 -0.14593 -0.4279 Yes 
NDUFA1 9897 -0.1461 -0.42133 Yes 
SDHA 9904 -0.14642 -0.41483 Yes 
IDH3A 9912 -0.1467 -0.4084 Yes 
COX8A 9960 -0.14831 -0.40524 Yes 
ATP6V1D 9967 -0.14861 -0.39863 Yes 
OGDH 10033 -0.15161 -0.39681 Yes 
NDUFB6 10057 -0.1525 -0.39144 Yes 
PDHB 10095 -0.15385 -0.38717 Yes 
ATP1B1 10098 -0.1539 -0.37998 Yes 
MAOB 10103 -0.15421 -0.37295 Yes 
COX5A 10197 -0.15862 -0.37313 Yes 
NDUFC1 10221 -0.15958 -0.36742 Yes 
IMMT 10248 -0.16064 -0.36191 Yes 
SLC25A20 10280 -0.16246 -0.35673 Yes 
ALDH6A1 10306 -0.1639 -0.35098 Yes 
NDUFB2 10326 -0.16478 -0.34469 Yes 
NDUFB3 10349 -0.16586 -0.3386 Yes 
NDUFA7 10403 -0.16816 -0.33498 Yes 
MRPS11 10417 -0.16885 -0.32799 Yes 
ETFA 10501 -0.17281 -0.32666 Yes 
NDUFS3 10561 -0.17596 -0.32317 Yes 
SLC25A11 10588 -0.17722 -0.31687 Yes 
NDUFA3 10601 -0.1782 -0.30935 Yes 
ACADVL 10662 -0.18122 -0.3057 Yes 
ALAS1 10663 -0.18129 -0.29703 Yes 
HADHB 10692 -0.18299 -0.29062 Yes 
TIMM8B 10796 -0.18799 -0.29023 Yes 
SDHD 10800 -0.18824 -0.28148 Yes 
BDH2 10819 -0.18978 -0.27391 Yes 
CYB5A 10820 -0.1898 -0.26484 Yes 
NDUFA8 10966 -0.20036 -0.26736 Yes 
NDUFA4 10972 -0.20069 -0.25819 Yes 
NDUFB5 11008 -0.20262 -0.25142 Yes 
HSD17B10 11096 -0.2092 -0.24868 Yes 
MTRR 11109 -0.21009 -0.23964 Yes 
SDHC 11138 -0.21285 -0.2318 Yes 
MRPL34 11236 -0.2196 -0.2294 Yes 
UQCR10 11267 -0.22253 -0.22127 Yes 
NDUFAB1 11347 -0.23029 -0.21685 Yes 
TOMM22 11353 -0.23074 -0.20624 Yes 
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MRPL15 11378 -0.23229 -0.19714 Yes 
ATP6V1H 11385 -0.23298 -0.1865 Yes 
MRPS22 11417 -0.2352 -0.17784 Yes 
POLR2F 11421 -0.23589 -0.16682 Yes 
COX7B 11446 -0.23795 -0.15745 Yes 
CYCS 11503 -0.24445 -0.15044 Yes 
SLC25A12 11505 -0.24459 -0.13883 Yes 
GOT2 11519 -0.24556 -0.12817 Yes 
COX7A2L 11618 -0.25726 -0.12405 Yes 
MGST3 11670 -0.2645 -0.11567 Yes 
ACAT1 11676 -0.26546 -0.10339 Yes 
HCCS 11684 -0.26675 -0.09123 Yes 
FDX1 11690 -0.26718 -0.07887 Yes 
NNT 11701 -0.26879 -0.06686 Yes 
MTX2 11816 -0.28687 -0.06266 Yes 
FH 11861 -0.29447 -0.05225 Yes 
SDHB 11865 -0.29521 -0.03839 Yes 
OAT 11907 -0.30608 -0.02718 Yes 
SLC25A5 11938 -0.31175 -0.01478 Yes 
COX17 12004 -0.33538 -0.00418 Yes 












ANGPTL4 11 0.442734 0.019645 No 
RIOK3 66 0.322412 0.030112 No 
BAZ2A 165 0.272676 0.034596 No 
TOB1 313 0.2336 0.033175 No 
BCKDHA 510 0.206071 0.026384 No 
PPP1R15B 617 0.195642 0.026622 No 
PIM3 706 0.188553 0.028034 No 
PDCD4 988 0.166974 0.012331 No 
TANK 1066 0.161049 0.013383 No 
JAGN1 1162 0.154284 0.012619 No 
UBC 1197 0.151903 0.016836 No 
PHLDB1 1600 0.12563 -0.01089 No 
CIDEA 1973 0.106146 -0.03701 No 
PPM1B 2240 0.094044 -0.05485 No 
NMT1 2241 0.09403 -0.05048 No 
ABCA1 2341 0.089301 -0.0546 No 
PFKFB3 2501 0.082248 -0.06405 No 
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G3BP2 2507 0.081926 -0.06066 No 
SPARCL1 2710 0.073975 -0.07409 No 
UCK1 2849 0.067731 -0.08247 No 
ABCB8 3048 0.060543 -0.09618 No 
NDUFA5 3292 0.050849 -0.11411 No 
GADD45A 3309 0.0504 -0.1131 No 
GPX3 3327 0.049877 -0.1122 No 
SLC19A1 3345 0.049219 -0.11134 No 
PEMT 3872 0.03095 -0.15381 No 
DBT 3968 0.027696 -0.16045 No 
LIFR 4162 0.021823 -0.17555 No 
ACOX1 4223 0.020022 -0.17963 No 
ACADS 4307 0.017029 -0.18577 No 
ETFB 4454 0.012729 -0.19736 No 
C3 4470 0.012314 -0.19804 No 
ITSN1 4581 0.008993 -0.20681 No 
APOE 4618 0.008222 -0.20943 No 
PEX14 4701 0.005434 -0.21603 No 
GRPEL1 4703 0.005416 -0.21586 No 
APLP2 4873 -2.03E-04 -0.22996 No 
LIPE 4881 -4.76E-04 -0.23052 No 
ADCY6 4887 -6.17E-04 -0.23091 No 
UCP2 5176 -0.00849 -0.25456 No 
UQCRC1 5184 -0.00877 -0.25473 No 
STOM 5231 -0.00998 -0.25811 No 
ESYT1 5265 -0.01097 -0.26035 No 
PTCD3 5315 -0.01261 -0.26386 No 
TKT 5326 -0.01283 -0.2641 No 
FZD4 5411 -0.01486 -0.27042 No 
ARL4A 5513 -0.01749 -0.27804 No 
ALDOA 5551 -0.01851 -0.28027 No 
SCARB1 5757 -0.0242 -0.29626 No 
CYP4B1 5766 -0.02442 -0.29579 No 
SLC25A10 5838 -0.02628 -0.3005 No 
ELOVL6 5908 -0.02827 -0.30494 No 
TALDO1 6046 -0.03172 -0.31491 No 
MGLL 6106 -0.03363 -0.31827 No 
AIFM1 6143 -0.03455 -0.31967 No 
REEP6 6228 -0.03668 -0.32498 No 
POR 6273 -0.03794 -0.32689 No 
ALDH2 6274 -0.03802 -0.32513 No 
RREB1 6347 -0.03972 -0.32929 No 
PFKL 6376 -0.04039 -0.32975 No 
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ENPP2 6491 -0.04351 -0.33725 No 
UQCRQ 6513 -0.04402 -0.33696 No 
VEGFB 6549 -0.04518 -0.33778 No 
FAH 6646 -0.0477 -0.34358 No 
SLC5A6 6662 -0.04797 -0.3426 No 
MYLK 6713 -0.04978 -0.34446 No 
ITGA7 6802 -0.05213 -0.34939 No 
ECHS1 6835 -0.05277 -0.34961 No 
CPT2 6910 -0.05468 -0.35325 No 
AGPAT3 6960 -0.05593 -0.35474 No 
SAMM50 6974 -0.05614 -0.35322 No 
CD151 7152 -0.06103 -0.36516 No 
ATP1B3 7230 -0.06322 -0.36865 No 
PHYH 7251 -0.06375 -0.36736 No 
DHRS7B 7346 -0.06604 -0.37214 No 
GHITM 7373 -0.06674 -0.37121 No 
ACLY 7488 -0.06961 -0.37749 No 
STAT5A 7525 -0.0702 -0.37724 No 
SULT1A1 7591 -0.07175 -0.37933 No 
CHUK 7647 -0.07308 -0.38053 No 
TST 7709 -0.0747 -0.38215 No 
QDPR 7764 -0.07619 -0.38312 Yes 
MCCC1 7779 -0.0765 -0.38074 Yes 
DRAM2 7785 -0.07672 -0.37759 Yes 
SLC25A1 7819 -0.0775 -0.37674 Yes 
CHCHD10 7889 -0.07979 -0.3788 Yes 
MAP4K3 7909 -0.08016 -0.37666 Yes 
SORBS1 7925 -0.08052 -0.37417 Yes 
REEP5 7967 -0.0817 -0.3738 Yes 
DGAT1 7989 -0.08232 -0.37173 Yes 
SLC1A5 8010 -0.0828 -0.36956 Yes 
LPL 8035 -0.08346 -0.36768 Yes 
IDH3G 8098 -0.08536 -0.36889 Yes 
RETSAT 8138 -0.0864 -0.36814 Yes 
UBQLN1 8239 -0.08942 -0.37233 Yes 
COX6A1 8245 -0.08962 -0.36859 Yes 
CS 8255 -0.09004 -0.36516 Yes 
ACAA2 8263 -0.09029 -0.36155 Yes 
RNF11 8338 -0.09287 -0.36341 Yes 
RAB34 8437 -0.09594 -0.36714 Yes 
ECH1 8438 -0.09595 -0.36268 Yes 
DECR1 8471 -0.09723 -0.36083 Yes 
SOD1 8574 -0.09991 -0.36471 Yes 
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CD36 8583 -0.10021 -0.36072 Yes 
SSPN 8701 -0.10399 -0.36566 Yes 
PLIN2 8702 -0.10408 -0.36083 Yes 
ADIPOR2 8738 -0.10528 -0.35886 Yes 
CYC1 8825 -0.1079 -0.36102 Yes 
ME1 8858 -0.10879 -0.35864 Yes 
DHRS7 8878 -0.10934 -0.35515 Yes 
OMD 8906 -0.11032 -0.35228 Yes 
IDH1 8960 -0.11195 -0.35151 Yes 
CCNG2 8993 -0.11319 -0.34892 Yes 
RTN3 9000 -0.11349 -0.34415 Yes 
PREB 9013 -0.11395 -0.33986 Yes 
YWHAG 9020 -0.11418 -0.33506 Yes 
MTCH2 9036 -0.11455 -0.33099 Yes 
DHCR7 9037 -0.11458 -0.32567 Yes 
UQCR11 9044 -0.11485 -0.32083 Yes 
ITIH5 9045 -0.11486 -0.3155 Yes 
BCL2L13 9073 -0.11578 -0.31237 Yes 
GPX4 9076 -0.11582 -0.30716 Yes 
LEP 9164 -0.11839 -0.30893 Yes 
AK2 9309 -0.12384 -0.31519 Yes 
ACADM 9346 -0.12477 -0.3124 Yes 
HSPB8 9428 -0.12752 -0.31324 Yes 
SUCLG1 9539 -0.13158 -0.31631 Yes 
DLAT 9562 -0.13257 -0.31199 Yes 
PTGER3 9683 -0.13717 -0.31564 Yes 
MDH2 9724 -0.13896 -0.31253 Yes 
DNAJC15 9734 -0.13915 -0.30681 Yes 
COQ9 9739 -0.13955 -0.30067 Yes 
SNCG 9741 -0.13959 -0.29427 Yes 
COL15A1 9780 -0.1415 -0.29087 Yes 
GPAM 9781 -0.14152 -0.28429 Yes 
RMDN3 9835 -0.14376 -0.28204 Yes 
GBE1 9838 -0.14382 -0.27553 Yes 
NABP1 9848 -0.14418 -0.26958 Yes 
LPCAT3 9857 -0.14451 -0.26354 Yes 
NDUFB7 9881 -0.14536 -0.25871 Yes 
DLD 9891 -0.14593 -0.25268 Yes 
IDH3A 9912 -0.1467 -0.24754 Yes 
COX8A 9960 -0.14831 -0.24457 Yes 
COQ3 9989 -0.14946 -0.23997 Yes 
CDKN2C 10015 -0.15083 -0.23505 Yes 
COL4A1 10108 -0.15451 -0.23555 Yes 
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PGM1 10175 -0.15761 -0.23374 Yes 
CMBL 10216 -0.15945 -0.22967 Yes 
IMMT 10248 -0.16064 -0.2248 Yes 
SOWAHC 10330 -0.16528 -0.22389 Yes 
ANGPT1 10337 -0.16542 -0.2167 Yes 
SLC27A1 10339 -0.1656 -0.2091 Yes 
IFNGR1 10342 -0.16569 -0.20157 Yes 
PQLC3 10547 -0.17527 -0.21046 Yes 
NDUFS3 10561 -0.17596 -0.20337 Yes 
EPHX2 10574 -0.17646 -0.19617 Yes 
NKIRAS1 10604 -0.17826 -0.19031 Yes 
CMPK1 10899 -0.19555 -0.20578 Yes 
HIBCH 11003 -0.20221 -0.20498 Yes 
LAMA4 11048 -0.20559 -0.19911 Yes 
SCP2 11101 -0.20959 -0.19371 Yes 
GPHN 11117 -0.21071 -0.18518 Yes 
ACADL 11132 -0.21256 -0.17647 Yes 
SDHC 11138 -0.21285 -0.167 Yes 
CAT 11187 -0.21618 -0.16097 Yes 
UQCR10 11267 -0.22253 -0.15723 Yes 
NDUFAB1 11347 -0.23029 -0.15313 Yes 
MRPL15 11378 -0.23229 -0.14484 Yes 
FABP4 11401 -0.23414 -0.13581 Yes 
COX7B 11446 -0.23795 -0.12843 Yes 
CRAT 11468 -0.24093 -0.11899 Yes 
HADH 11469 -0.24138 -0.10778 Yes 
ADIPOQ 11642 -0.26048 -0.11004 Yes 
MGST3 11670 -0.2645 -0.10001 Yes 
BCL6 11689 -0.26717 -0.0891 Yes 
ARAF 11741 -0.27602 -0.08054 Yes 
COQ5 11752 -0.27774 -0.06847 Yes 
ELMOD3 11761 -0.27928 -0.05617 Yes 
SDHB 11865 -0.29521 -0.05106 Yes 
PPARG 11921 -0.30739 -0.04137 Yes 
ATL2 11945 -0.31411 -0.0287 Yes 
DNAJB9 11960 -0.31827 -0.01509 Yes 
GPD2 11974 -0.32283 -0.00118 Yes 













HSD17B11 101 0.297262 0.023973 No 
ABCB4 980 0.16753 -0.03048 No 
SLC25A17 1375 0.13915 -0.04795 No 
MLYCD 1651 0.122937 -0.05734 No 
SLC23A2 1886 0.11036 -0.0647 No 
VPS4B 2041 0.103112 -0.06624 No 
ACSL5 2308 0.090852 -0.07837 No 
ATXN1 2638 0.076581 -0.09727 No 
PRDX5 2789 0.070637 -0.102 No 
DHRS3 3176 0.055714 -0.12789 No 
SOD2 3488 0.044359 -0.14881 No 
RDH11 3587 0.040577 -0.1525 No 
CNBP 3643 0.038375 -0.15288 No 
EHHADH 4026 0.025569 -0.18172 No 
ACOX1 4223 0.020022 -0.19576 No 
BCL10 4294 0.017611 -0.19964 No 
GSTK1 4358 0.015669 -0.20315 No 
CADM1 4473 0.012234 -0.21126 No 
IDH2 4638 0.007704 -0.22399 No 
ABCB1 4667 0.006412 -0.22561 No 
PEX11B 4680 0.006116 -0.22594 No 
PEX14 4701 0.005434 -0.22701 No 
SMARCC1 4779 0.002923 -0.23306 No 
PEX5 5206 -0.00938 -0.2673 No 
CTPS1 5651 -0.0215 -0.30171 No 
MVP 5681 -0.02251 -0.30166 No 
SLC25A4 5810 -0.02544 -0.30949 No 
HMGCL 5866 -0.02693 -0.31111 No 
SIAH1 6199 -0.0359 -0.33469 No 
LONP2 6528 -0.04462 -0.35698 No 
ERCC1 6562 -0.0455 -0.35476 No 
CLN8 6631 -0.04729 -0.35525 No 
DLG4 6655 -0.04783 -0.35195 No 
ACAA1 6885 -0.0539 -0.36504 No 
FIS1 6900 -0.05433 -0.36029 No 
PABPC1 7179 -0.06185 -0.37657 No 
STS 7270 -0.06404 -0.37706 No 
NUDT19 7298 -0.06485 -0.37224 No 
TSPO 7461 -0.06905 -0.37814 No 
FADS1 7480 -0.06951 -0.37207 No 
PEX11A 7625 -0.07246 -0.3761 No 
PEX13 7627 -0.07253 -0.3683 No 
HSD17B4 7681 -0.07408 -0.36462 No 
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PEX6 7950 -0.08128 -0.37797 No 
HSD3B7 8102 -0.08552 -0.38116 No 
RETSAT 8138 -0.0864 -0.37466 No 
ECH1 8438 -0.09595 -0.38897 Yes 
ISOC1 8469 -0.09718 -0.38089 Yes 
SOD1 8574 -0.09991 -0.37863 Yes 
HRAS 8673 -0.1032 -0.37551 Yes 
ACSL4 8920 -0.11069 -0.38384 Yes 
IDH1 8960 -0.11195 -0.37489 Yes 
YWHAH 9114 -0.11707 -0.37482 Yes 
ALDH9A1 9179 -0.1189 -0.36718 Yes 
DHCR24 9250 -0.12144 -0.35977 Yes 
TOP2A 9281 -0.12259 -0.34891 Yes 
ACSL1 9394 -0.12655 -0.34442 Yes 
ITGB1BP1 9667 -0.13667 -0.35207 Yes 
ALDH1A1 9892 -0.146 -0.35473 Yes 
CLN6 9985 -0.1493 -0.3461 Yes 
ELOVL5 10099 -0.15398 -0.33871 Yes 
SLC35B2 10126 -0.15532 -0.32397 Yes 
IDI1 10529 -0.17442 -0.33827 Yes 
EPHX2 10574 -0.17646 -0.32272 Yes 
ERCC3 10640 -0.18019 -0.3085 Yes 
GNPAT 10643 -0.18039 -0.28904 Yes 
ABCD2 10694 -0.18305 -0.27327 Yes 
ECI2 10905 -0.19581 -0.26935 Yes 
SCP2 11101 -0.20959 -0.26269 Yes 
SEMA3C 11123 -0.2116 -0.24142 Yes 
PEX2 11158 -0.21453 -0.2209 Yes 
CAT 11187 -0.21618 -0.1997 Yes 
CRABP2 11230 -0.21939 -0.17932 Yes 
CRAT 11468 -0.24093 -0.17273 Yes 
MSH2 11633 -0.2585 -0.15818 Yes 
CDK7 11648 -0.26134 -0.13092 Yes 
PRDX1 11779 -0.28133 -0.11108 Yes 
ABCD3 11796 -0.28401 -0.08151 Yes 
IDE 11811 -0.28608 -0.05155 Yes 
CTBP1 11956 -0.31685 -0.02901 Yes 
ABCC5 12134 -0.42269 0.002317 Yes 
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Appendix D – Adipose Tissue SVC Isolation for Flow Cytometry and Flow Analysis 
 
Note: Processing notes for human subcutaneous adipose tissue collected by aspiration 
 
Reagents  
Gibco Collagenase II, 15 mg/g tissue 
HBSS+Ca/Mg 
Buffer:  0.5% BSA/HBSS+Ca/Mg, 1-2 x 0.5 L (“FACS buffer”) 
RBC lysis buffer: 155mM NH4Cl, 10mM KHCO3, 1mM EDTA 
(82.9 g Ammonium Chloride + 10.0g Potassium Bicarbonate + 0.37g EDTA, QS 1 liter with 
sterile water; pH will be 7.3, no need to testà dilute to 1x with sterile water on experiment day, 





50 ml conical tubes 
100 um cell strainers  
Transfer pipettes 





RBC Lysis Recipe from O’Rourke Lab 
 
Trial Day Prep  
1. Perform all steps handling human tissue or cells in biosafety cabinet with BSL2 
practice 
2. Prep all reagents in sterile hood for FACS 
3. First thing in AM 
a. Take 1X RBC lysis buffer to room temp 
b. Make 2X (6 mg/mL) collagenase solution in 0.5% BSA/HBSS and 
pre-warm at 37C 
i. 60mg/10mL for 2g sample; tweak volume from there and adjust to 6 
mg/mL 
ii. Pre-warm equal volume of buffer to 37C 




*Time of mincing is important, 8-10’ rapid mincing for every 10g tissue is recommended, and no 
more than 20’ total mincing time to retain viability of cells. Process in parallel if possible, with 1 




1. Tissue collected straight into ~10mL FACS buffer on ice (after cleaning in saline) 
2. Weigh desired tissue amount (protocol tailored for 2g; 20g yields 1-20E6 cells) 
a. To weigh, waste infranatant with glass pipette and tip fat into 
weigh boat; if bloody sample, can rinse with PBS a few times in tube and gently 
rock by hand; can pick out visible clots from weigh boat 
3. Mince pieces > ~3mm3 with scissors quickly if needed (in weigh boat) 
4. Divide into 50 ml conicals (2g/tube) with 10mL FACS buffer per tube 
5. Add 10 ml pre-warmed 6 mg/mL collagenase solution per tube for final 
concentration of 3 mg/mL 
6. Digest 30-45’ on rocker at 37C, shaking by hand every 5-7’ (tubes in box or tip 
box lids to contain leakage) 
a. Visually inspect tubes, solution should be cloudy, and if many 
pieces still visible digest max 10’ more 
7. During digest, prepare cell strainers 
a. Uncap new 50 ml conicals, one for every digest tube  
b. Pre-wet 100 um cell strainers by laying them in 50 ml conical caps, 
then adding and removing about 10 ml buffer 
c. Place strainers in the 50 ml conicals 
8. Use transfer pipettes to collect pink aqueous layer under lipids and dispense over 
100 um strainers into the conicals, then add lipid layer to avoid clogging filter 
(alternatively, pour) 
a. Gelatinous, fibrous aggregations are common, gently scrape the 
strainer surface with the transfer pipettes if needed 
9. Wash buffer over strainer, bringing volume to 40 ml 
10. Spin 300 x g for 7’ at 4C (updated by L.G. 7-14-17 - slower and shorter spin than 
previous protocol yields more cells) 
11. Aspirate adipocyte layer and supernatant, pouring buffer away from pellet during 
aspiration (use aspirator and glass pipet and can smoothly aspirate, tilting tube to parallel 
with ground as approaching pellet to collect all supernatant in lip at ~5mL mark) 
12. Incubate in 3mL RBC lysis buffer for 6’ at RT (pipet-mix). 
13. If working with multiple 2g samples, transfer to new 50 ml conicals, pooling 
every 10 old tubes into 4 new (or 15 -> 6); working from aspirate, can pool all 2g 
samples together but usually only yield one 2g sample. Dilute lysis solution with buffer 
to 45 ml mark. 
14. Spin 300 x g for 7’ at 4C 
15. Aspirate supernatant, pouring buffer away from pellet during aspiration (same 
technique); resuspend pellet in ~300-1000mL (depending on estimated cell yield) HBSS 
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without BSA if using a live/dead fixable stain and/or Arc reactive compensation 
beads because BSA interferes with the stain, measure final volume with pipette 
16. Keep sample on ice in hood until use 
17. Note: for rodent samples (with greater yield), there is an additional wash step 
through 70um filter + spin at 300G for 5 min (4C) at this stage; this reduces yield and is 
not usually recommended with human samples 
18. Mix well and take 10 ul for counting, typical dilution is 10uL SVF prep with 
20uL trypan blue (incorporate this e.g. 2-fold dilution into hemocytometer calculation). 
To minimize bias from chunks of cells, mix e.g. 10uL Trypan with 10uL cell solution; 
draw up 10uL and set aside inside wall of Trypan tube (chunks usually in first 
aspiration); take remaining 10uL for hemocytometer. 
19. Count w/ hemocytometer, live & total in 4 quadrants (count both round and 
irregularly shaped white or off-white/lighter blue cells; dead cells will appear very 
dark; RBC are noticeably smaller than SVC; exclude via a consistent size cut-off (by 
eye)) 
#cells/mL = average of 4 quadrants·trypan dilution factor·hemocytometer factor 10^4 
 
Flow staining SVCs 
1. Thaw any antibodies in DMSO in advance 
2. Label 5mL round-bottomed tubes for all controls and samples (unstained control, single 
stained controls, FMO’s, full stain) 
3. Keep samples on ice in hood when required 
4. Divide 0.2E6 - 0.4E6 cells into control FACS tubes, divide remainder into sample FACS 
tubes: 0.4E6 - 6E6 cells per tube 
a. Can aliquot full stain sample and then volume up remaining sample with ice-cold 
PBS to dispense even amounts to control tubes (using one draw from serological) 
b. Can get away with 0.1E6 cells in unstained control 
5. Volume all tubes to ~3mL; not to wash sample but to facilitate decanting after wash (this 
step is actually concentrating samples) 
6. Spin 400 x g for 7’ at 4C (with caps since human samples) 
7. Decant supe by pouring 2 samples at a time: past 90 degrees, and firmly shake one time 
(pellet sticks well but will loose upon backwashing supernatant, so do not re-invert after 
decanting). Volume tubes to 200uL (shoot into each tube with P200) and resuspend 
pellets by flicking/roughing along flow tube rack 
8. Add FC block to sample tubes (full stain and FMO’s) 
9. Pipet-mix in single/control stains first, then FMOs, then full stain for samples (see tables) 
10. Stain 30’ at 4C protected from light (wrap tube rack in foil and keep in fridge) 
11. Wash:  add 3 ml buffer, spin 400 x g for 7’ at 4C, decant, and resuspend pellets in 500uL 
for Fortessa (or decant and volume to 200uL for fixing per below) 
12. Fix if not sorting, by adding 100 ul 0.1% PFA to the vol after decanting, pulse vortex, 
and leave it in the sample until cytometer day 
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** FMO = “Fluorescence Minus One,” all stains are added except for the one listed 
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Flow Cytometry Analyzer Operation 
 
Software Operation: LSR Fortessa 
Sample Prep: Cells stained/fixed and resuspend cells in 300ul of FACS buffer, stored dark at 4C.  
Final volume can be adjusted before running on the cytometer:  
a. If using a FACS Canto, 200ul is more appropriate. 
b. I volume up to 500uL day of running on the Fortessa to give myself more wiggle 
room 
 
Bring to Core: Protocol, color names for filter sets, flash drive, size M gloves, lab coat, samples 
(with foil cover in styrofoam box) 
 
If First in AM:  
1. Empty waste (with bleach) 
2. Check that sheath fluid is full (add 1X if needed – can dilute from 10X in cabinet if 
needed) 
3. Turn on main power (2xgreen lights – instructions on the cytometer) 
4. Log on to computer (password = flowlab; software = BD FACS Diva; no password – at 
popup, hit DetailsàUse CST Settings) 
 
BD FACS Diva Software Set-up 
 
1. Go to Horowitz folder à  Experiment à  New Experiment 
a. Experiment templates pop up, select (General à blank experiment with sample 
tube, or choose an existing experiment from template) 
b. Name according to archiving system (F1JHFEB1418 for Fortessa1, PI initials, 
date), and change to 5 log decades 
2. Create experiment groups 
Notes: Lindsey creates 2 groups here upon running for samples and controls. I have so far 
not separated tubes upon running. 
a. Select “Experiment” from tool bar à New Specimen 
b. Label tubes; F1JH021418_001, etc. 
c. Activate the Inspector window (click the green box to the left of the tube setup) 
d. Set up the parameters you will be using: 
i. Select FSC: (A(rea), H(eight), and W(idth)). FSC and SSC should be 
linear scale, not log scale! 
ii. Delete colors not being used in your panel 
iii. Label each color with its corresponding antigen (CD45, etc.) – use filter 
set list, or BD spectra viewer. 
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Note: could remove height information if this isn’t used in analyses to reduce the number of 
options for axes and the size of data files. 
3. Set up a global worksheet gating on cell populations of interest – note: plots on white 
space are recorded; plots on grey area are play space – see Flow Study plot setup. Create 
anticipated scatter gate at this time. 
4. Run unstained sample to adjust voltages (steps below still occurring in Parameters tab 
in Inspector window): 
a. Set up FSC-A by count and SSC-A by count (mountain plots) in play area to look 
at alongside first scatter plot while adjusting FSC and SSC voltages to pull 
majority of cells into preemptive scatter gate (the only gate drawn in advance of 
running any samples; upon setting up the global workspace above) 
Any time you add a tube: vortex your tube, flip the arm to the left while holding on to the 
existing tube (usually diH2O, but you can switch directly between samples if you don’t need 
time to make adjustments in between), remove the existing tube, replace with your tube of 
interest, and slide the arm back to hold your tube of interest in place. Note: for Fortessa, a 
decent bit of sample is sucked up right away, so you want to acquire/record quickly after 
tube is replaced provided you are running the sample throughout (we are usually running 
sample or water, unless the instrument is in turned in to Standby if e.g. you are pausing within a 
particular sample; common with unstained – acquire, adjust voltages, acquire again) 
b. Add unstained sampleàhit Acquire and run on LOW (at least to start, until you 
get a feel for how much sample/cells you have 
c. Gate off debris – on scatter plot in global worksheet (goal is to have most cells 
fall in the gate and exclude the small population of debris near the origin as well 
as some debris typically with very low FSC-A and very high SSC-A). This first 
adjustment may require large voltage changes! E.g. Cara typically sets voltages 
for adipose tissue FCS at 150 and SSC 210. Can also look at count plots to the 
right (play area) 
d. Pay attention to sample yield during this time - if it is low, you can record a 
population of cells after gating off scatter and can create doublets gates on 
this population to give yourself more time to play with gates while machine is 
not recording (and importantly is in standby to preserve unstained sample - 
always want to save some for later in case you need to come back to 
unstained sample) If sample yield is not limiting, keep acquiring unstained 
sample and go through subsequent steps: 
e. Gate off both doublet discriminators: 
i. Draw gate on FSC-A by FSC-H off of scatter gate (P1) by right clicking 
inside of the new graphàGo to Populationàselect P1; this is P2 
ii. Draw second doublet discriminator gate on SSC-A by SSC-H off of P2 
and call this gate P3 
iii. Set up all subsequent graphs to be presented on P3 even before adjusting 
voltages or set up a live cell gate (P4) if doable (it looked tricky during our 
run). Could then collect 100k cells on live cell gate rather than 200k cells 
on singlets. 
f. Adjust voltages for individual fluorophores using this unstained sample: 
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i. Prepare mountain plot for first two fluorophores (fluorophore by count) 
and be ready to cycle through samples;  can present plots as red dots on 
black background to help with visibility 
ii. For each fluorophore, quickly adjust voltage so that the peak of the 
unstained population is around 10^2 and trailed off by 10^3 (prioritize the 
latter if). 
5. Area Scaling - now go through all channels (FSC, SSC, all colors) and perform area 
scaling using each single stain control one by one. The goal here is to make sure voltage 
peaks are aligned for area and height for each channel. E.g. set up 2 mountain plots x 
count to display area (e.g. FSC-A on the x-axis on the one graph vertically centered 
above the other and FSC-H on the x-axis, centered below) - These are obviously the 
same channel because this is what we are trying to scale - the area for one channel 
with its height - will do this for all channels - steps: 
a. If the peak is right at the far right/end of the x-axis, bump down voltage (normal 
voltage adjustment, same as above - one adjustment per channel) 
b. If the two peaks are not centered over each other, in the laser tab (of the same 
window - the Parameter window - where voltage adjustments are being made), 
adjust the area scaling. This means adjust the number for whatever laser of 
interest to be lower if the area peak is to the right of the height peak (i.e. if it is 
higher, scale the laser lower). For the size lasers, the adjustment is in the drop 
down box below the table with the settings for all 4 excitation lasers where I will 
make the adjustments for colors. Note - I went through all single stain controls. 
Sometimes, I did not need to scale the excitation laser until the third fluorophore 
on that excitation laser  
6. Voltage Adjustments on FMOs - two primary goals: 
a. Bring down voltage if an FMO has really high signal for the protein that is not 
supposed to be present (so there is actual space on the graph for the positive 
population to be gated); 
b. Adjust any voltages that have signal way against the axes 
 
NOTE: DO NOT ADJUST VOLTAGES AFTER THIS STEP OR YOU WILL HAVE TO 
RERUN ALL SUBSEQUENT STEPS (COMPENSATION CONTROLS AND SAMPLES) 
WITH THESE ADJUSTED VOLTAGE SETTINGS 
 
Make sure the sample doesn’t have a plus sign next to the radio button. This will ensure that 
settings are kept constant for remaining samples (mostly relevant if compensating on the 
cytometer). For additional samples select “Next Tube”. 
7. Run all samples! Unstained, single stain controls, FMOs, sample tubes. Set up the 
Acquisition dashboard: 
Note: a threshold rate above 12k is high! Lower the run speed if this happens. 10-12k is still 
high, but not concerning. 
a. Storage gateàCollect all events 
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b. Stopping gateà P3: Collect 100 000 events on live cells (can set options that 
aren’t displayed in the drop down menu by typing), medium rate 
i. Don’t need as many cells in unstained control tube (10-20k should suffice) 
or in single stain control tubes - especially if using beads, which will be 
very bright (I collected 2k because had super low numbers because I 
didn’t sufficiently vortex beads - again 10k would probably be sufficient) 
ii. Ideally want a similar number of cells in FMO as full stain tubes for ease 
of comparing between plots and having same amount of background/etc. 
100-150k is a decent comparison to 200k. 200k would be the best if time 
is not an issue! 
c. Events to displayà5000 events 
8. After data is recorded, click on the experiment in the left panel dashboardà right click 
à Export à FCS files 
a. FCS3.1 file version, BD export/FCS à Save) 
b. Right click à close experiment 
c. Look for FCS files in the desktop FCS shortcut folder 
Can also save an experiment template and open this at the start of the next data collection for the 
same experiment (will be found in Horowitz folder under New Experiment 
If Last in PM: Follow the shutdown instructions clearly written on the cytometer (20-30 min) 
LSR Fortessa Panel for Exercise Study 
        Protein Excitation Laser: 488nm 
 




Protein Color Excitation Emission 
CD3 FITC 530/30 
 
L/D L/D yellow 405 540/30 
CD34 PerCPcy5.5 710/50 
 
CD45 e450 405 450/50 
    
CD64 APC 640 670/14 
 
Excitation Laser: 640nm 
 




CD34 PerCPcy5.5 488 710/50 
CD64 APC 670/14 
 
CD31 APCcy7 640 780/60 
CD31 APCcy7 780/60 
 
CD29 PE 561 586/15 
    
CD3 FITC 488 530/30 
 
Excitation Laser: 405nm 
 
CD206 BV650 405 670/30 
 
Color Filter 
     L/D L/D yellow 540/30 
     CD45 e450 450/50 
     CD16 BV 670/30 
     
        
 
Excitation Laser: 561nm 
     
 
Color Filter 
     CD29 PE 586/15 
     CD11c PEcy7 780/60 
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Appendix E – Adipose Tissue Cell Separation Protocol to Recover SVF and Adipocytes 
 
Prep fresh in AM: 
• Thaw Protease/Phosphatase Inhibitor Cocktails, HI-FBS (2 1mL aliquots) 
• Make up 2% FBS/PBS (1mL FBS in 49mL PBS) 
• Make up collagenase and warm 
 
A. Adipose Tissue Digestion 
1. Collect ~2g aspirate into cold PBS in 15mL conical tube and store on ice until processing 
2. Mince large pieces (>3mm3) with scissors 
3. Incubate tissue in 2 mg/mL Collagenase Type 2 in HBSS, rocking gently @ 37°C for 30-
50 min as needed (check for consistent slurry and don’t over-digest) 
NOTE: for Pre and Post samples, mix collagenase uniformly and distribute into 2 sample tubes - 
pre-warm before digestion 
4. Strain digested tissue through 300 µm nylon mesh (affixed with rubber band to end of cut 
10 mL syringe) in 50 mL conical tube – rinse mesh with 5 mL PBS. 
5. Float adipocytes (5-10 min) 
6. Carefully remove infranatant with glass pipette (try not to disturb floating adipocytes) 
into new 50 mL conical tube through a 70 µm cell strainer and rinse with FBS/PBS à 
SVF isolation; remaining adipocytes à MA isolation; in parallel. 
 
B. Mature Adipocyte Isolation 
1. Wash adipocytes by gently adding ~2 ml FBS/PBS Bx with a transfer pipette and gently 
mixing. 
2. Transfer adipocytes and Bx to a 3ml Falcon tube 
3. Float adipocytes and then carefully remove infranatant with a glass pipette and discard. 
4. Repeat washing step twice, for a total of 3 washes. 
5. Storage: 
• 200uL MA in 1mL RNA-stat 60 - incubate @ RT for 10 minute, vortexing occasionally. 
Store @ -80°C. 
• If more MA available: 200uL MA in 250uL fat cake lysis buffer (add PICs); or if more 
remaining, lyse 250-350uL in 500uL buffer; vortex well and store @ -80°C. 
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C. SVF Isolation 
1. Move SVF mixture (after filtering through 70 µm cell strainer) into a clean 15 mL tube 
2. Centrifuge @ 500xg, RT, for 7 minutes. Remove any remaining adipocytes or free lipid 
along with supernatant 
3. Add 2 mL RBC lysis Bx, mix by pipetting, and incubate 5 min @ RT. Deactivate RBC 
lysis Bx with FBS/PBS. 
4. Centrifuge @ 500xg, RT, for 7 minutes. Remove supernatant. 
5. Resuspend pellet in FBS/PBS and move to polystyrene tube. Centrifuge @ 500xg, RT, 
for 7 minutes. Remove supernatant. (first wash) 
6. Wash pellet two more times in in FBS/PBS (three washes total) 
a. Resuspend pellet in 1mL and take 10uL after second wash to plate in 10mL 
growth media in round dish if plating; volume up to 2mL and complete third wash 
7. Resuspend pellet in 100uL FBS/PBS and label CD14+ 
8. Pipet-mix 10uL of Human CD14+ Selection Cocktail into SVF and incubate for 15 min 
on bench (cap on) 
9. Pipet-mix 5uL CD14+ Magnetic Nanopartcles (mix well before use!) and incubate for 10 
min on bench (cap on) 
10. Volume sample to 3 mL and incubate in EasySep magnet for 5 min on bench (cap off) 
11. In one movement, pick up magnet with tube and pour contents into a 5 mL tube labeled 
CD14+ 
a. Add this tube to the magnet and incubate again for 5 min on bench (cap off); for 
second collection of CD14+ cells that may have been lost in first pour 
b. Volume first CD14+ selected tube back to 3mL 
12. In one movement, pick up magnet with tube and pour contents into a 5 mL tube labeled 
CD14-; this is the final CD14– fraction 
a. Combine two CD14+ tubes into one 
b. There should now be one each of a CD14– and CD14+ tube 
13. Pipet-mix both samples and centrifuge @ 500xg, RT, for 7 minutes. 
14. Remove supernatant, resuspend pellets in 1mL RNA-Stat60 and transfer to 1.5mL 
eppendorf tubes. Vortex. Let tubes sit on bench for 5-10 min vortexing occasionally. 
Store at -80C. 
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Appendix F – RNA Isolation for qPCR 
 
RNA Isolation from Whole Adipose Tissue 
Note: this is the non-column isolation procedure used for Study 3. Modifications for RNA 
sequencing are shown in Appendix B. 
1. Clean all supplies, gloves, and bench top with RNAse-away (repeat as needed throughout 
procedureàessential for RNA purity and yield) 
2. Cool centrifuge and tissue lyser units to 4C 
3. Chip 40-60mg adipose tissue using clean scalpel in mortar with liquid nitrogen (blood 
contamination becomes a problem with larger pieces) 
4. Store samples in eppendorf tubes on dry ice until immediately before lysing in Cartee lab 
tissue lyser 
5. Prep 2mL heavy-duty round-bottom eppendorf tubes with 2 steel ball bearings (RNAse-
cleaned) and 1mL RNA-Stat 60 on RNAse-cleaned ice bucket 
6. Add samples to RNA-Stat 60 quickly and lyse 60 seconds (max speed) on Cartee lab 
tissue lyseràcheck for homogenous slurryàrepeat for 30-60 seconds as needed until 
sample is homogenous 
7. Spin samples at 12 000G, 10 min, 4C to separate fat to top 
8. Carefully waste top fat layer if too thick to access infranatant without contamination 
9. Transfer infranatant (avoiding pelleted waste) into new 1.5mL eppendorf, entering 
through middle of sample to avoid lipid contamination 
10. Add 200uL chloroform per 1mL RNA-Stat (starting volume), invert to mix, incubate 
5min at room temp, spin at 12 000G, 15 min, 4Càthis yields RNA fraction in clear top 
layer; be careful not to disturb 
11. Carefully move upper phase only into new 1.5mL eppendorf tube (leave bottom ~1/3 of 
this layer to avoid protein and DNA contamination) 
12. Add 0.5mL 2-propanol (GC grade), invert to mix, incubate 10min at room temp (or 
20min to overnight at -20C; however, longer incubation may trade-off yield) 
13. Pellet by centrifugation at 12 000G, 20 min, 4C 
14. Pour off supernatant (invert tube and shake firmly one time – pellet sticks well) and wash 
pellet with 1mL 75% ethanol (mixed with RNAse-free H2O); vortex pellet each time to 
clean, and spin at 7500G, 5 min, 4C – 3 total washes 
15. Pour off supernatant and remove residual with P200; let pellet dry (in chemical fume 
hood for air circulation) 10-15 min (careful not to over-dry) 
16. Resuspend pellet in 25uL RNAse-free H2O, mixing vigorously 
17. Spec concentration with nanodrop immediately before RT 
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RNA Isolation from Mature Adipocytes 
Notes: samples collected directly into RNA-Stat 60. Procedure is identical except mechanical 
homogenization not required and lipid layer may be thicker; careful to avoid contamination of 
sample (step 8 above is particularly important) 
RNA Isolation from SVF 
Notes: samples collected directly into RNA-State 60. Procedure is identical except mechanical 
homogenization is not required and centrifugation to remove lipid layer is not required. 
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Appendix G – Protein Isolation and Western Blotting 
 
SML Adipose Tissue Homogenization Protocol: 
 
1. Cool tissue lyser blocks in freezer 
2. Prep 2.0mL round-bottom Eppendorf tubes with steel ball bearing and 1.0mL ice-cold 
lysis buffer 
3. Add 125-150mg adipose tissue to each tube (keep on ice) 
4. Place samples in tissue lyser blocks (cold) and run at max for ~30sec to homogenize 
(confirm slurry) 
5. Solubilize samples by placing in rotary wheel at 4˚C for 1 hour at 50rpm 
6. Centrifuge samples for 15 min at 15 000G, 4˚C 
7. Transfer supernatant to new tubes 
8. Repeat steps 6 & 7 as necessary until all excess fat & debris clear (may take 4-5 spins) 
9. Freeze lysates in -80˚C until BCA analysis 
 
SML Tissue Lysis Buffer for Adipose Tissue: 
**NOTE: This can be stored as “stock” buffer. Only add protease and phosphatase inhibitors 
to amount needed for samples when ready to use. DO NOT add inhibitors to entire stock of 
buffer.** 
 
50mM Tris-HCl pH=7.4 
1mM EDTA 
0.5% SDS 
0.01% Triton X-100 
 
Directions to make stock: 
1. Add Tris base to water 
2. pH to 7.4 
3. add appropriate amount of EDTA, SDS, and Triton (depends on final volume) 
 
Example for 100ml of stock buffer: 
1. Add 0.605g Tris base to 70ml H2O 
2. pH to 7.4 
3. Add 0.0292g EDTA 
4. Add 0.5g SDS 
5. Add 100ul Triton X-100 
 
When ready to use buffer, aliquot the volume you need and add 1%volume/volume inhibitor 
cocktails 
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1. Clean glass plates with 70% ETOH, rinse with H2O and dry  
2. Place glass plates together (with spacers forming gap between plates) and slip into green 
clamp (large plate behind small plate).   
3. Place grey rubber strip on base of gel casting stand and put green clamp-glass plate combo on 
top of the grey strip. Secure into place with the spring loaded lever on top of the casting stand 
4. Press down firmly on both glass plates and lock plates into place using the levers on the green 
clamp assembly. 
5. Place comb between glass plates.  Mark 1 cm below where teeth are on outside of glass plate. 
Remove comb. 
6. Make separating gel in a 50 ml beaker.  
 
Reagent 7.5% gel 10% gel 15% gel 
30% Acrylamide/ 0.8% Bis 5 ml 7 ml 10 ml 
4X Separating buffer 5 ml 5 ml 5 ml 
dH2O 10 ml 8 ml 5 ml 
10% APS 100 µl 100 µl 100 µl 
Temed 20 µl 20 µl 20 µl 
 
 





Add 10% APS and Temed last and in a relatively rapid sequence.  The solution will begin to gel 
after these agents are added 
 
7. Working quickly, pipette the gel solution between the plates using the automated pipette-man. 
Fill to the mark you made on the outside of the glass (1 cm below the comb)  
8. Add 500 ul of dH2O to help form smooth top surface of gel.  Let sit for 30-45 minutes. 
9. When gel is polymerized, invert apparatus to empty H2O.  Blot with filter paper to remove 
any excess water between the plates.  Be careful not to “rough up” the gel. 
10. Make stacking gel: 
Reagent Volume 
30% Acrylamide/ 0.8% Bis 1.6 ml 
Stacking Buffer 3 ml 
dH2O 7.2 ml 
10% APS 60 µl 
Temed 12 µl 
Add 10% APS and Temed last and in a relatively rapid sequence.  The solution will begin to gel 
after these agents are added 
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12. Working quickly, pipette the gel solution between the plates using the automated pipette-
man, fill close to the top. 




1. Once gel is polymerized, remove the gel and glass plates from casting stand and unlock the 
green clamps 
2. Insert the plates and gel into inner core of “running rig” and lock into place. 
3. Make ~800ml of 1X running buffer 
4. Fill inner core with running buffer.  Fill outer chamber with running buffer until glass plates 
are nearly submerged. 
5. CAREFULLY remove comb from the gel 
6. Blow out wells to eliminate air bubbles. 
7. Load samples per antibody protocol 
8. Place lid on running rig and set power-pac to 200 volts for ~45 min for cells; 100 volts for ~2 
hours for adipose tissue. 
9. When loading dye front gets the bottom of the plate, turn off power. 
 
Setting up Transfer sandwich: 
 
A. Before gel is done running, get 3 Pyrex dishes and fill with cold transfer buffer. 
B. Put 2 filter papers and 2 fiber pads per gel in one dish.  Ensure that they are soaking in the 
buffer 
C. Cut membrane to proper size and place it in another Pyrex dish to soak in transfer buffer (5-10 
min) 
D. After gel is complete, remove glass plates and gel from rig.  Carefully separate glass plates 
and cut off stacking gel with green tool or razor. 
E. Put glass plate/gel into transfer buffer and carefully nudge gel off plate with spatula.   
F. Soak gel in transfer buffer for 5-10 minutes. 
G. Open transfer sandwich assembly and place things on it in the following order in this order:  
- fiber pad 
- filter paper 
- gel 
- nitrocellulose membrane  
- filter paper 
- fiber pad.   
Make sure to roll out bubbles after each item (use test tube to help roll out bubbles). 
H. Close the transfer assembly sandwich and slide into transfer chamber (Black to back). 
I. Put in frozen block.  
J. Fill chamber half-way with transfer buffer.  Fill middle chamber all the way. (Get bubbles out 
of chamber by tilting) 




Washes and Detection: 
 
1. Take apart membrane assembly.  Put membrane in clean container. 
2. Rinse membrane with dH2O. 
3. To assess quality of gel, pour small amount of ponceau S stain on gel (Ponceau S can be 
reused, so pour it back into storage vial/tube).  After examining general gel quality, rinse with 
dH2O to remove excess Ponceau S and Rinse with TBS-T. Perform Memcode total protein stain 
at this stage if required. 
4. Block with 50 ml for 1 hr on rocker (gentle swirl).  (Blocking solution: 50 ml TBS-T + 5g dry 
milk or BSA) 
5. Add primary antibody and incubate overnight at 4C on rocker. (POUR ANTIBODY BACK!) 
6. Wash in TBS-T (1 x 15 min and 2 x 5 min) on rocker 
7. Add secondary antibody and incubate for 1 hour on rocker.  (1:3000 in TBS-T)  
8. Wash in TBS-T (1x 15 min and 2 x 5 min) on rocker. 
9. For ECL detection…  Aliquot 3 mls of Reagent A and then 3 mls of Reagent B into tube. 
Invert to mix and pipette onto blot (ensure entire blot is covered.  Incubate for 5 minutes.   
10. Lift membrane up to pour off the ECL solution and remove excess ECL with Kim wipe. 
11. Cover membrane with saran wrap.   




Separating Gel Bx (for 150 mL): 
1.5M Tris base (27.23 g) 
pH to 8.8  with 6N HCl 
store at 4C 
 
Stacking Gel Bx (for 100 mL): 
0.5M Tris base 6 g) 
pH to 6.8 with 6N HCl 
store at 4C 
 
10X Running Bx (for 1L) 
0.25M Tris base (30.3 g) 
1.92M glycine (144 g) 
1% SDS (10g) 
 
10X Transfer Bx (for 1L) 
0.25M Tris base (30.3 g) 
1.92M glycine (144 g) 
 
To make 2L of 1X Transfer Bx:  
400 mL methanol 
200 mL 10X Transfer Bx 
1400 mL dH2O 
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10X TBS (for 1L) 
200mM Tris base (24 g) 
1.5 M NaCl (88 g) 
 
Dissolve in 900 mL dH2O 
pH to 7.6 with 12N HCl 
Add dH2O to final volume of 1 L 
 
TBST (for 1 L) 
100 mL 10X TBS 
900 mL dH2O 
1 mL Tween 20 
 
